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1 Introduction 
 
1.1 Synaptic plasticity  
The communication between an axon of one neuron and a dendrite of another neuron is 
mediated by so-called synapses whose strength can be either increased or decreased. This 
phenomenon is widely known as synaptic plasticity. Synaptic plasticity in the adult central 
nervous system (CNS) is best studied in the rodent hippocampus in situ. The hippocampus is 
essential for memory formation and its anatomy is suitable for electrophysiological 
investigations. A total of three pathways were proposed (Figure 1) for synaptic plasticity in 
the rodent hippocampus in situ (Kandel et al., 2000):  
 
i) Perforant pathway, in which the axons from the cortex surrounding the 
hippocampus (entorhinal cortex) form synapses onto the dendrites of granule cells.  
ii) Mossy fibre pathway, in which the synapses are formed onto the dendrites of 
CA3 pyramidal neurons by the axons of dentate granule cells. 
iii) Schaffer collateral pathway, in which the synapses are formed onto the dendrites 
of CA1 neurons by the axons of CA3 neurons.  
 
 
Figure 1: An experimental model to study activity-dependent synaptic plasticity in the rodent hippocampus. 
Three pathways, namely, perforant, mossy fibre and schaffer collateral pathways are described. The figure was 
adapted from Kandel et al., (2000).   
 
Synaptic plasticity is thought to be the cellular basis for learning and memory. Changes in 
synaptic plasticity are described as long term potentiation (LTP) and long term depression 
(LTD) in vertebrates and long term facilitation (LTF) in invertebrates (Kandel, 2001; Malenka 
and Bear, 2004). LTP comprises two phases: i) an early phase (E-LTP, lasts for minutes to 
hours) which is protein-synthesis independent, and ii) a late phase (L-LTP, lasts for hours to 
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days) which is dependent on protein synthesis (Bramham and Wells, 2007). The synthesis of 
new proteins is important in order to convert the short term memory into long term memory. 
Both the long-lasting forms of synaptic plasticity and memory require protein synthesis 
(Kandel, 2001). Single high-frequency stimulation such as tetanus to any of the three 
pathways can increase the excitatory post synaptic potentials (EPSPs), this increase is termed 
LTP. Although the mechanism of LTP is not the same in all three pathways described, several 
experimental models exist to study LTP. It can be studied in acute hippocampal slices or in 
cell culture or in the intact animal where LTP can last for days to weeks (Kandel et al., 2000).  
In a typical experiment to study synaptic plasticity in situ, LTP can be induced by stimulating 
hippocampal CA3 neurons by a single tetanic stimulation or repeated trains of stimuli while 
recording the postsynaptic responses from CA1 neurons. The communication at the synapse is 
mediated by neurotransmitter release. Action potentials generated at the axon hillock at the 
soma are propagated to the presynaptic release sites of the axon. At this site, depolarization 
opens voltage-gated Ca
2+
 channels which then lead to fusion of docked vesicles and to the 
release of neurotransmitters. These transmitters diffuse into the synaptic cleft and bind to the 
postsynaptic receptors present in the post synaptic density (PSD) which leads to de- or 
hyperpolarizations of the postsynaptic cell and activation of intracellular signalling pathways. 
The depolarization of membrane makes the synapse excitatory whereas the hyperpolarization 
makes the synapse inhibitory. A number of receptors are present at the postsynaptic site which 
includes two major classes: ionotropic and metabotropic. For the induction of LTP, especially 
two types of ionotropic glutamate receptors such as, NMDA (N-methyl D-aspartate) and 
AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptors are important. In 
the early LTP (E-LTP), the stimulation caused by the high frequency depolarizes the 
membrane and detaches the Mg
2+
 ions that preoccupied and blocked NMDA receptors (Figure 
2). This in turn allows the entry of Ca
2+ 
into the cell which is necessary for the activation of 
various kinases such as Ca
2+
/calmodulin dependent protein kinase (CaMKII), protein kinase C 
(PKC), and tyrosine kinase (Kandel et al., 2000). CaMKII is particularly important as it not 
only enhances the presynaptic release of transmitters by sending a retrograde signal (for 
example, nitric oxide, NO) but also phosphorylates AMPA receptors to increase the synaptic 
response. It also participates in the late phase of LTP, (L-LTP), in which the Ca
2+
 activates 
Ca
2+
/calmodulin which is necessary to activate other kinases such as cyclic adenosine 
monophosphate (cAMP) kinase and adenylyl cyclase. The activated cAMP translocates to the 
nucleus of the cell and initiates transcription followed by protein synthesis (translation) which 
results in formation of new synapses.  
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Figure 2: A schematic representing both early and late phases of LTP. Induction of LTP by single high 
frequency stimulation causes the activation of NMDA receptors thereby allowing Ca2+ to enter the cell. This 
entry of Ca2+ is necessary for the activation of several kinases shown in the schematic. LTP induction by 
repeated stimuli also leads to a persistent increase in intracellular Ca2+ which leads to the activation of adenylyl 
cyclase, which further activates cAMP-dependent protein kinase (cAMP kinase). This cAMP kinase translocates 
to the nucleus and phosphorylates cAMP response binding element (CREB) which in turn initiates the 
transcription of a set of genes. Effectors such as brain derived neurotrophic factor (BDNF), tissue plasminogen 
activator (tPA) and C/EBP beta transcription factor (regulators) are also involved. P = phosphate, PKA = protein 
kinase A, R (AB) = dominant negative PKA. The figure was adapted from Kandel et al., (2000).  
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1.2 Synapse-specific local protein synthesis 
A number of synaptic proteins including receptors and several signalling molecules are 
present at synapses (Harris and Kater, 1994) whose transport and subsequent regulation is 
important for the synaptic strength (Tang and Schuman, 2002). According to an earlier view, 
proteins were thought to be synthesized in the cell body (soma) and then transported to 
dendrites. But, the modern view gave a clue about the dendritic protein synthesis with the 
discovery of a complete protein synthesis machinery (mRNAs, polyribosomes) in dendrites 
(Steward and Levy, 1982). This concept was further supported by the identification of several 
ribosomal proteins, initiation and elongation factors of translation as well as transfer RNAs 
(tRNAs) within the dendritic compartments (Tiedge and Brosius, 1996). Several mRNAs are 
transported and localized in dendrites which include activity-related cytoskeletal protein, Arc 
(Lyford et al., 1995), brain derived neurotrophic factor (BDNF; Tongiorgi et al., 1997), the α-
subunit of CaMKII (Miyashiro et al., 1994), FMR1, the gene encoding FMRP (Antar et al., 
2004), the NR1 subunit of the NMDA receptor (Pal et al., 2003), the α subunit of the glycine 
receptor (Racca et al., 1997), the microtubule associated protein (MAP2; Garner et al., 1988) 
and the tyrosine-related kinase B (TrkB) receptor (Martin and Zukin, 2006). The mRNAs are 
transported to the dendrites as RNA granules with the help of molecular motors such as 
members of the kinesin and dynein super families (Kanai et al., 2004), and RNA binding 
proteins such as Staufen (Kiebler et al., 1999), Zip code binding proteins (ZBP) 1 and 2 
(Tiruchinapalli et al., 2003), cytoplasmic polyadenylation element binding (CPEB) protein 
(Huang et al., 2003), and fragile X mental retardation protein, FMRP (Eberhart et al., 1996).  
 
1.3 Mechanisms of translational regulation  
The functional expression of a gene can be regulated at different levels: transcription, mRNA 
splicing, nuclear mRNA export, mRNA transport and translation. The regulation of 
eukaryotic mRNAs can be modulated by elements present in either the 5’ or the 3’ 
untranslated region (UTR) of the mRNA. The 5’UTR has been reported to control the 
translation at the level of initiation (Pickering and Willis, 2005) whereas the 3’UTR 
contributes to several mechanisms such as mRNA transport, localization, stability and the 
efficiency of translation (Moore, 2005). The 3’UTRs of mRNAs were found to be extremely 
important for the transport of mRNAs to various subcellular compartments as well as in 
modulating their translation (Andreassi and Riccio, 2009). They harbor various cis-elements 
(those which can modulate the expression of its own mRNA), to which specific trans-acting 
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proteins bind and modulate the translation of bound mRNAs. The binding of these proteins 
depends either on sequence specificity or on the secondary structure of an mRNA. These cis-
elements can be present either as a single copy or in multiple copies over the entire length of 
the 3’UTR and can range from few nucleotides to over 1 kb in length (Jambhekar and Derisi, 
2007). In addition, translation can also be regulated by microRNAs (miRNAs), which are 
small non-coding RNAs of ~21 nucleotides in length and have binding sites in the 3’UTRs of 
several mRNAs (Kosik, 2006).  
 
1.3.1 RNA binding proteins  
There are several mechanisms proposed for the regulation of dendritic mRNAs. Increasing 
evidence suggests an important role for the RNA binding proteins in translational regulation. 
The regulation of these dendritic mRNAs by different RNA binding proteins was found to be 
crucial for synaptic plasticity (Kang and Schuman, 1996; Klann and Dever, 2004). Several 
RNA binding proteins were identified which regulate the translation of various proteins. 
Some of them include Staufen, FMRP, ZBP1, ZBP2, and CPEBs.  
 
CPEBs are RNA binding proteins which regulate the translation of mRNAs depending on 
their phosphorylation status. Under basal conditions, CPEB trans-acting proteins bind to 
consensus cytoplasmic polyadenylation elements (CPE) present in the 3’UTR of many 
mRNAs (Mendez and Richter, 2001) and repress their translation. This repression is relieved 
upon phosphorylation of CPEBs which eventually stimulates the polyadenylation and protein 
synthesis of bound mRNAs (Richter, 2007).   
 
1.4 The CPEB family  
CPEB is a sequence-specific RNA binding protein which binds to the consensus CPE 
(UUUUUAU) present in the 3’UTR of many mRNAs (Mendez and Richter, 2001), usually in 
the vicinity of 100-300 bases from the polyadenylation sequence AAUAAA (McGrew and 
Richter, 1990). Although the classical (canonical) CPE is defined as UUUUUAU, variations 
from this sequence have been proposed (Du and Richter, 2005). Under basal conditions, 
CPEBs repress the translation of bound mRNA. Upon stimulation, CPEBs get phosphorylated 
and enhance the polyadenylation of the bound mRNA (Richter, 2007). CPEB1 regulates the 
translation of cyclin B1 mRNA (Kim et al., 2011). Based on a combinatorial code proposed in 
Xenopus oocytes (Pique et al., 2008), the timing and extent of translational regulation may 
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vary depending on i) the number of CPEs, ii) the distance between two CPEs, iii) the distance 
between CPE and poly(A), and iv) other regulatory elements surrounding the CPEs. The 
CPEB family includes four members: CPEB 1-4. Based on amino acid comparison and 
structural similarity, the CPEB family can be divided into two groups: CPEB1 and the CPEB 
2-4 subfamily (Kurihara et al., 2003; Theis et al., 2003). The founding member CPEB1 was 
first described in Xenopus oocytes being involved in the maturation of oocytes (Hake and 
Richter, 1994) and later was also reported at the postsynaptic density of mouse brain (Wu et 
al., 1998). CPEB2 was described in germ cells (Kurihara et al., 2003) and in mouse brain 
(Theis et al., 2003; Turimella et al., in revision). CPEB3 and 4 were described in mouse 
hippocampus (Theis et al., 2003). They all share a similar structure with an N-terminal 
recognition motif and a C-terminal RNA binding motif which in turn includes two RNA 
recognition motifs (RRM) and a zinc finger (Znf). The N-terminal motif harbors a variable 
region which can be alternatively spliced to give rise to multiple splice isoforms for CPEB 2-
4, while CPEB1 harbors a site for alternative splicing in the first RRM (Figure 3).  
 
 
Figure 3: A) The general protein structure of all four CPEBs. The N-terminal regulatory domain and a C-
terminal RNA binding domain with two RNA recognition motifs (RRM1 and RRM2) and a zinc finger (Znf) are 
shown. B) The protein structures of CPEB 1-4. CPEB1 contains a variable region in RRM1, the deletion of 
either one or both the regions (filled and striped boxes) marked give rise to different splice isoforms. In the 
CPEB 2-4 subfamily, the regulatory domain harbors a variable region: the B-region with a putative 
phosphorylation site (filled circle), and the C-region (striated box). CPEB2 possesses an extra region named the 
E-region (white box) which is not present in other CPEBs. Both ‘B’ and ‘C’ regions are separated in CPEB2 and 
CPEB3, whereas in the case of CPEB4, they are together. Adapted and modified from Theis et al., (2003) and 
Turimella et al., (in revision). 
 
For CPEB1, three splice isoforms were described: A full length version (n) and a form with a 
small deletion in the RRM1 (∆5) were reported (Wilczynska et al., 2005). Another isoform 
with a long deletion in the RRM1 (∆17) was recently identified (Turimella et al., in revision). 
For CPEB2, four splice isoforms were identified in mouse brain (2a, 2a*, 2c and 2c*) 
(Turimella et al., in revision). For CPEB3 and CPEB4, four splice isoforms each were 
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identified. CPEB3 isoforms: 3a, 3b, 3c and 3d; CPEB4 isoforms: 4a, 4b, 4c and 4d. (Theis et 
al., 2003). Additional splice isoforms of CPEB3 have been described in mouse retina (Wang 
and Cooper, 2009). A summary of different splice isoforms described for each CPEB with 
their domain compositions can be found below in table 1.  
 
Table 1: A summary of multiple splice isoforms identified for each CPEB. Note that some isoforms of CPEB 2-4 
contain a B-domain proposed to contain a putative phosphorylation site for different kinases. Some isoforms of 
CPEB2 differ from CPEB3 and 4 in having an extra E-domain of 3 aa.  aa – amino acids, sm - small, lg - long. 
 
The N-terminal region also possesses a putative phosphorylation site for different kinases. 
CPEB1 differs from the CPEB 2-4 subfamily in having a phosphorylation site for Aurora A 
kinase (Mendez et al., 2000) which is not found in the CPEB 2-4 subfamily. CPEB1 is known 
to be phosphorylated by CaMKIIα (Atkins et al., 2004), whereas for the other CPEBs (CPEB 
2-4), putative phosphorylation sites were predicted for CaMKIIα, protein kinase-A (PKA) and 
S6 kinase (Theis et al., 2003). The zinc finger present in the C-terminal RNA binding domain 
is rich in cysteine and histidine amino acids and is shown to be essential for RNA binding 
(Hake et al., 1998; Theis et al., in revision; Turimella et al., in revision).  
 
CPEB Isoform Domain composition Reference 
 
CPEB1 
full length (n) full length isoform Gebauer and Richter, 1996 
Wilczynska et al., 2005 
Turimella et al.,  in revision 
short (sm/∆5) deletion of 5 aa  
long (lg/∆17) deletion of 17 aa 
 
 
 
CPEB2 
2a B+C+E-  
 
Turimella et al.,  in revision 
2a* B+C+E+ 
2c B+C-E- 
2c* B+C-E+ 
 
 
 
CPEB3 
3a B+C+  
 
Theis et al., 2003 
3b B-C+ 
3c B+C- 
3d B-C- 
 
 
 
CPEB4 
4a B+C+  
 
Theis et al., 2003 
4b B-C+ 
4c B+C- 
4d B-C- 
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1.4.1 Mechanism of CPEB regulation  
Among all CPEBs, much information is available about how CPEB1 regulates activity-
induced polyadenylation and translation of bound mRNA. Figure 4 depicts the role of CPEB1 
in neurons. CPEB1 binds to CPE containing mRNA and represses its translation (Richter, 
2007). In this state, CPEB is being bound by maskin (a translational inhibitor) (Stebbins-Boaz 
et al., 1999) which also interacts with the eukaryotic initiation factor 4E (eIF4E). The 
interaction of maskin with eIF4E prevents its association with eIF4G which is necessary to 
recruit the 40S ribosomal subunit to the AUG start codon in the 5’end of mRNA, in this way 
maskin prevents the initiation of translation (Gingras et al., 1999). This repression is relieved 
by phosphorylating CPEB1 which induces polyadenylation of bound mRNA. Polyadenylation 
causes the dissociation of maskin from eIF4E (Cao and Richter, 2002), the eIF4E in turn 
interacts with eIF4G and initiates the translation along with the other protein complex 
(Stebbins-Boaz et al., 1999). Maskin is not present in the brain, where a related protein 
(neurogidin) exerts maskin’s function (Richter, 2007).  
 
CPEB1 can be phosphorylated by two kinases: by Aurora A kinase (a serine/threonine kinase) 
in Xenopus oocytes (Mendez et al., 2000) at the serine 174 residue (Sarkissian et al., 2004) 
and by CaMKIIα in rodent neurons at the threonine 171 residue (Atkins et al., 2004). Both 
progesterone (Mendez et al., 2000) and glutamate (Atkins et al., 2004) stimulate the 
phosphorylation of CPEB1 in oocytes and hippocampal neurons respectively. 
Phosphorylation induces CPEB1 to recruit cleavage and polyadenylation specificity factor 
(CPSF) and stabilizes it on the hexanucleotide sequence (AAUAAA) (Mendez et al., 2000) 
and recruits poly(A) binding protein (PABP) (Kahvejian et al., 2005) and poly(A) polymerase 
to elongate the poly(A) tail of bound mRNA.  
 
CPEB1 localizes at the postsynaptic density in neurons (Wu et al., 1998) and modulates the 
translation of CaMKIIα mRNA. In neurons, glutamate released from the presynapse activates 
the NMDA receptor which further activates Aurora A kinase to phosphorylate CPEB1 (Figure 
4) (Atkins et al., 2004). This phosphorylation breaks down the dormancy and relieves the 
maskin from eIF4E which in turn can interact with eIF4G and recruits a complex of proteins 
to initiate translation.  
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Figure 4: CPEB1-mediated translational regulation in neurons. Under basal conditions, CPEBs bind to CPEs and 
keep the mRNA in a dormant state. Following NMDA receptor activation, the aurora kinase gets activated and 
phosphorylates CPEB. CaMKII has also been shown to phosphorylate CPEB (Atkins et al., 2004). 
Phosphorylation stabilizes CPSF on the AAUAAA hexanucleotide, which attracts PAP to catalyze 
polyadenylation. Maskin dissociates from eIF4E (cap binding factor). The eIF4G then binds eIF4E and initiates 
translation. The figure was adapted and modified from Richter and Lorenz (2002).   
 
1.4.2 Role of CPEBs in different cell types 
CPEBs are important translational regulators which control several key processes both in 
invertebrates and vertebrates. Much of the work has been done in elucidating the function of 
CPEB1 in various cell types. CPEB1 was first described in Xenopus oocytes where it 
regulates the maturation of oocytes (Hake and Richter, 1994). CPEB1 was found to be 
essential for the germ-cell development as the ablation of this gene impaired the translation of 
two synaptonemal complex proteins 1 and 3 (SCP1 and SCP3) and further inhibiting the 
germ-cell development (Tay and Richter, 2001). In addition, CPEB1 is also important for cell 
division in Xenopus embryos. In mouse embryonic fibroblasts (MEFs), CPEB1 represses the 
translation of a transcription factor, myc which encodes a proto-oncogene, thereby driving the 
cells into senescence (Groisman et al., 2006).  
 
In neurons, CPEB1 regulates a number of mRNAs such as β-catenin in growth cones (Kundel 
et al., 2009), CaMKIIα (Wu et al., 1998) at synapses, and tissue plasminogen activator (tPA), 
a protease important for synaptic plasticity (Shin et al., 2004). Among the CPEB 2-4 
subfamily members, CPEB2 interacts with hypoxia inducible factor (Hif-1α) (Hagele et al., 
2009). CPEB3 and CPEB4 regulate the translation of GluR2, an AMPA receptor subunit 
regulating calcium permeability of the receptors (Huang et al., 2006). The translation of a 
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number of target mRNAs is regulated by different CPEBs in different cell types. A list of 
proven CPEB targets is shown in table 2. 
 
CPEB Target mRNA Function Reference 
 
 
 
 
 
CPEB1 
p53 Cell senescence Groisman et al., 2006 
β-catenin Neuronal morphogenesis Kundel et al., 2009 
CaMKIIα Synaptic plasticity Wu et al., 1998 
Cyclin B1 Cell cycle Hake and Richter, 1994 
Kim et al., 2011 
MAP2 Microtubule associated protein  Huang et al., 2003 
Myc Proto oncogene Groisman et al., 2006 
Synaptonemal complex proteins  
(SCP1 and SCP3) 
Germ-cell development Tay and Richter, 2001 
tPA Serine protease Shin et al., 2004 
CPEB2 Hif-1α Hypoxia Hagele et al., 2009 
Eukaryotic elongation factor,  
eEF2 
Elongation step of translation Chen and Huang, 2011 
TWIST1 Breast cancer progression Nairismaegi et al., 2012 
CPEB3 GluR2 Ca2+ permeability Huang et al., 2006 
CPEB4 GluR2 Ca2+ permeability Huang et al., 2006 
Table 2: A list of proven CPEB targets in different cell types and their functions.  
 
1.4.3 CPEBs in synaptic plasticity, learning and memory  
Increasing evidence suggests that local protein synthesis is important for certain forms of 
synaptic plasticity (Kandel, 2001). CPEB1 is present in the postsynaptic density and regulates 
the translation of the α subunit of CaMKII (Wu et al., 1998), a key player involved in synaptic 
plasticity. To find out if ablation of CPEB1 impairs synaptic plasticity, LTP experiments were 
performed in CPEB1 knockout (CPEB1 KO) mice (Tay and Richter, 2001). In classical LTP 
experiments (induced by theta-burst stimulation), only a modest deficit was observed in 
CPEB1 KO mice compared to their wild type littermates (Alarcon et al., 2004). As the other 
CPEB family members (CPEB 2-4) were reportedly present in the postsynaptic density 
(Huang et al., 2006) and share similarity in their RNA binding domains (Theis et al., 2003), 
the authors speculated that the mild deficit in LTP observed might be due to a compensatory 
effect by the other CPEB family members (CPEB 2-4) for CPEB1 ablation. In addition, 
CPEB1 KO mice showed impairments in extinction of memory which is dependent on the 
hippocampus (Berger-Sweeney et al., 2006). Extinction is a type of behavioral response 
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where memory engrams gradually become extinct if not reinforced; this results in the 
formation of new memories (Abel and Lattal, 2001), but is not equal to forgetting. In addition, 
transgenic mice expressing dominant negative CPEB (DN-CPEB) in neurons which competes 
with endogenous CPEBs for binding to CPE containing mRNAs, showed impairments in L-
LTP (which is dependent on protein synthesis) and memory (Theis et al., in revision). DN-
CPEB is CPEB1 without the N-terminal regulatory domain containing the critical 
phosphorylation site for activation; hence it can’t be activated by phosphorylation. Altogether, 
these findings suggest that CPEBs, and not only CPEB1, in neurons are required for synaptic 
plasticity, learning and memory. 
 
1.4.4 CPEBs in Epilepsy 
Epilepsy is a common neurological disorder affecting 1% of the world population (Binder and 
Steinhauser, 2006), and is characterized by gliosis and recurrent seizures (Seifert et al., 2006). 
The seizures might arise either from the temporal lobe (called mesial temporal lobe epilepsy, 
MTLE) or from hippocampus (called lateral TLE, LTLE). The spontaneous seizures arise due 
to the hyper-activation of neurons leading to excitotoxicity, neurodegeneration and mossy 
fibre sprouting, the hallmarks of epilepsy (Morimoto et al., 2004). The seizure activity also 
leads to reorganization of the brain which is contributed by several factors including protein 
synthesis. The application of kainic acid (KA) leads to hyperactivity of neurons in the 
hippocampus (recurrent seizures), to status epilepticus (SE) and neurodegeneration (Zagulska-
Szymczak et al., 2001). 
 
CPEB3 and CPEB4 transcripts levels were upregulated in vivo by the administration of KA, a 
glutamate receptor agonist (Theis et al., 2003). As some of the CPEB transcripts are 
upregulated following KA treatment which also causes seizures, and seizure activity results in 
protein synthesis, it can be speculated that CPEBs might play an important role in the 
development and progression of epilepsy.  
 
1.5 CPEB2 
CPEB2 is a 63 kDa molecular weight protein and together with CPEB3 (KIAA0940) and 
CPEB4 (KIAA1673) make the CPEB 2-4 subfamily. Though it was first described in germ 
cells (Kurihara et al., 2003), later reports claim the expression of CPEB2 in mouse brain 
(Theis et al., 2003; Hagele et al., 2009). But, it remained to be unexplored among the CPEB 
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family members in mouse CNS until the description of the multiple splice isoforms of CPEB2 
as well as the protein distribution in mouse brain (Turimella et al., in revision). Only few 
reports show that CPEB2, similar to CPEB1 binds to the 3’UTRs of CaMKIIα (Turimella et 
al., in revision) and Hif-1α (Hagele et al., 2009) mRNAs. Because of its similarity with the 
other CPEB family members and potential expression in mouse CNS, CPEB2 could very well 
be a translational regulator, the role of which is yet to be explored.    
 
1.5.1 Putative targets of CPEB2 
The translation of several mRNAs in neurons is regulated by CPEB family members. CPEB3 
and CPEB4 were thought to regulate translation not by binding to CPEs but depending on the 
secondary structure of the 3’UTR (Huang et al., 2006). CPEB2 interacts with Hif-1α (Hagele 
et al., 2009) and CamKIIα (Turimella et al., in revision). As several mRNAs contain CPEs in 
their 3’UTRs (Du and Richter, 2005), CPEB2 might likely regulate translation of any of the 
target mRNAs. A description of some of the putative targets of CPEB2 can be found below. 
Some of these mRNAs have been reportedly regulated by other CPEB family members. 
 
1.5.1.1 β-catenin 
The protein complexes that are present at cell-cell junctions and anchor the cells are called 
adherens junction (AJ) or zonula adherens which constitute the classical cadherins and their 
cytoplasmic partners, catenins. There are more than 80 members in the cadherin family, 
which constitute type I and II cadherins. They interact by their cytoplasmic domains with 
catenins. Catenins  include three subgroups: two β-catenin like proteins (β-catenin and 
plakoglobin), three α-catenins and four p120catenin-related proteins (Arikkath and Reichardt, 
2008). The cadherin/catenin complex is present early in development (Benson and Tanaka, 
1998) at high levels in neuronal processes and colocalizes with synaptic proteins (Togashi et 
al., 2002). Cadherins are present at the synaptic junctions (Uchida et al., 1996). In neurons, 
they are present at the synapses as visualized by immunoelectron microscopy and participate 
in the induction of LTP (Huntley et al., 2002). 
 
β-catenin is one of the AJ proteins which participate in both cell-cell signalling and in various 
stages of neuronal development. On one side, it interacts with α-catenin and on the other side, 
it interacts with actin cytoskeleton (Gumbiner, 1996) thereby participating in the intracellular 
signalling. It is an important component of the classical Wnt signalling pathway (Clevers, 
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2006). The Wnt signal inactivates glycogen synthase kinase 3β (GSK-3β) which otherwise 
phosphorylates β-catenin and subsequently degrades it by ubiquitinylation, thereby leading to 
the accumulation of β-catenin in the cytoplasm of the cell. This β-catenin then enters the 
nucleus to mediate the transcription of several genes together with lymphoid enhancer 
factor/T-cell factor (LEF/TCF) family of transcription factors (Cadigan and Nusse, 1997). 
 
β-catenin functions at both pre- and postsynaptic sites (Arikkath and Reichardt, 2008). By 
binding to cadherin and recruiting PDZ domain-containing proteins with its C-terminal PDZ-
binding motif, β-catenin participates in synaptic vesicle localization at presynaptic sites. This 
is supported by the reduction in the reserve pool of vesicles observed in the absence of β-
catenin (Bamji et al., 2003). The PDZ domain is a ~ 90 amino acids long protein-protein 
interaction motif, which links several proteins. The PDZ domain occurs either as a single 
domain or in repeats in a particular protein. The name is derived from three proteins which 
contain this motif: PSD-95 (Cho et al., 1992), its homologue Drosophila discs-large tumour 
suppressor gene (Dlg-A) product (Woods and Bryant, 1991) and ZO-1, a tight junction 
protein (Itoh et al., 1993). At postsynaptic sites, β-catenin influences the structure of the 
synapse. β-catenin is critical for dendritic morphogenesis (Yu and Malenka, 2003) and the 
loss of β-catenin negatively affects the synaptogenesis as well as the morphology of spines 
(Okuda et al., 2007). The overexpression of GFP tagged β-catenin enhanced the dendritic 
arborization. On the other hand, the sequestration of endogenous β-catenin by the intracellular 
domain of N-cadherin prevented the arborization (Yu and Malenka, 2003).  
 
Both synaptic activity (Takeichi and Abe, 2005) and post-translational modifications such as 
tyrosine phosphorylation (Murase et al., 2002) regulate β-catenin. As β-catenin possesses 
multiple roles in neuronal development and as the loss of β-catenin leads to abnormalities in 
dendritic spines, the regulation of the expression and function of β-catenin is of high 
importance. Indeed, Clapper et al (2004) suggested that targeting of β-catenin-mediated gene 
regulation could be a promising strategy for treating several cancers. RNA binding proteins 
such as CPEBs regulate β-catenin translation (Jones et al., 2008; Kundel et al., 2009). 
Recently, CPEB1 was shown to regulate the translation of β-catenin in neurons (Kundel et al., 
2009). The authors have shown that β-catenin is present in the growth cones and upon treating 
the neurons with neurotrophin-3 (NT3), β-catenin protein synthesis was enhanced by CPEB1 
(stimulated protein synthesis). A schematic of β-catenin 3’UTR with potential binding sites 
for CPEB can be found in figure 5. 
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Figure 5: The 3’UTR of β-catenin with CPEs and poly(A) marked. The numbers indicate the distance in bases 
between two elements.  
 
1.5.1.2 GluR2  
GluR2 is an important subunit of the AMPA receptor complex. AMPA receptors (AMPAR) 
mediate fast synaptic transmission in the CNS. They are composed of up to four subunits: 
GluR1-4 (also called as GluR A-D) (Dingledine et al., 1999). All four subunits share a similar 
structure with an amino terminal domain, three membrane associated domains (M1-4) and a 
C-terminal domain (Isaac et al., 2007); out of which the membrane associated domain M2 
forms a hairpin loop and is a site for RNA editing. The subunits are synthesized in the 
endoplasmic reticulum (ER), they first form dimers and later two dimers combine together to 
form tetramers (Cull-Candy et al., 2006) which are the functional AMPA receptors. 
Depending on their subunit assembly, AMPAR can be formed as homotetramers or various 
heterotetramers. Among the different combinations, the most favoured combination is a 
heteromeric complex of GluR1 and GluR2 (Cull-Candy et al., 2006). It is already known that 
AMPAR exist both in neurons and glia (Belachew and Gallo, 2004). In the CNS, most of the 
AMPAR exist as GluR2 containing heteromers (Greger et al., 2002). GluR1 and GluR2 were 
reported as the predominant subunits in forebrain especially in hippocampus whereas GluR3 
and GluR4 are of rather low abundance (Tsuzuki et al., 2001; Sans et al., 2003). The subunit 
composition also varies based on the region of brain, cell type as well as developmental stage 
(Song and Huganir, 2002).  
 
GluR2 is a subunit which has a strong influence on AMPAR function. GluR2 differs from the 
other subunits in having an edited arginine (R) in place of glutamine (G). This editing occurs 
due to the change of a single adenosine to inosine by the enzyme adenosine deaminase 
(ADAR2) (Higuchi et al., 1993a) and is specific for GluR2 (> 95% of GluR2 mRNA 
transcripts in postnatal brain are edited). In addition to RNA editing, alternative splicing also 
accounts for the diversity of different subunits (Liu and Zukin, 2007). The channels which 
lack edited GluR2 subunit allow more divalent cations such as Ca
2+
 and Zn
2+
 to permeate and 
exhibit an inwardly-rectifying current-voltage (I-V) relationship (Burnashev et al., 1992). Due 
to the extra positive charge introduced by the presence of arginine (Q/R editing) in GluR2, 
AMPAR which contain the edited GluR2 subunit are impermeable to Ca
2+
 and Zn
2+
. They 
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exhibit a linear current-voltage relationship (Boulter et al., 1990) and can be blocked by 
intracellular polyamines. The presence of GluR2 not only changes the channel conductance 
(Swanson et al., 1997), but also influences AMPAR assembly and trafficking from ER and 
targeting to the postsynaptic density (Passafaro et al., 2001; Greger et al., 2002).  
 
Ca
2+ 
permeable AMPA receptors play a major role in synaptic plasticity. The entry of Ca
2+
 
into the cell modulates synaptic plasticity by several mechanisms, for example Ca
2+
 activates 
the intracellular signalling cascades which in turn influences AMPA receptor trafficking. The 
Ca
2+ 
entry can also change the subunit composition of AMPARs in the postsynaptic density 
which further leads to changes in the properties of synapses such as AMPAR kinetics and 
permeability (Liu and Zukin, 2007). In addition to a rise in Ca
2+ 
levels, AMPAR with 
unedited GluR2 (or lacking edited GluR2) might lead to a later rise in toxic Zn
2+
 levels 
supporting excitotoxic death of neurons (Kwak and Weiss, 2006). Ca
2+ 
permeable AMPA 
receptors not only alter the properties of a synapse but also contribute to various neurological 
disorders. A number of diseases including excitotoxicity, epilepsy, amyotrophic lateral 
sclerosis (ALS), ischemia (Liu et al., 2004) and pain were shown to be associated with altered 
GluR2 function (Cull-Candy et al., 2006). The excess flow of Ca
2+ 
into the cell leads to 
spontaneous seizures thereby increasing the excitability of hippocampal neurons (Brusa et al., 
1995). A summary of various neurological disorders associated with altered GluR2 expression 
or function can be found below in table 3.   
 
Neurological disorders linked to altered GluR2 function 
Disease Reference 
Alzheimer’s disease Ikonomovic et al., 1997 
Amyotrophic lateral sclerosis (ALS)  Kawahara et al., 2004 
Antipsychotics Fitzgerald et al., 1995 
Corticosteroids Nair et al., 1998 
Drugs of abuse Fitzgerald et al., 1996 
Epilepsy Brusa et al., 1995 
Excitotoxicity Carriedo et al., 1998 
Ischemia Noh et al., 2005 
Pain Hartmann et al., 2004 
Spinal cord injury Grossman et al., 1999 
Stroke Liu et al., 2004 
White matter injury Follett et al., 2004 
   Table 3: A summary of various neurological disorders associated with altered GluR2 expression/function.  
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It has been shown that GluR2 translation is regulated by CPEB3 in neurons based on its 
3’UTRs secondary structure (Huang et al., 2006). Two transcripts for GluR2: 4 kb and 6 kb in 
length were described which differ in their 3’UTRs (Kohler et al., 1994). In addition, miRNA 
binding sites were found in rat GluR2 3’UTR, hence miRNAs might also participate in the 
regulation of GluR2 translation (Rocchi and Tkatch, A179, IBRO abstract, 2011). In the 
present study, the analysis of the 3’UTR revealed a number of potential CPEB binding sites 
and poly(A) sequences, but no information is available about which of them are functional. 
As GluR2 influences synaptic properties and is associated with several neurological disorders, 
it is important to regulate GluR2 function. Therefore, understanding the complex mechanisms 
that regulate the expression and localization at synapse as well as subunit composition of 
AMPA receptors are of high interest.  
 
1.5.1.3 GluR2 interacting partners 
As GluR2 plays a crucial role in determining the AMPA receptor function, the mechanisms 
that regulate the insertion of functional AMPARs at synapses are of great interest. The 
trafficking of AMPA receptors to and from synapses is the underlying mechanism for long-
term changes in the synaptic efficiency (Liu and Zukin, 2007). In addition to trafficking, 
recent findings claim that activity-dependent local protein synthesis of AMPAR in dendrites 
also plays an important role in regulating the number and distribution of AMPAR (Grooms et 
al., 2006). The interaction of GluR2 with several proteins is important for the expression and 
trafficking of AMPAR as well as for post-translational modifications (Braithwaite et al., 
2000). These proteins interact with the C-terminus of GluR2 at i) the N-ethylamide-sensitive 
factor /adaptor protein-2 (AP2) binding site and ii) at the PDZ binding site. NSF is an ATPase 
that regulates the membrane insertion and stabilization of GluR2 containing functional 
AMPAR at synapses (Lee et al., 2002), whereas AP2 is an adaptor protein which has a role in 
clathrin-dependent endocytosis.  
 
The PDZ domain-containing proteins that interact with the C-terminus of GluR2 include the 
glutamate receptor interacting protein 1 (GRIP1), AMPAR binding protein (ABP) (also called 
GRIP2) (Osten et al., 1998; Srivastava et al., 1998), and the protein interacting with C-kinase 
1 (PICK1) (Xia et al., 1999). GRIP1 contains seven PDZ domains and has been described as 
the first protein interacting with the C-terminus of GluR2 by yeast hybrid assay (Dong et al., 
1997). ABP (also called GRIP2) shares 64-93% similarity with GRIP1, and only differs from 
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it by lacking the seventh PDZ domain. Both ABP/GRIP2 and GRIP1 are splice isoforms of 
the same gene with six and seven PDZ domains, respectively (Wyszynski et al., 1999) and are 
present in the PSD. Both ABP/GRIP2 and GRIP1 are important for clustering of AMPAR at 
synapses (Srivastava et al., 1998). PICK1 contains a single PDZ domain and is important for 
the clustering of AMPAR at synapses as well as for facilitating the expression of AMPAR at 
the cell surface (Braithwaite et al., 2000). The interaction of GluR2 with the PDZ domain 
containing proteins found to assist with the exit of assembled AMPAR from ER as well as 
trafficking to the synapse (Cull-Candy et al., 2006). Another class of proteins interacting with 
GluR2 are transmembrane AMPAR regulatory proteins (TARPs). These are auxiliary 
subunits of AMPAR which help in the trafficking of AMPAR and also affect their 
conductance (Rouach et al., 2005; Nicoll et al., 2006). A summary of different proteins that 
interact with the C-terminus of GluR2 and their functions can be found below in table 4. 
 
Table 4: A summary of proteins shown to interact with the C-terminus of GluR2.  
 
Bioinformatics indicated potential binding sites for CPEBs in the 3’UTR of some of the 
GluR2 interacting partners. Although there might be CPEs in several of the GluR2 interacting 
partners, ABP was shown to undergo stimulated polyadenylation (Du and Richter, 2005) and 
has been confirmed as a CPEB target (Theis et al., in revision). The authors found impaired 
protein synthesis of ABP after kainate injection (stimulated protein synthesis). Both ABP 
(GRIP2) and GRIP1 possess CPEs in their 3’UTRs (Figure 6).  
 
 
Figure 6: The 3’UTRs of ABP/GRIP2 and GRIP1 with CPEs and poly(A) marked. The numbers indicate the 
distance in bases between two elements.  
Proteins  interacting with GluR2 Function Reference 
Adaptor protein-2 (AP2) Clathrin-dependent endocytosis Lee et al., 2002 
AMPA receptor binding protein 
(ABP/GRIP2) 
Clustering of AMPAR at synapses Srivastava et al., 
1998 
Glutamate receptor interacting protein 1 
(GRIP1) 
Clustering of AMPAR at synapses Dong et al., 1997 
N-ethylamide-sensitive factor  Expression of GluR2-containing AMPAR 
at synapse 
Lee et al., 2002 
Protein interacting with C-kinase 1 
(PICK1) 
Clustering of AMPAR at synapses Xia et al., 1999 
Transmembrane AMPAR regulatory 
proteins (TARP) 
Trafficking and conductance of AMPAR Nicoll et al., 2006 
Rouach et al., 2005 
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1.5.1.4 EphA4 
The Ephrin (Eph) receptors are the largest family of receptor tyrosine kinases (RTKs) (Zhou, 
1998), present in both developing and mature tissues with predominant expression in neurons 
(Murai and Pasquale, 2003). The Eph receptors were first identified as tyrosine kinases 
involved in cancer and were named after their source of isolation, erythropoietin-producing 
hepatocellular carcinoma cell line  (Hirai et al., 1987). Eph receptors are divided into two 
subclasses based on their affinity for the ligands: i) EphA receptors and ii) EphB receptors. 
The ligands that interact with Eph receptors were named as Eph family receptor interacting 
proteins or simply ephrins (Committee, 1997). In mammals, the Eph receptor family includes 
14 members: nine EphA (EphA1-EphA8 and EphA10) receptors and five EphB (EphB1-
EphB4 and EphB6) receptors. Their ligands, the ephrins, constitute a family of 8 members: 
five ephrin-A (ephrinA1-A5) ligands and three ephrin-B (ephrin B1-B3) ligands (Murai and 
Pasquale, 2003; Calo et al., 2006). Although both Eph receptor subtypes share a similar 
structure, they differ in their affinities to their ligands: the A-type receptors bind to glycosyl 
phosphatidyl inositol (GPI)-linked ephrin-A ligands, whereas the B-type receptors bind to 
transmembrane ephrin-B ligands. EphA4 is an exception, since it can interact with both 
ephrin-A and ephrin-B ligands (Pasquale, 2005).  
 
The Eph receptors and their transmembrane ligands, the ephrins, are collectively named ‘‘Eph 
proteins’’. The binding of an ephrin ligand to its respective Eph receptor results in 
bidirectional signalling: it will affect both the receptor expressing cells (called forward 
signalling), as well as the ligand expressing cells (called reverse signalling) (Pasquale, 2005). 
Although the classical signalling of Eph proteins is bidirectional, ephrins and Eph receptors 
can function independently of each other or function in association with other cell signalling 
systems (Pasquale, 2008). The Eph proteins contribute to several mechanisms which include 
cell migration, axon guidance (Kullander and Klein, 2002), activity-dependent synaptic 
plasticity and subsequently learning and memory (Yamaguchi and Pasquale, 2004). They 
were also reported to be important in actin cytoskeleton remodelling (Noren and Pasquale, 
2004) and in clustering of NMDA receptors (Murai and Pasquale, 2004). An important 
function of Eph proteins is the neuron-glia crosstalk in the hippocampus (Murai et al., 2003). 
 
Among Eph receptors, EphA4 is very interesting and unique because of its interaction with 
both classes of ligands (ephrin-A and -B) as well as its role in neuron-glia crosstalk (Filosa et 
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al., 2009). EphA4 is highly expressed in the adult hippocampus, particularly in the dendritic 
spines of hippocampal neurons where it modulates the spine architecture (Murai et al., 2003). 
It is also present in the PSD where it co-localizes with PSD-95 (Carmona et al., 2009). EphA4 
interacts with ephrin-A3 ligand present in astrocytes (Figure 7) thereby participating in the 
neuron-glia crosstalk (Murai et al., 2003; Carmona et al., 2009). It leads to bidirectional 
effects: EphA4 modulates the spine length by forward signalling and on the other hand, 
ephrin-A3 ligand negatively regulates the expression of astrocytic glutamate transporters by 
reverse signalling. The interaction between neuronal EphA4 and astrocytic ephrin-A3 is 
important for the regulation of glutamate transport which further regulates the synaptic 
glutamate concentration thereby modulating LTP at excitatory synapses (Filosa et al., 2009).  
 
Figure 7: EphA4-ephrin-A3 bidirectional signalling at hippocampal synapses. The interaction of astrocytic 
ephrin-A3 with postsynaptic EphA4 leads to forward signalling in neurons, inducing the retraction of dendritic 
spine; and ephrin-A3 reverse signalling in astrocytes, downregulating glutamate transport. The presynaptic 
terminal is shown in gray, the postsynaptic dendritic spine in red and a glial process near synapse is shown in 
blue. The figure was adapted from Carmona et al., (2009).  
 
In addition, enhanced protein levels of both the glutamate transporters: glutamate transporter-
1 (GLT-1) and glutamate aspartate transporter (GLAST) were observed in knockout mice that 
lack either EphA4 or ephrin-A3, but their transcript levels remained unaltered which 
suggested that there might be a posttranscriptional form of regulation (Carmona et al., 2009). 
These results were further confirmed by the reduction in glutamate transporter levels observed 
with transgenic overexpression of ephrin-A3, and subsequent glutamate excitotoxicity which 
might further lead to dendritic swellings (Filosa et al., 2009). The dysfunction of Eph results 
in  dendritic spine abnormalities which might eventually lead to several neurological disorders 
such as schizophrenia (Glantz and Lewis, 2000), autism and mental retardation (Kaufmann 
and Moser, 2000).  
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It was already shown that the 3’untranslated region of EphA4 contains binding sites for 
several regulatory proteins such as CPEs, AU-rich elements (AREs) and Hu antigen R (HuR) 
binding sites (Winter et al., 2008). Either of these binding sites is bound by the regulatory 
proteins which might control the translation of EphA4 thereby indirectly regulating glutamate 
transporter expression. A schematic of the EphA4 3’UTR with its CPEs and the 
polyadenylation signal is shown in figure 8.  
 
 
Figure 8: EphA4 3’UTR with CPEs and poly(A) marked. The numbers indicate the distance in bases between 
the two elements.  
 
1.6 Conditional transgenic systems to study gene function in vivo 
The function of a gene can be studied by developing animal models with either gain or loss of 
function of the particular gene. The development of these animal models which mimic a 
disease condition in humans will help in understanding the disease as well as in designing 
treatment approaches (Sun et al., 2007). To do so, the gene expression should be controlled in 
a precise way. A number of genetic manipulation techniques have been developed which 
comprise the use of conventional transgenic systems (overexpression of a protein or of a 
dominant negative protein) and knock-out approaches (gene deletion). As knock-out 
approaches are sometimes deleterious during development, the best approach to study gene 
function would be a “conditional transgenic system”. The ideal system should meet the 
following criteria: i) it should be possible to switch on or off the transgene expression at any 
time point, ii) it should be possible to reverse the expression rapidly in the desired cell or 
tissue type (Sun et al., 2007).  
 
Among the transgenic systems, the tetracycline-inducible system developed by Manfred 
Gossen and Hermann Bujard is most widely used (Gossen and Bujard, 1992) because of its 
spatial and temporal control of the transgene. The tet-inducible system is the preferred system 
for transgene overexpression due to several advantages (Gingrich and Roder, 1998): i) it is 
based on cis regulatory elements from bacteria (prokaryotes); these elements were known to 
cause no/minimal pleiotropic effects, ii) it shows a very low level of basal expression, iii) it is 
easily inducible and iv) transgene regulation (switching on or off) is easily achieved in desired 
cells or tissues. The system is easily inducible by tetracycline or its derivatives such as 
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doxycycline. This inducer is ideal for the generation of transgenic animals (Kistner et al., 
1996) as it is cost effective, nontoxic, and can penetrate the placenta and blood/brain barrier 
which eventually can be taken up rapidly by the cells. There are two versions of the tet 
system, called tet-OFF (Gossen and Bujard, 1992) and tet-ON (Gossen et al., 1995) systems. 
 
The tet-inducible systems consist of two major components (see also Figure 9): 
a) Transcriptional transactivators [eg., tTA (tetracycline transactivator), rtTA (reverse 
tTA)]: they interact with bacterial cis regulatory elements called tet operator (tetO).  
b) Antibiotics: they modulate the binding of transactivators at doses below toxic levels 
(Shockett and Schatz, 1996). eg., tetracycline, doxycycline.  
 
The tTA is a fusion protein of Escherichia coli tetracycline-repressor protein (TetR) and the 
C-terminus (activation domain) of the protein 16 of herpes simplex virus (VP16). The tTA 
can be controlled by either tetracycline or its derivatives such as doxycycline. Another 
important component of the system is a tissue specific promoter (TSP), which drives the 
transgene expression in a specific cell type. For example, the CaMKIIα promoter drives the 
expression specifically in forebrain neurons such as pyramidal neurons of the hippocampus 
and cortex (Mayford et al., 1997) whereas the human GFAP promoter is specific to astrocytes 
and radial glia (Fiacco et al., 2007). The promoter is composed of a minimal promoter 
containing the binding site for RNA polymerase II (TATA box) fused to tet operator 
sequences to which the tTA binds. The fusion with the VP16 activation domain transforms 
the tet repressor into a transcriptional transactivator in eukaryotic cells.  
 
The original tet system developed was the tet-OFF system in which the transcription of a gene 
occurs in the absence of an inducer [tetracycline or doxycycline (Dox)] (Figure 9A; 
Lewandoski, 2001). In the absence of Dox, the tTA binds to tetO and the tTA-dependent 
promoter drives the transgene expression in the desired cell type. But, in the presence of Dox, 
the tTA undergoes a conformational change and can’t bind to the tetO thereby not driving the 
transgene expression. As the antibiotics (tet or Dox) are not present endogenously in the 
animals, their exogenous application allows the temporal control of gene expression. Since 
the presence of Dox silences the transgene expression, it is termed tet-OFF system. A 
modified version, called tet-ON system (Gossen et al., 1995) was developed later in which the 
transcription occurs only in the presence of an inducer (Figure 9B; Lewandoski, 2001). In this 
system, a mutant form of tTA, called reverse tTA (rtTA) binds to recombinant tetO and drives 
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the transcription only when Dox is present. Since the presence of Dox allows the gene 
expression, it is termed tet-ON system (Gossen et al., 1995).  
 
A)   tet-OFF system
B)   tet-ON system
 
Figure 9: Two variants of tet-inducible conditional transgenic systems. A) tet-OFF system, in which tTA binds 
to tetO and drives the expression of a target open reading frame when the Dox is not present. B) tet-ON system, 
in which a variant of tTA, rtTA, binds to tetO and drives the expression of a target open reading frame only in 
the presence of Dox. TSP: tissue-specific promoter, tetR: tetracycline response, pA: polyadenylation, Dox: 
doxycycline, tetO: tet operator, ORF: open reading frame. The figure was adapted and modified from 
Lewandoski, (2001).  
 
 
 
 
 
 
 
 
 
Doctoral thesis – Sada Turimella                                                                  Aim of the thesis  
 23 
2 Aim of the thesis 
The main aim of the thesis was to investigate the expression of CPEBs in neurons and glial 
cells of mouse hippocampus, particularly focussing on CPEB2 function in neurons. The 
following questions were addressed:  
 
1) Investigating the expression pattern of CPEBs (1-4) in neurons and glia 
Even though the expression of CPEBs (1-4) was reported in neurons, astrocytes and 
microglia, the expression of CPEBs in NG2 glia was not studied before. Only few reports 
indicated the presence of multiple splice isoforms for each CPEB. Until now, none of the 
reports have described the distribution of various splice isoforms of each CPEB in different 
cell types and across different species. Hence, the present study was aimed to investigate the 
expression of different splice isoforms of CPEBs (1-4) in detail in neurons and glial cells 
(astrocytes, NG2 glia and microglia) as well as in different species.  
 
2) Investigating the role of CPEB2 in neurons  
CPEB2 is not a well described member of the CPEB family. Even though the expression of 
CPEB2 was reported in mouse brain, the functional role of it in mouse brain is not known. 
Therefore, and to avoid compensatory effects by other CPEBs, a conditional tet-OFF 
approach was used to generate transgenic mice which overexpress CPEB2 in neurons of the 
mouse brain hippocampus and cortex. CPEB1 requires the zinc finger in order to bind to the 
target mRNAs. To find out whether CPEB2 requires the zinc finger for translational 
regulation, a zinc finger mutant (CPEB2∆Zn) was generated in the present study. Using this 
set of transgenic mice, the impact of CPEB2 on the translation of target mRNAs was studied.  
 
3) Investigating the interaction of CPEB2 with target mRNAs in vitro 
So far CPEB2 is known to interact with few mRNAs. Since the RNA binding domain is 
conserved across CPEB family members, more than one CPEB can regulate same target 
mRNA. Hence, the present study was aimed to find out if there is any overlap in the binding 
specificity of CPEB1 and CPEB2 to the target mRNAs.  
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3 Materials and Methods 
 
3.1 Materials 
 
3.1.1 Chemicals  
The chemicals were purchased from Applichem (Darmstadt, Germany), Carl Roth (Karlsruhe, 
Germany), New England Biolabs (Frankfurt, Germany) Invitrogen (Darmstadt, Germany), 
Roche (Mannheim, Germany) and Sigma-Aldrich (Munich, Germany). All the cell culture 
media, antibiotics and serum were purchased from Gibco (Darmstadt, Germany). All the 
primers were purchased from MWG (Ebersberg, Germany). Restriction enzymes were 
purchased from New England Biolabs (Frankfurt, Germany).  
 
3.1.2 Buffers for Western blotting 
Buffer  Composition  Final 
concentration  
 
Lysis buffer  
(modified RIPA 
buffer) 
6.05 g Tris 
8.76 g NaCl 
5 ml NP40 
5 g Sodium deoxycholate 
10 ml Triton X-100 
The contents (except NP40 and triton) were 
dissolved in 700 ml dH2O, and the pH was 
adjusted to 7.5. Later, NP40 and triton were 
added and the volume was adjusted to 1l. The 
buffer was aliquoted 10 ml each and stored at -
20
o
C.  
50 mM  
150 mM  
0.5%  
0.5%  
1%  
 
1.5 M Tris  
(pH 8.8) 
18.16 g Tris was dissolved in 100 ml dH2O, the 
pH was adjusted to 8.8 and the solution was 
stored at +4
o
C. 
1.5 M  
0.5 M Tris  
(pH 6.8) 
6.05 g Tris was dissolved in 100 ml dH2O, the 
pH was adjusted to 6.8 and stored at +4
o
C. 
0.5 M  
APS 0.1 g APS was dissolved in 1 ml of dH2O 10% 
Doctoral thesis – Sada Turimella                                                       Materials and Methods  
 25 
(always prepared immediately before use) 
SDS 10 g SDS was dissolved in 100 ml of dH2O 
and stored at RT. 
10% 
Resolving gel  
(10%) 
6.15 ml 
3.75 ml 
150 µl 
4.95 ml 
75 µl 
7.5 µl 
The components were added in the same order 
as above and mixed gently before use. 
dH2O 
1.5 M Tris (pH 
8.8) 
10% SDS 
Acrylamide 
10% APS 
TEMED  
Stacking gel 
(4%) 
6.1 ml 
2.5 ml 
100 µl 
1.3 ml 
50 µl 
10 µl 
The components were added in the same order 
as above and mixed gently before use.  
dH2O 
0.5 M Tris (pH 
6.8) 
10% SDS 
Acrylamide 
10% APS 
TEMED  
3x Sample buffer 0.77 g 
 
2 g 
1.54 g 
10 ml 
10 µl 
The contents were dissolved in 100 ml dH2O, 
aliquoted 1 ml each and stored at -20
o
C. 
50 mM Tris HCl 
(pH6.8) 
2% SDS (w/v) 
100 mM DTT  
10% Glycerol 
(v/v) 
0.01% 
Bromophenol blue 
(w/v) 
10X Tris-Glycine-
SDS buffer  
(gel running buffer) 
30.3 g 
144 g 
10 g 
The contents were dissolved in 1l dH2O.  
25 mM Tris 
192 mM Glycine 
0.1% SDS 
pH 8.3 
1x gel running 50 ml of 10x Tris-Glycine-SDS buffer and  1x Tris-Glycine-
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buffer 450 ml of distilled water. SDS  
10x Tris-Glycine 
buffer 
(Blotting buffer) 
30.3 g 
144 g 
The contents were dissolved in 1l dH2O.  
25 mM Tris 
192 mM glycine 
pH 8.3 
1x Blotting buffer 50 ml of 10x Tris-Glycine buffer  
100 ml of methanol 
Volume was adjusted to 500 ml with distilled 
water.  
1x Tris-Glycine 
20% methanol  
10x TBST 
(pH 7.4) 
30.28 g 
87.66 g 
0.5 ml 
Tris and NaCl were dissolved in 700 ml dH2O, 
adjusted the pH to 7.4. Later, Tween was 
added and the volume was adjusted to 1l.  
25 mM Tris 
150 mM NaCl 
0.05% Tween-20 
1x TBST 
(pH 7.4) 
100 ml of 10x TBST and 900 ml of distilled 
water. Stored at +4
o
C. 
1x  
1x TBST with  
0.1% Tween-20 
(pH 7.4) 
50 ml of 1x TBST with 0.05% tween-20 was 
taken and 250 µl Tween-20 was added. The 
volume was adjusted to 500 ml. 
1x  
Blocking solution 
for all blots 
0.5 g milk powder  
10 ml 1x TBST (pH 7.4) 
5% milk powder 
1x TBST (pH 7.4) 
Blocking solution 
for EphA4 blot 
0.3 g bovine serum albumin (BSA) 
10 ml 1x TBST with 0.1% Tween-20 (pH 7.4) 
3% BSA 
0.1% Tween-20 
1X TBST (pH 7.4) 
 
 
3.1.3 Buffers for RNA Co-immunoprecipitation 
Buffer (Stock) Composition Final 
concentration  
0.5 M HEPES 11.92 g of HEPES was dissolved in 100 ml dH2O  0.5M  
1 M NaCl 5.84 g of NaCl was dissolved in 100 ml dH2O 1 M  
0.5 M EDTA 14.61 g of EDTA was dissolved in 100 ml dH2O 0.5 M 
20%  10 ml of TritonX-100 dissolved in 50 ml of 20% 
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Triton X-100 RNase-free water and stored at +4
o
C. 
RNA-FLAG 
Lysis buffer 
HEPES (1 ml of 0.5 M) 
NaCl (10 ml of 1 M) 
EDTA (3 ml of 0.5 M) 
Triton X-100 (1.25 ml of 20%) 
RNasin 
The volume was adjusted to 50 ml with RNase-
free water. Before use, one complete mini 
protease inhibitor cocktail tablet and 10 µg 
tRNA/10 ml of buffer was dissolved and the 
solution was sterile filtered.  
10 mM 
200 mM 
30 mM 
0.5% 
200 U/ml  
RNA-FLAG 
wash buffer 
HEPES (1 ml of 0.5 M) 
NaCl (25 ml of 1 M) 
EDTA (3 ml of 0.5 M) 
1.25 ml of 20% 
The volume was adjusted to 50 ml with RNase-
free water. Before use, 100 U RNasin and one 
complete mini protease inhibitor cocktail 
tablet/50 ml of buffer was dissolved and the 
solution was sterile filtered. 
10 mM 
500 mM  
30 mM  
0.5% Triton X-100 
 
 
3.1.4 Solutions for Genotyping 
Solution Composition 
Laird buffer 100 mM Tris, pH 8.5 
200 mM NaCl 
5 mM EDTA 
0.2% SDS 
1l dH2O  
Tris and NaCl were mixed, the pH adjusted to 8.5, and 
then EDTA and SDS were added. The volume was 
adjusted to 1l with dH2O. 
Proteinase-K (50 μg) The working concentration was 20 mg/ml in dH20. 
Doctoral thesis – Sada Turimella                                                       Materials and Methods  
 28 
70% Ethanol 70 ml of > 99% ethanol  
30 ml of dH2O 
10x Tris Borate EDTA buffer  
(10x TBE) 
1 M Tris  
0.83 M boric acid  
10 mM EDTA 
1l dH2O 
1x TBE 100 ml of 10x TBE 
900 ml of dH2O 
Ethidium Bromide (10 mg/ml) The solution was diluted 1:10 with 1x TBE. 
 
 
3.1.5 Solutions for Immunocytochemistry (ICC) 
Solution Composition 
Fixative 4% PFA, 5% sucrose in 1x PBS 
Permeabilizing Solution 0.5% Triton in 1x PBS 
Blocking Solution 1% BSA, 3% NGS in 1x PBS 
Primary antibody solution Appropriate primary antibodies were diluted in 
blocking solution. 
Secondary antibody solution Appropriate secondary antibodies were diluted in 1x 
PBS with 0.1% Tween-20. 
Hoechst 1:10,000 Hoechst, 0.1% Tween-20 in 1x PBS 
 
 
3.1.6 Solutions for Immunohistochemistry (IHC) 
Solution  Composition 
4% PFA  4 g of PFA was dissolved in 90 ml dH2O, heated to 
60
o
C and 1M NaOH was added to clear the solution. 
Later ~10 ml of 10x PBS (pH 7.4) was added, mixed 
and the pH was adjusted to 7.4. The solution was 
filtered and stored at -20
o
C. 
10x PBS (pH 7.4) 2.04 g NaH2PO4 (17 mM) and 14.77 g Na2HPO4.2H2O 
(3 mM), 87.6g NaCl (1.5 mM) were dissolved in 1l 
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dH2O and the pH was adjusted to 7.4. 
1x PBS 100 ml of 10x PBS (pH 7.4) was taken and the volume 
adjusted to 1l. 
1x PBS with  
0.01% sodium azide 
0.1 g of sodium azide was dissolved in 100 ml of 10x 
PBS, adjusted the volume to 800 ml. The pH was 
adjusted to 7.4 and the volume was adjusted to 1l with 
dH2O. 
30% sucrose in 1x PBS 30 g of sucrose was dissolved in 100 ml of 1x PBS, pH 
7.4. 
 Blocking solution 10% Normal Goat Serum (NGS), 0.4% Triton X-100 in 
1x PBS pH 7.4. 
Primary antibody solution  
 
Appropriate dilutions of primary antibodies were 
prepared in 5% NGS, 0.1% Triton X-100 in 1x PBS. 
Secondary antibody solution Appropriate dilutions of secondary antibodies were 
prepared in 1x PBS. 
Hoechst  
(Nuclei staining solution) 
1:50 dilution of Hoechst was prepared in distilled 
water. 
 
 
3.1.7 Ready-to-use solutions 
Chemical Company 
Acrylamide-Bis ready-to-use solution (30%) Merck 
Ethanol Carl Roth 
Glycerol Carl Roth 
Hoechst Molecular probes 
Methanol Applichem 
Normal Goat Serum (NGS) Millipore 
Nonidet P-40 (NP-40) Carl Roth 
Permafluor Thermo Scientific 
2-Propanol (Isopropanol) Carl Roth 
Qiazol Qiagen 
Restore Western Blot Stripping Buffer Thermo Scientific 
RNase Away Molecular Bioproducts 
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RNase Zap Ambion 
Stripping Buffer Thermo Scientific 
SuperSignal West Dura Extended Duration Substrate Thermo Scientific 
TEMED Carl Roth  
Tissue-Tek Sakura Finetek  
Triton X-100 Carl Roth 
Tween-20  Carl Roth 
 
 
3.1.8 Antibiotics 
Antibiotic Concentration  Supplier 
Ampicillin 100 μg/ml Carl Roth  
Kanamycin 50 μg/ml Carl Roth 
Penicillin/Streptomycin 100 u/ml Gibco 
 
 
3.1.9 Restriction Enzymes 
Enzyme Restriction site Incubation Heat 
inactivation 
Company 
EcoRI 5´- GAATTC –3´ 37oC 65oC/20 min NEB 
EcoRV 5’- GATATC -3’ 37oC 80oC/20 min NEB 
NotI 5’- GCGGCCGC -3’ 37oC 65oC/20 min NEB 
SalI 5’- GTCGAC -3’ 37oC 65oC/20 min NEB 
SfiI 5’- GGCCNNNNNGGCC -3’ 50oC No NEB 
XbaI 5’- TCTAGA -3’ 37oC 65oC/20 min NEB 
 
 
3.1.10 DNA Polymerases 
Enzyme Purpose Supplier 
Advantage2 polymerase 3’ RACE Clontech 
Advantage HD polymerase In-fusion cloning Clontech 
Advantage HF2 polymerase Cloning Clontech 
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GoTaq Flexi DNA polymerase Genotyping Promega 
Platinum Taq DNA polymerase Nested PCR Invitrogen 
Superscript III reverse transcriptase Reverse transcription Invitrogen 
Taq DNA polymerase First round of PCR Invitrogen 
 
3.1.11 Antibodies 
3.1.11.1 Primary Antibodies 
Antibody Species Type Dilution 
(WB) 
Dilution 
(ICC/IHC) 
Catalogue 
no. 
Company 
β-actin Ms M 1:5000 ----- A3853 Sigma-Aldrich 
β-catenin Ms  M 1:1000 1:500 MAB2081 Millipore 
ABP/GRIP2 Rb  P 1:1000 ----- AB5569 Millipore 
CPEB1  Rb  P ----- 1:100 #65 Custom made 
CPEB2  Rb  P ----- 1:250/1:500 #68 Custom made 
CPEB3 Rb  P ----- 1:100 ab10883 Abcam 
CPEB4 Rb  P ----- 1:100 #71 Custom made 
EphA4 Ms  M 1:500 ----- 37-1600 Invitrogen 
GFP Rb  P ----- 1:1000 132002/12 Synaptic 
Systems 
GFP Ch  P ----- 1:500 Ab13970 Abcam 
GluR1 Rb  P 1:1000 ----- AB1504 Millipore 
GluR2 Rb  P 1:1000 ----- AB1768 Millipore 
GLT-1 Gp  P 1:1000 ----- AB1783 Millipore 
GRIP1 Ms  M 1:1000 ----- 611318 BD Biosciences 
M2 FLAG Ms  M 1:1000 
(IP) 
----- F3165 Sigma-Aldrich 
MAP2 Ms  M ----- 1:200 
(IHC) 
188 011 Synaptic 
Systems 
MAP2 Ms  M ----- 1:100(ICC) M4403 Sigma-Aldrich 
NeuN Ms  M ----- 1:500 MAB377 Millipore 
Synaptophysin Ms   ----- ----- MAB5258 Millipore 
Tubulin Ms M 1:10,000 ----- T9026 Sigma-Aldrich 
Ms: mouse, Rb: rabbit, Ch: chicken, GP: guinea pig, M: monoclonal, P: polyclonal, WB: Western blotting, 
IP: immunoprecipitation, ICC: immunocytochemistry, IHC: immunohistochemistry.  
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3.1.11.2 Secondary Antibodies 
 
 
3.1.12 Kits used 
Name of the kit Company 
Advantage2 PCR kit Clontech 
Advantage HD polymerase Clontech 
BCA Protein Assay kit Pierce 
Endofree plasmid maxi kit Qiagen 
Expand High Fidelity PCR System Roche  
In-fusion Dry down PCR cloning kit Clontech 
Marathon Ready cDNA amplification kit Clontech 
PeqGold Gel Extraction kit (C-Line) Peqlab 
PeqGold Plasmid Miniprep kit I (C-Line) Peqlab 
PureLink HiPure Plasmid Filter Midiprep kit Invitrogen 
QIAprep Spin Miniprep kit Qiagen 
QIAquick Gel extraction kit Qiagen 
RNeasy Mini kit Qiagen 
TOPO XL PCR Cloning kit Invitrogen 
Wizard SV Gel and PCR Clean-up system Promega 
Wizard Plus SV Miniprep DNA Purification system Promega 
 
 
Antibody Dilution Company 
Sheep anti-mouse-HRP 1:10,000 (WB) Amersham 
Donkey anti-rabbit-HRP 1:10,000 (WB) Amersham 
Goat anti-guinea pig-HRP 1:5,000 (WB) Abcam 
Alexa 488 Goat anti mouse IgG 1:500 (IHC) Molecular Probes 
Alexa 488 Goat anti rabbit IgG 1:500 (IHC) Molecular Probes 
Alexa 594 Goat anti mouse IgG 1:500 (IHC) Molecular Probes 
Alexa 594 Goat anti rabbit IgG 1:500 (IHC) Molecular Probes 
Alexa 488 Goat anti chicken IgG 1:500 (IHC) Molecular Probes 
WB: Western blotting, IHC: immunohistochemistry. 
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3.1.13 Competent E. coli 
Competent cells Source 
Fusion Blue Competent E. coli Clontech 
TOP10 chemically competent E. coli Invitrogen 
TOP10 chemically competent E. coli Made in the lab (Appendix A9.1) 
 
 
3.1.14 Molecular weight markers 
Marker Company 
1 kb DNA Extension Ladder (1 µg/µl) Invitrogen 
100 bp  DNA Ladder (1 µg/µl) Invitrogen 
DNA Molecular Weight Marker VIII Roche 
Novex Sharp Protein Standard Invitrogen 
 
 
3.1.15 General lab materials 
Material Company 
Agarose Invitrogen 
Blotting paper Whatman 
Cell culture equipment Gibco/Invitrogen 
Sterile Filters Whatman 
Sterile filters Millipore 
LB Agar Carl Roth 
LB broth Carl Roth 
SuperFrost Ultra Plus microscope slides Thermo Scientific 
Proteinase-K Carl Roth 
Pipette tips, plastic ware Sarstedt 
Polyvinylidene fluoride (PVDF) membrane Millipore 
27G needles B. Braun 
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3.1.16 Laboratory Equipment 
Equipment Company 
ABI 7900HT Fast Real-Time PCR system Applied Biosystems 
Axiophot microscope Carl Zeiss 
Biophotometer Eppendorf 
Centrifuge 5424 Eppendorf 
Cooled centrifuge Thermo Scientific 
Cryo-star 560 Cryostat Microm 
DynaMag magnet Invitrogen 
Gel documentation system Syngene 
Gene Gnome Imaging system Syngene 
Heat block VWR 
Heildolph Rotamax120 Heidolph 
Heraeus Labofuge 400 centrifuge Thermo Scientific 
Microwave Severin 700 
Mycycler Thermal Cycler Bio-rad 
Nanodrop Eppendorf 
Pearl Nanophotometer Implen 
Owl Agarose gel electrophoresis systems Thermo Scientific  
pH meter Mettler Toledo 
PTC-200 Peltier Thermal Gradient Cycler  Bio-Rad 
Rotator PTR-30 Grant Bio 
SDS gel Electrophoresis power supply Bio-Rad 
Shaker Grant Bio 
Vortexer VWR 
Water bath P-D Industriegesellschaft GmbH 
Weighing balance Acculab 
Western blot module Invitrogen 
37
o
C incubator Binder 
37
o
C shaking incubator G.F.L 
55
o
C shaking water bath Memmert 
+4
o
C Refrigerator Liebherr 
-20
o
C Freezer Liebherr 
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-80
o
C Freezer Thermo Scientific 
 
 
3.1.17 Softwares used 
Software Purpose Source 
Gene Tools Quantification of Western blots Syngene 
In-fusion primer 
designer 
Designing primers for in-fusion cloning Clontech 
Multalin Alignment of DNA sequences (Corpet, 1988) 
Primer3 Designing PCR primers  (Rozen and Skaletsky, 
2000) 
Primer Express 3.0 Designing primers/probe set for  
Real Time PCR 
Applied Biosystems 
SDS 5.0 qPCR  Quantitative Real Time PCR Applied Biosystems 
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3.2 Methods 
 
3.2.1 RT-PCR of rat/human hippocampus 
Human brain hippocampal cDNA was purchased from Clontech (France) where as rat brain 
hippocampal cDNA was isolated in the lab. Hippocampus was isolated from rat brain, 
homogenized in trizol and then chloroform was added and mixed vigorously for 30 sec. The 
tubes were centrifuged at 10,000g for 10 min at 4
o
C and the upper aqueous layer was 
collected into new eppendorf tubes. The RNA was precipitated with isopropanol, incubated 
on ice for 10 min and centrifuged at 10,000g for 10 min at 4
o
C. The supernatant was removed, 
washed with 70% ethanol and centrifuged at 7,500g for 5 min at 4
o
C. Ethanol was removed, 
the RNA pellets were air dried for 5 min and dissolved in DEPC-water and the RNA samples 
were stored at -20
o
C until use. The first strand cDNA was synthesized from the RNA samples 
using Omniscript RT kit (Qiagen, Hilden, Germany), protocol followed according to 
manufacturer’s instructions.  
 
The hippocampal cDNAs from rat and human brains was PCR amplified with the 
corresponding species specific primers. Accuprime kit (Invitrogen, Darmstadt, Germany) with 
the following PCR program was used: initial denaturation at 94
o
C/2 min, followed by 35 
cycles of denaturation at 94
o
C/30 sec, annealing at 54
o
C (rCPEB2) or 55
o
C 
(rCPEB2/hCPEB2/hCPEB3) or 58
o
C (rCPEB4) or 53
o
C (hCPEB4) for 30 sec, 68
o
C/1 min 
and a final elongation at 68
o
C/20 min. The primers used were, rCPEB3: 5’- GGA TAT GAT 
CAG GAC TGA TCA TGA GCC TCT GAA AG -3’ (forward) and 5’- CCA TGG CTG TCA 
TCC AAG AAG GCG TC -3’ (reverse); rCPEB4: 5’- CCC AGG ACA TTT GAC ATG CAC 
TCA TTG -3’ (forward) and 5’- CAG ACC ACT GTG AAG AGG CTG GTC CCC ACG G -
3’ (reverse). hCPEB2: 5´- AAC TCC ATC ACT GAC TCC AAA ATC T -3´ (forward) and 
5´-  CAA GCC ATC ATC TAT TGG AAA GAG GGA AGA -3´ (reverse); hCPEB3: 5´- 
CAA AAA GCC CTT CTC CAG CAA C -3´ (forward) and 5´- TTC AGC TTT GTG AGG 
CCA GTC TA -3´ (reverse); hCPEB4: 5´- CAG CTC TGC CTT TGC ACC TAA AT -3´ 
(forward) and 5´- GGC CAT CAT CCA AGA ATC CAT C -3´ (reverse). For rCPEB2, 
primers #177 and #179 listed in table 8 were used.  
 
The PCR products were run on a 1.5% agarose gel, the bands excised and cloned into PCR-
XL-TOPO vector (Invitrogen) with manufacturer’s instructions. TOP10 E. coli were 
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transformed with the resulting clones and the DNA was plated onto Luria Bertani (LB) plates 
containing 50 µg/ml kanamycin (Carl Roth, Karlsruhe, Germany) and incubated overnight at 
37
o
C.  Single colonies were inoculated each in 2 ml of LB with kanamycin and grown 
overnight at 37
o
C with 250 rpm rotation. After 12-16 h of incubation, DNA was isolated from 
overnight cultures using Qiagen miniprep kit (Qiagen) with manufacturer’s instructions. The 
concentration of minipreps was checked and the DNA was sent for sequencing (Sequencing 
service, Qiagen). For sequencing, two primers which bind in the TOPO vector region (M13f-
20 and M13r-24) were used. The Multalin program (Corpet, 1988) was used to align the 
sequencing reads with reference sequences of different CPEBs and the different splice 
isoforms for each CPEB were analyzed.  
 
3.2.2 Immunocytochemistry 
The expression of all CPEBs (1-4) was investigated in primary hippocampal cultures (PHCs). 
The cultures were provided by Dr. Georg Zoidl, Ruhr University, Bochum (Zoidl et al., 
2002). Experiments were done on 7 day old cultures (7 days in vitro, DIV). The cells were 
plated on cover slips, washed twice with 1x PBS (5 min each) and fixed with 4% PFA and 5% 
sucrose in 1x PBS for 20 min at room temperature. After fixing, they were washed two times 
with 1x PBS (each time 5 min) and permeabilized using 0.5% triton in 1x PBS for 5 min at 
room temperature. After washing twice quickly with 1x PBS, blocking was done with 1% 
BSA, 3% normal goat serum (NGS) for 1h at room temperature. Then, they were incubated in 
respective primary antibodies diluted in blocking solution overnight at 4
o
C. The antibodies 
used were custom made affinity purified rabbit polyclonal antibodies raised against CPEB1 
(#65; 1:100), CPEB2 (#68; 1:250) and CPEB4 (#71; 1:100) (Eurogentec, Cologne, Germany). 
For CPEB3, a 1:100 dilution of rabbit polyclonal antibody from Abcam (ab10883) was used 
(Abcam, Cambridge, UK). Double stainings were performed together with neuron-specific 
MAP2 antibody for specificity (cat. No. 4403; 1:100, mouse monoclonal, Sigma-Aldrich, 
Munich, Germany). After 24h incubation, the cells were washed three times with 1x PBS (5 
min each) and incubated with secondary antibodies (1:500, Alexa 488 goat anti-rabbit and 
1:500 Alexa 594 goat anti-mouse) for 1h at room temperature. They were washed again with 
1x PBS (3 times, 5 min each), followed by counterstaining with Hoechst (1:10,000 in 0.1% 
tween-20 in dH2O) for 5 min. After washing with 1x PBS (3 times, 5 min each), the cover 
slips were mounted in Prolong Gold (Invitrogen).  
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3.2.3 Single cell RT-PCR 
 
3.2.3.1 Harvesting cytoplasm from neurons, astrocytes, NG2 glia and microglia 
The cell type specific expression of different CPEBs (1-4) was investigated using single cell 
(sc) RT-PCR. A two round multiplex PCR was done from harvested cytoplasm of different 
cell types (neurons, astrocytes, NG2 glia and microglia) after electrophysiological 
characterization of the cell type. For harvesting CA1 pyramidal neurons and astrocytes, 
hGFAP/EGFP transgenic mice (Nolte et al., 2001) were used. For harvesting NG2 cells, 
NG2ki-EYFP mice (Karram et al., 2008) were used. For harvesting microglia, Cx3cr1ki-
EGFP mice were used. The different cell types were identified based on their current pattern 
and morphology. The harvesting was done by Dr. Peter Bedner and Mr. Vamshidhar Vangoor 
in the institute. The mice were anesthetized and the brain was isolated. Hippocampal coronal 
sections of 200 μm thickness were made with a vibratome (Leica Microsystems, Wetzlar, 
Germany) and incubated in artificial cerebrospinal fluid (ACSF) with continuous carbogen 
supply. There are two types of glial cells which co-exist in the mouse hippocampus (Matthias 
et al., 2003) which include astrocytes and NG2 glia. These two cell types differ in their 
current patterns, antigen profiles as well as in their functional properties (Wallraff et al., 
2004). As various reporter mice were used for harvesting, the different cell types were 
identified because of their fluorescence. Astrocytes can be identified by their time and voltage 
independent passive current pattern whereas NG2 glia shows a time and voltage dependent 
complex current pattern (Matthias et al., 2003). Membrane currents were measured in the 
whole cell configuration in situ with an upright microscope Nikon Eclipse FN1 equipped with 
infra red differential interference contrast (IR/DIC) optics (Nikon, Dusseldorf, Germany). 
Current signals were amplified (EPC-8, HEKA, Lambrecht, Germany), filtered at 3 and 10 
kHz and sampled at 10 and 100 kHz by an interface connected to a computer system. After 
electrophysiological characterization of different cell types, the cytoplasm of the respective 
cell was harvested under careful supervision with an CCD camera (VX45, Optronics, Kehl, 
Germany) in a tube filled with DEPC-water (~3 μl). The tubes were frozen immediately in 
liquid nitrogen, and then stored at -80
o
C until use. The authenticity of the harvested cytoplasm 
was tested by amplifying with cell-type specific markers (synaptophysin for neurons, S100β 
for astrocytes, NG2 for NG2 glia and Iba-I for microglia). The procedure of patch clamping 
and harvesting cytoplasm from a typical pyramidal neuron is depicted schematically in figure 
10A. The typical current patterns of all the cell types analyzed are shown in figure 10 B-D. 
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Figure 10: A) Procedure for patch clamp analysis and subsequent harvesting of cytoplasm from a typical 
pyramidal neuron. The figure was adopted and modified from Seifert and Steinhaeuser, (2007). B-D: Typical 
current patterns of different neural cells analyzed: B) Astrocytes C) NG2 glia and D) Microglia. na – nano 
amperes, s – seconds.  
 
 
3.2.3.2 Reverse transcription of RNA to first strand cDNA 
RNA present in the cytoplasm of harvested cells was reverse transcribed to synthesize first 
strand cDNA. Superscript III reverse transcriptase (Invitrogen) was used and the reaction mix 
is shown in table 5. The reaction mixture was added to the cytoplasm harvested and incubated 
at 37
o
C for 1h. 
5x RT buffer (Invitrogen) 2 μl 
10 mM Dithiothreitol (DTT) (Invitrogen) 1 μl 
dNTPs (2.5 mM each) (Applied Biosystems)  1 μl 
Recombinant RNasin ribonuclease Inhibitor  (40 U/μl; Promega) 0.5 μl 
Random hexamer  (50 U/ml; Roche) 0.5 μl 
100 U/μl Superscript III reverse transcriptase (Invitrogen) 0.5 μl 
Total volume  5.5 μl 
Table 5: Reaction mix for Reverse transcription reaction.  
 
3.2.3.3 Two round multiplex PCR 
A two round multiplex PCR was done in parallel to identify both the CPEB expression as well 
as expression of a cell-type specific gene to confirm the origin of cytoplasm. The schematic 
showing the two round PCR can be found in figure 11.   
Doctoral thesis – Sada Turimella                                                       Materials and Methods  
 40 
 
Figure 11: The procedure of two round multiplex PCR. As an example, primers designed for CPEB2 were 
shown in the figure; similar strategy was followed for other CPEBs as well. The splicing region of CPEB2 
contains an ‘E’ region (striped box), ‘C’ region (dotted box) and a ‘B’ region (squared box) harboring a putative 
phosphorylation site (filled circle). Both sets of primers were marked in the CPEB2 coding region. The arrows 
represent the outer primer set where as the dotted arrows indicate the nested primer set. The nested primers flank 
the alternatively spliced region there by making it possible to detect multiple isoforms by PCR. RRM – RNA 
recognition motif, Zn2+ - zinc finger. 
 
In the first round of PCR, two sets of primers were added to the reaction mix (one for a 
housekeeping gene and another one for CPEB). The PCR mix was prepared as shown in table 
6. This mix was added directly to the cDNA samples and PCR amplification was applied.  
10x reaction buffer  5 μl 
2.5 mM MgCl2 2.5 μl 
Upstream primer (for CPEB1/2/3/4) (10 pmol/μl) 1 μl 
Downstream primer (for CPEB1/2/3/4) (10 pmol/μl) 1 μl 
Upstream primer (for a housekeeping gene) 1 μl 
Downstream primer (for a housekeeping gene) 1 μl 
dH2O 27.5 μl 
Total volume  39 μl 
Table 6: Master mix used for the first round of PCR. This master mix was added directly to the cDNA which is 
~10 μl. Whenever NG2 primers were used, 0.5 μl each of dimethyl sulfoxide (DMSO) and betaine were added to 
the master mix.   
 
The typical PCR program used for the first round of PCR can be found below in table 7. The 
annealing temperature used for CPEB1 was 51
o
C and for CPEBs (2-4), 54
o
C. 
95oC 3 min 
85oC hold (during this time, 1 μl of Taq DNA polymerase was added) 
95oC 25 sec 
54oC 2 min  
95oC   25 sec 
54oC 45 sec 
72oC 25 sec 
72oC   7 min 
Table 7: PCR program used for the first round of PCR.  
 
5x 
40x 
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All the primers were designed using Primer 3.0 software (Rozen and Skaletsky, 2000) and 
synthesized from MWG. The annealing temperatures were calculated depending on the 
melting temperatures of the primers used in that particular master mix. A list of primers used 
can be found below in table 8.  
Primer Sequence Gene 
C1 outer left 5´- AGGCTGCAGCTGTGAATGAAGCTA -3´  
 
CPEB1 
C1 outer right 5´- CAAGACCCAAGGGATTACCTGTACC -3´ 
# 31 5´- AGGCCATCTGGGCTCAGCGGG -3´ 
# 52 5´- GGATTGGTTAACACCTTCCGTGTTTTTGGC -3´ 
Primers C1 outer left and C1 outer right (outer set), primers 31 and 52 (nested set) 
# 194 5´ - TAC TCC ATC ACT GAC TCC AAA ATC T – 3´  
 
CPEB2 
# 195 5´ - AAA TAG GAT TTA CTT TCT GCT TTG TGG – 3´ 
# 177 5´ - ATG TGT TCA GGA CAG ACA ACA ATA GTA ACA – 3´ 
# 179 5´ - CAA GCT ATC ATC TAT TGG AAA TAG GGA AGA –3´ 
Primers 194 and 195 (outer set), primers 177 and 179 (nested set) 
# 34 5´ - GGT CGG CGT GGG CGT GGG TGT AGG TGT G – 3´  
 
CPEB3 
# 60 5´ - GTC CAC CAC AAG GGG TCC AAA CCT GCG AAA GC – 3´ 
# 81 5´ - GGA TAT GAT AAG GAC TGA CCA TGA GCC TCT GAA AG –3´ 
# 82 5´ - CCA TGG CTG TCA TCC AAG AAG GCG TC – 3´ 
Primers 34 and 60 (outer set), primers 81 and 82 (nested set) 
# 209 5´ - AGC AGC TAC CAG AGT CCT TCT CCA – 3´  
 
CPEB4 
# 210 5´ - TCA TCA ATA TCA GGA GGC AAT CCA – 3´ 
# 55 5´ - CCC AGG ACG TTT GAC ATG CAC TCA CTG – 3´ 
# 54 5´ - CAG ACC ACT ATG AAG AGG TTG ATC CCC ACG –3´ 
Primers 209 and 210 (outer set), primers 55 and 54 (nested set) 
Syn us 5’-AGG TGC TGC AGT GGG TCT TT -3’  
 
Synaptophysin 
Syn ds 5’- GTC TGG CGG CAC ATA GGC ATC T -3’ 
Syn ne us 5’- CGG CTG AGC GTG GAG TGT GC -3’ 
Syn ne ds 5’- AGG GCC CCC ATGGAG TAG AGG AA -3’ 
Primers Syn us and ds(outer set), primers Syn ne us and ne ds (nested set) 
S100β us 5’- AGG CCA TGG TTG CCC TCA TTG AT -3’  
S100β S100β ds 5’- ACT CAT GGC AGG CCG TGG TCA -3’ 
S100β ne us 5’- TAC TCC GGG CGA GAG GGT GAC AA -3’ 
S100β ne ds 5’- GGC GAC GAA GGC CAT GAA CTC C -3’ 
Primers S100β us and ds (outer set), primers S100β ne us and ne ds (nested set) 
NG2 us 5’- CACACTTCTCCTGGACATTTCTTC- 3’  
 
NG2 
NG2 ds 5’- TGGCAGGTGGTGAGGACAGT- 3’ 
NG2 ne us 5’- GGAGGGCACCCGGAAGTTGA- 3’ 
NG2 ne ds 5’- GCTGGGCATGGAGGAGTCG- 3’ 
Primers NG2 us and ds (outer set), primers NG2 ne us and ne ds (nested set) 
Iba-I us 5’-TTCCTCGATGATCCCAAATAC-3’  
 
Iba-I 
Iba-I ds 5’-CTGTAGGTGGAGGTTAGT-3’ 
Iba-I ne us 5’-GGATCTGCCGTCCAAACTTGAA-3’ 
Iba-I ne ds 5’-GAGAACGGGTCGTAGTAAGACTC-3’ 
Primers IbaI us and ds (outer set), primers IbaI ne us and ne ds (nested set) 
Table 8: List of primers used for single cell RT-PCR.  
 
The second PCR (nested) was performed using nested primers and 2 µl of first PCR product 
as a template. The master mix and PCR program used for nested PCR were as in tables 9 and 
10 respectively.  
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10x reaction buffer  5 μl 
2.5 mM MgCl2 2.5 μl 
dNTPs (2.5 mM each) 1 μl 
Nested upstream primer (for CPEB1/2/3/4) (10 pmol/μl) 1 μl 
Nested downstream primer (for CPEB1/2/3/4) (10 pmol/μl) 1 μl 
Platinum Taq DNA polymerase  0.5 μl 
dH2O 37 μl 
Total volume  48 μl 
Table 9: Master mix used for nested PCR. This table shows a typical master mix prepared for nested PCR. Two 
PCRs were performed with a similar mix as above in parallel, one for CPEB (1/2/3/4) and another one for a 
house keeping gene (synaptophysin/s100β/NG2/Iba-I). Respective nested primers (table 11) were used. 0.5 μl of 
each of DMSO and betaine were added to the master mix when NG2 primers were used.  
 
95oC 25 sec 
95oC 25 sec            5x   
54oC 2 min 
95oC 25 sec           30x 
54oC 25 sec 
72oC 25 sec 
72oC   7 min 
Table 10: PCR program used for nested PCR.  
 
3.2.3.4 Analysis of the PCR products 
The PCR products were run on 1.5% agarose gel at 90 V for 1.5 h. A DNA ladder was run 
along with the samples to estimate the size of the PCR product. The bands corresponding to 
different PCR products were excised and the DNA was purified using Peqlab gel extraction 
kit (Peqlab) according to the manufacturer’s instructions. The purified PCR products were 
cloned into PCR-XL-TOPO vector. TOP10 competent E. coli (Invitrogen) were transformed 
with the TOPO cloned gel products and the DNA was plated on to LB plates with 50 µg/ml 
kanamycin (Carl Roth), incubated overnight at 37
o
C overnight. The procedure was done 
according to the manufacturer’s instructions.  
 
Single colonies were placed in 2 ml of LB medium with kanamycin (50 µg/ml) (Carl Roth) 
and incubated at 37
o
C overnight with 250 rpm rotation. After 12-16 h of incubation, DNA 
was isolated from overnight cultures using the Peqlab miniprep kit (Peqlab, Erlangen, 
Germany) or Promega miniprep kit (Promega, Mannheim, Germany). The procedure was 
followed as per the manufacturer’s instructions. The concentration of minipreps was checked 
Doctoral thesis – Sada Turimella                                                       Materials and Methods  
 43 
after which the DNA was sent for sequencing (Qiagen). For sequencing, two primers which 
bind in the TOPO vector region (M13f-20 and M13r-24) were used. The Multalin program 
(Corpet, 1988) was used to align the sequencing reads with reference sequences of different 
CPEBs and the different splice isoforms for each CPEB were analyzed.  
 
3.2.4 Generation of vectors for generation of transgenic mice 
In order to study CPEB2 function in neurons, transgenic mice which overexpress CPEB2 
protein specifically in pyramidal neurons of the mouse hippocampus were generated using the 
tet-OFF system. The CamKIIα promoter was used to drive the expression of transgene; tTA in 
turn binds to tetO and drives transgene expression (Gossen and Bujard, 1992; Mayford et al., 
1996) specifically in pyramidal neurons. Both CPEB2-EGFP and CPEB2∆Zn-EGFP proteins 
were cloned separately into the pMM403-400 vector, which has tetO and a simian virus 
polyadenylation signal (SV40 pA), using in-fusion technology (Clontech).  
 
3.2.4.1 Restriction digestion of pMM403-400 vector 
Five micrograms of pMM403-400 vector was digested with EcoRV (New England Biolabs, 
Frankfurt, Germany) for 2 h at 37
o
C. The enzyme mix used for restriction digestion is shown 
in table 11. After restriction digestion, the DNA was run on a 1% agarose gel, run for 2 h at 
90 V. The band corresponding to linearized pMM403-400 was excised and the DNA was 
purified using Qiagen Gel extraction kit according to manufacturer’s instructions (Qiagen).  
pMM403-400 midiprep DNA  
(339 ng/μl) 
14.7 μl  
NEB buffer ‘3’ 3 μl 
10x BSA 3 μl 
EcoRV 2 μl 
dH2O 7.3 μl 
Total volume 30 μl 
Table 11: Restriction digestion of pMM403-400 vector.  
 
3.2.4.2 Amplification of insert (CPEB2-EGFP/CPEB2∆Zn-EGFP) 
CPEB2 or CPEB2∆Zn-EGFP was amplified using Advantage HD Polymerase (Clontech). In-
fusion primers were designed using the in-fusion primer design tool (Clontech) and 
synthesized from MWG. Primers: INF1 (forward): 5’- GCG GAT CCT GCG GAT CCG 
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CCA TGA ATT TAC CTC AA- 3’ and INF2 (reverse): 5’- ACG TGA TGG ATG GAT TTA 
CTT GTA CAG CTC GTC CA- 3’. A two step-PCR method was employed: initial 
denaturation at 98
o
C for 30 sec followed by 30 cycles of 98
o
C/10 sec, 68
o
C/2.5 min and a 
final extension at 68
o
C for 20 min. The master mix used for the PCR was as in table 12; a 
total of 100 ng of each DNA sample was used as a template.   
5x Advantage HD buffer with Mg2+ 5μl 
dNTP mixture 2 μl 
Left primer (10 pmol/μl) 1 μl 
Right primer (10 pmol/μl) 1 μl 
Advantage HD polymerase 0.25 μl 
Template DNA (20 ng/μl) 5 μl 
dH2O 10.75 μl 
Total reaction volume 25 μl 
Table 12: PCR reaction mix for amplification of CPEB2/CPEB2∆Zn-EGFP.  
 
3.2.4.3 Infusion cloning 
As the PCR amplified products seemed to be specific without any smear, they were treated 
with cloning enhancer as per the manufacturer’s recommendations (Clontech). A 2 μl of 
cloning enhancer was added to 5 μl of PCR product and incubated at 37oC for 15 min 
followed by 80
o
C for 20 min; this mix was subsequently used in ligation reaction. Cloning 
enhancer treated PCR products (either CPEB2-EGFP or CPEB2∆Zn-EGFP) were separately 
cloned into pMM403-400 vector; the volumes of both the insert and vector were taken as in 
table 13. This mix (10 μl) was added to infusion dry-down mix and incubated at 37oC for 15 
min followed by 50
o
C for 15 min and then kept on ice. This infusion mix was diluted further 
with 40 μl of TE buffer (pH 8.0), and Fusion Blue competent cells (Clontech) were 
transformed with the plasmid according to the manufacturer’s recommendations (Clontech).  
 
Cloning enhancer treated PCR product (CPEB2/2∆Zn-EGFP) 2 μl 
Linearized pMM403-400 vector 2.2 μl 
dH2O  5.6 μl 
Total volume 10 μl 
Table 13: Infusion cloning of CPEB2/CPEB2∆Zn-EGFP into pMM403-400 vector. 
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3.2.4.4 Analysis of clones  
Single colonies from each cloning (CPEB2-pMM and CPEB2∆Zn-pMM) were inoculated 
each into 2 ml of LB with 100 μg/ml ampicillin (Carl Roth), incubated at 37oC overnight with 
250 rpm rotation. DNA was isolated from the clones using Qiagen miniprep kit with 
manufacturer’s instructions (Qiagen). The clones obtained were analyzed by restriction 
digestion of minipreps as well as by sequencing. DNA from minipreps was digested with NotI 
(NEB) at 37
o
C for 1.5 h, run on 1% agarose gel, for 2 h at 90 V. The reaction mix used for 
restriction digestion was as in table 14. The positive clones which gave expected band sizes in 
the restriction digestion were selected and sequenced at Qiagen Sequencing Service (Qiagen). 
The primers used for sequencing are primer 207: 5’- GTG ACA ATG ACA TCC ACT TTG 
CC- 3’ and primer 208: 5’- GAT CCT CTA GCA TTT AGG TGA CAC TAT AGA ATA 
GG- 3’.  
Miniprep DNA 3 μl 
NEB buffer ‘3’ 2 μl 
10x BSA 2 μl 
NotI 0.5 μl 
dH2O 12.5 μl 
Total volume 20 μl 
Table 14: Restriction digestion of CPEB/CPEB2∆Zn-pMM minis with NotI.  
 
3.2.5 Generation of transgenic mice with overexpression of CPEB2/CPEB2∆Zn in 
pyramidal neurons of mouse hippocampus 
One clone each for CPEB2 and CPEB2∆Zn with the correct reading frame was selected and 
retransformed using chemically competent E. coli made in the lab (Appendix A9.1). To each 
vial, 2 μl of DNA was added and the transformation was done as above. Single colony each 
from CPEB2-pMM and CPEB2∆Zn-pMM clonings were inoculated in 100 ml of Luria 
Bertani (LB) broth with 100 μg/ml ampicillin, incubated at 37oC overnight with 250 rpm 
rotation. Maxiprep kit (Qiagen) was used to prepare pure and endotoxin free DNA and the 
procedure was followed as in the manual.   
 
The maxipreps were digested with SfiI (NEB) for 2 h and run on 1% agarose gel.  The 
respective bands (4.1 kb band for CPEB2-pMM and 3.9 kb band for CPEB2∆Zn-pMM) were 
excised and the DNA was purified using Peqlab gel extraction kit with manufacturer’s 
instructions. Purified DNA was eluted in an injection buffer (centrifuged at 4
o
C for 20 min 
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before use), and the concentration was checked using a Pearl nanophotometer (Implen, 
Munich, Germany). The DNA was diluted with injection buffer to a concentration of 4 ng/μl 
and given to the house for experimental therapy for injection into the male pronucleus of the 
zygotes. 
 
3.2.6 Screening of newborn mice for transgene expression  
3.2.6.1 Lysis of tail tips from mice and isolation of DNA 
The mice tails were lysed in 250 μl of Laird buffer (100 mM Tris, pH 8.5, 200 mM NaCl, 5 
mM EDTA, 0.2% SDS) with proteinase-K (20 U/ml) overnight at 55
o
C. The samples were 
centrifuged at 13,500 rpm for 10 min and the supernatant was mixed with 250 μl of 
ispropanol to precipitate the DNA, centrifuged at 13,500 rpm for 10 min. The supernatant 
from this step was discarded and the DNA pellet was washed with 250 μl of 70% ethanol, 
centrifuged at 13,500 rpm for 10 min at +4
o
C. The DNA pellet was air dried for 10 min and 
later dissolved in an appropriate volume (50-100 μl) of tris EDTA (TE) buffer (pH 8.0) or in 
distilled water.  
 
3.2.6.2 Genotyping (tTA and tetO PCRs)  
The newborn pups were genotyped at three weeks of age with two different sets of primers 
(tetO PCR, table 15) to confirm the presence of transgene (tetO-CPEB2/CPEB2∆Zn). The 
reaction mix used was as in table 16. The PCR program used was initial denaturation at 
94
o
C/3 min followed by 30 cycles of 94
o
C/30 sec, 62
o
C/1 min and a final extension at 72
o
C/2 
min.  A 5 sec additional time was performed with each cycle to increase the amplification 
efficiency. 
 
Primer Sequence PCR product size 
tTA-A1  5´- GCG CTG TGG GGC ATT TTA CTT TAG -3´ 318 bp. 
tTA-A2  5´- CCG CCA GCC CCG CCT CTT C -3´ 
tTA-B1  5´- TAG AAG GGG AAA GCT GGC AAG ATT -3´ 539 bp. 
tTA-B2  5´- CCG CGG GGA GAA AGG AC -3´ 
Primer combinations: tTA A1+A2; B1+B2 
tetO-A/B  5´- GCG GCC GCC AAC TCT CG -3´ 419 bp. (A+A/B) 
445 bp. (B+A/B) tetO-A  5´- TCA AAA CAG CGT GGA TGG CGT CTC -3´ 
tetO-B  5´- GAT CGG TCC CGG TGT CTT CTA TG -3´ 
Primer combinations: tetO A+A/B; B+A/B  
Table 15: Primers used for tTA and tetO PCRs, bp: base pairs.  
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5x Promega PCR-buffer 5 µl 
25 mM MgCl2 1 µl 
2.5 mM each dNTPs 1 µl 
Primer up (10 µM)  1 µl 
Primer down (10 µM) 1 µl 
GoTaq Flexi DNA polymerase 0.2 µl 
Template DNA 1 µl 
dH2O 14.8 µl 
Total Volume 25 µl 
Table 16: The PCR reaction mix used to genotype the newborn mice.  
 
3.2.6.3 Breeding of tetO-CPEB2/tetO-CPEB2∆Zn mice with CamKII-tTA mice  
The founder animals which were positive for either tetO-CPEB2/tetO-CPEB2∆Zn transgene 
were bred with CamKII-tTA mice. The tTA binds to tetO and the CamKII promoter drives the 
transgene expression specifically in pyramidal neurons of mouse hippocampus. The newborn 
pups from the tetO-CPEB2/tetO-CPEB2∆Zn X CamKII-tTA breedings were analyzed for the 
presence of both CamKII-tTA and tetO-CPEB2/tetO-CPEB2∆Zn transgenes. For both PCRs, 
two sets of primers were used (Table 15). Both positive and negative controls were included 
in the PCR. The PCR products were run on a 1% agarose gel. Based on the amplicon size, 
double transgenic (DT) animals (with both tetO and tTA) were identified.  
 
3.2.7 Analysis of transgenic mice 
3.2.7.1 Perfusion and cryosectioning 
After genotyping, DT mice (tTA+tetO+) were selected for further screening. The mice were 
anaesthetized with 10% ketamine and cepetor and transcardially perfused with 4% PFA. The 
brains were fixed in 4% PFA overnight, then transferred to 30% sucrose in 1x PBS, left for 
24-48 h. Later, the brains were cryoprotected in tissue-tek (Sakura Finetek, Staufen, 
Germany) and stored at -80
o
C until further use. A total of five different lines were screened 
for CPEB2 (10 mice in total; lines 63, 104, 58, 94 and 27) and two different lines (6 mice in 
total; lines 35 and 6) for CPEB2∆Zn transgene expression. Coronal sections of 40 μm 
thickness were made using a Cryo-star HM560 cryostat (Microm, Walldorf, Germany) and 
stored at 4
o
C in 1x PBS with 0.01% sodium azide. 
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3.2.7.2 Immunohistochemistry 
The transgene (either CPEB2 or CPEB2∆Zn) expression was confirmed with GFP 
fluorescence since both proteins are tagged with EGFP protein at the C-terminus. The coronal 
sections from both DT animals and their control littermates were stained with rabbit GFP 
antibodies (Synaptic Systems, Goettingen, Germany). The sections were washed 3 times, 10 
min each with 1x PBS, blocked with 10% NGS (Millipore, Germany), 0.4% Triton (Carl 
Roth) in 1x PBS, pH 7.4 for 2h at RT and then incubated at 4
o
C overnight with the primary 
antibody in 5% NGS, 0.1% Triton in 1x PBS. After washing 3 times, 10 min each with 1x 
PBS, the sections were incubated in Alexa 488 goat anti-rabbit (1:500; Invitrogen) secondary 
antibody for 1.5h at room temperature. Then, the sections were washed three times 10 min 
each with 1x PBS, counterstained with Hoechst (1:50 in dH2O; Invitrogen), again washed 3 
times 10 min each and then mounted in permafluor (Thermo Scientific, Bonn, Germany). 
 
As CPEB2/CPEB2∆Zn expression is confined to pyramidal neurons of hippocampus, double 
stainings with GFP and either MAP2 (which localizes to dendrites) or NeuN (which localizes 
to neuronal cell bodies) were done. CPEB2 and GFP double stainings were also performed to 
study if there is any colocalization of endogenous and overexpressed CPEB2. The staining 
protocol was the same as above, the antibodies used were: rabbit CPEB2 purified antibody 
(custom made #68, 1:500; Eurogentec), mouse NeuN (1:500; Millipore), mouse MAP2 
(1:200; Synaptic Systems). Since β-catenin is a putative target of CPEB2, the sections were 
also stained with mouse β-catenin (1:500; Millipore) and rabbit GFP (1:1000; Synaptic 
Systems). The secondary antibodies used were Alexa 488 goat anti-rabbit (1:500; Invitrogen) 
and Alexa 594 goat anti-mouse (1:500; Invitrogen). Images were obtained using an Axiophot 
microscope (Carl Zeiss, Goettingen, Germany). Similar exposure times were set for both 
control and DT sections. The images were processed with Image J software (NIH). 
 
3.2.8 Analysis of target protein levels in CPEB2/CPEB2∆Zn transgenic mice 
3.2.8.1 Isolation of mouse hippocampus 
The mice were sacrificed by cervical dislocation; brain was isolated and divided into two 
parts. One half of the brain was used for preparing protein lysates and the other half for 
immunohistochemistry to verify the transgene expression (this half of the brain was 
immediately fixed in 4% PFA overnight at 4
o
C, then cryoprotected in 30% sucrose in 1x PBS 
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for 24-48 h and stored in tissue-tek at -80
o
C). Only the hippocampus was used for Western 
blot. If not used immediately, the tissues were frozen in liquid nitrogen and stored at -80
o
C. 
 
3.2.8.2 Preparation of hippocampal protein lysates  
To each tissue sample, 350 μl of prechilled modified RNA Immuno Precipitation Assay 
(RIPA) lysis buffer (50 mM Tris, 150 mM NaCl, 0.5% NP40, 0.5% sodium deoxycholate, 1% 
triton X-100, pH 7.5) containing complete mini protease inhibitor tablet (1 tablet/10 ml 
buffer; Roche, Mannheim, Germany) was added and homogenized using a plastic pistil until 
no further tissue chunks were visible. The lysate was passed through a 27G needle 
(prechilled) approximately 5-6 times to shear the genomic DNA, incubated on ice for 30 min 
and centrifuged at 13,000 g, 4
o
C for 30 min. After centrifugation, the protein containing 
supernatant was transferred to a fresh tube. When the samples were not clear, they were 
briefly sonicated (10 sec) and then centrifuged. Five microlitres of each supernatant was used 
for measuring the protein concentration using BCA protein assay kit and the assay was done 
as per the manufacturer’s instructions (Thermo Scientific).  
 
3.2.8.3 Western blotting 
Western blotting of the hippocampal lysates from DT animals (either tetO-CPEB2-EGFP or 
tetO-CPEB2∆Zn-EGFP) and their control littermates was done. Thirty μg of each protein 
sample was used for analysis. The samples were denatured at 65
o
C for 10 min in 3x sample 
buffer (50 mM Tris HCl (pH 6.8), 2% SDS, 100 mM DTT, 10% glycerol and 0.01% 
bromophenol blue). The denatured protein samples were run on 10% SDS-PAGE gel and 
blotted onto polyvinylidene fluoride (PVDF) membrane (Millipore) as per the manufacturer’s 
instructions (Invitrogen). The membranes were blocked for 1 h with 5% milk in 1x tris 
buffered saline containing 0.05% tween-20 (TBST) buffer and incubated with primary 
antibodies diluted in the same blocking solution with 0.01% sodium azide overnight at 4
o
C. 
For EphA4, the membrane was blocked with 1X TBST with 0.1% tween-20 and 3% BSA and 
incubated with EphA4 primary antibody in the same blocking solution with 0.01% sodium 
azide overnight at 4
o
C. Primary antibodies used were ABP (1:1000; AB5569, Millipore), β-
actin (1:5000; Sigma-Aldrich), β-catenin (1:1000; MAB2081,  Millipore), GluR1 (1:1000; 
AB1504, Millipore), GluR2 (1:1000; AB1768, Millipore), EphA4 (1:500; cat. no. 37-1600, 
Invitrogen), GLT-1 (1:500; AB1783, Millipore), GRIP1 (1:1000; cat. No. 611318, BD 
Biosciences, Heidelberg, Germany) and Tubulin (1:10,000; T9026, Sigma-Aldrich). Next 
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day, the membrane was washed 3 times with 1x TBST, incubated with respective secondary 
antibodies (diluted in 2.5% milk) for 1 h at RT. For EphA4, the secondary antibody was 
diluted in 1X TBST with 0.1% tween-20 and 3% BSA. Secondary antibodies used were 
sheep-anti-mouse IgG HRP (1:10,000; GE Healthcare, Munich, Germany), donkey-anti-rabbit 
IgG HRP (1:10000, GE Healthcare) and goat anti guinea pig HRP (1:5000, Abcam). After 
washing with 1x TBST (3 times, 5 min each time), Supersignal WestDura extended duration 
substrate (Thermo scientific) was added and the chemiluminiscence was detected using the 
Gene Gnome Imaging system (Syngene, Cambridge, UK). For loading control, membranes 
were stripped using restore western blot stripping buffer (Thermo scientific) for 15 min, 
washed with 1x TBST (3 times, 10 min each). The blots were blocked with 5% milk for 1 h at 
RT and then incubated with α-tubulin (1:10,000) or β-actin (1:5000) primary antibody 
overnight a 4
o
C. After washing with 1x TBST (3 times, 10 min each), membranes were 
incubated with respective secondary antibodies for 1 h at RT and the blots were developed as 
above.  
 
3.2.8.4 Quantification of blots 
The images were quantified by densitometric analysis using Gene tools software (Syngene). 
The values of control animals were set to 100% basing on which the values of DT animals 
were calculated. The results were normalized to loading control used (tubulin or actin). 
Statistical analysis was carried out using student’s t-test and the value p<0.05 was considered 
as significant.  
 
3.2.9 Analysis of transcript levels of different targets in CPEB2/CPEB2∆Zn transgenic 
mice 
3.2.9.1 Isolation of RNA from mouse hippocampus 
The mice were sacrificed by cervical dislocation; brain was isolated and divided into two 
parts. One half of the brain was used for isolating RNA and the other half for 
immunohistochemistry to verify the transgene expression (this half of the brain was 
immediately fixed in 4% PFA overnight at 4
o
C, cryoprotected in 30% sucrose in 1x PBS for 
24-48 h and stored in tissue-tek at  -80
o
C). Hippocampus was isolated and used for RNA 
analysis. If not used immediately, the tissues were frozen in liquid nitrogen and stored at -
80
o
C.  
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RNA was isolated using the RNeasy mini kit (Qiagen). The entire protocol was performed in 
an RNase-free environment. The hippocampus was homogenized in 1ml of qiazol each using 
a plastic pistil until no visible chunks were observed. The whole reaction mixture was 
incubated at room temperature for 5 min, 200 µl of chloroform was added and vortexed 
vigorously. It was incubated again for 3 min and centrifuged at 12,000 g for 15 min at 4
o
C. 
After centrifugation, the upper aqueous phase containing RNA was precipitated with 70% 
ethanol (600 µl each). The complete reaction mixture was then applied onto an RNeasy 
column, centrifuged at 10,000 g for 1 min. The supernatant was discarded and the columns 
were washed with 350 µl of RW buffer at 10,000 g for 1 min and the flow through was 
discarded. During this time, RNase-free DNase working solution was prepared by mixing 70 
µl of RDD buffer with 10 µl DNase. The DNase working solution was added to each column 
and incubated at room temperature for 30 min. After DNase digestion, the columns were 
washed with 350 µl of RW1 buffer and centrifuged at 10,000 g for 1 min. The columns were 
washed two times each with 500 µl of RPE buffer and centrifuged at 10,000 g for 1 min. The 
flow through was discarded and the columns were placed in a new clean 2 ml tube and 
centrifuged at 14,000 g for 5 min to remove any residual ethanol left in the column. The 
columns were transferred to a clean RNase-free tube, and the RNA was eluted with 30 µl of 
RNase-free water at 10,000 g for 1 min.  
 
3.2.9.2 Reverse transcription of RNA into cDNA 
The concentrations of all the RNA samples were checked using a Pearl nanophotometer 
(Implen) and equal amounts were taken for reverse transcription reaction. One µg of each 
RNA sample was used and the reaction mix was as in table 17. The reaction was setup in a 
thermal cycler: 50
o
C for 1 h followed by 70
o
C for 15 min (Invitrogen).  
 
5x First strand buffer 4 µl 
Dithiothreitol (DTT) 1 µl 
dNTPs  1 µl 
Random hexamers  1 µl 
Superscript III reverse transcriptase 1 µl 
RNasin  1 µl 
Template RNA 5 µl (250 ng/µl)  
dH2O 6 µl 
Total volume 20 µl 
Table 17: Reverse transcription master mix for mouse brain hippocampal RNA samples. 
Doctoral thesis – Sada Turimella                                                       Materials and Methods  
 52 
3.2.9.3 Estimating the efficiencies of real time PCR primers 
The efficiencies of the different taqman primers used were calculated using the standard CT 
slope method (Liu and Saint, 2002). The rate of amplification for each primer set was 
calculated from the linear regression slope obtained from dilution series. Mouse brain cDNA 
was serially diluted in a 10-fold dilution series (100 ng, 10 ng, 1 ng, 0.1 ng, 0.01 ng, and 
0.001 ng) and amplified with the respective primers using an ABI 7900 HT real time PCR 
system. The taqman primers and probe for each transcript were designed using primer express 
3.0 software (Applied Biosystems).  The CT values were plotted versus the concentration of 
cDNA samples. The slopes (R
2
 values) for a 10-fold dilution series of the cDNA sample were 
calculated.  The efficiencies of the amplification were calculated from the slope of the graph 
obtained for each primer set. The following equation was used for estimating the efficiency 
(E) (Higuchi et al., 1993b).  
 
E = 10 
(-1/slope) 
 
3.2.9.4 Quantitative real time PCR 
Quantitative real time PCR was performed to analyze the transcript levels of β-catenin, GluR2 
and EphA4 in DT animals compared to their control littermates. For β-catenin and GluR2, 
taqman primers and probe were designed using Primer express 3.0 software (Applied 
Biosytems). The probes are labelled at the 5’ end with fluorescein amidite (FAM) and at the 
3’ end with carboxytetramethylrhodamine (TAMRA). The β-actin primers/probe set (mouse 
ACTB, 4352933E, 5’FAM-probe-MGB3’) was provided by Dr. Gerald Seifert in the institute 
(Seifert et al., 2004). EphA4 primers and probe were ordered from Applied Biosystems 
(TaqMan Gene Expression Assays #4331182, Mm00433056_m1). The reaction mix 
contained 6.25 μl gene expression master mix (Applied Biosystems), 0.5 μl of primers/probe 
mix and 5.75 μl of diluted cDNA sample. A primers/probe mix was prepared using 10 μM of 
each primer and 5 μM probe. The cDNA dilutions were prepared using 0.5 μl of each cDNA 
and 5.25 μl of water. The amplification was performed in a 384-well plate in the ABI 7900HT 
Real Time PCR instrument (Applied Biosystems). PCR conditions used were: 50
o
C/2 min, 
95
o
C/10 min, 95
o
C/15 sec, 60
o
C/1 min. The PCR program was run for 40 cycles. Both an 
RNA control (RNA as a template without reverse transcription) and a non template control 
(NTC) were included in the reaction. The samples were analyzed in triplicates for each gene. 
Two house keeping genes: β-actin and GAPDH were used, to which the results were 
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normalized. A student’s t-test was done to analyze the statistical significance. The 
primers/probe sequences were as in table 18.   
Primer Sequence Gene 
Forward primer 5’- ACA CCT CCC AAG TCC TTT ATG AAT -3’  
β-catenin Reverse primer 5’- CCC GTC AAT ATC AGC TAC TTG CT -3’ 
Probe  5’- AGG CTT TTC CCA GTC CTT CAC GCA A -3’ 
Forward primer 5’- GAC TGA CAC CCC ATA TCG ACA A -3’  
GluR2 Reverse primer 5’- TCG CAT AGA CGC CTC TTG AA -3’ 
Probe  5’- CAG TCA CCA ATG CTT TCT GCT CCC AGT -3’ 
Forward primer 5’- CGA CAG TCA GCC GCA TCT T -3’  
GAPDH Reverse primer 5’- CCG TTG ACT CCG ACC TTC AC -3’ 
Probe  5’- CGT CGC CAG CCG AGC CAC A -3’ 
Table 18: List of Taqman primers and probes used for real time PCR. 
 
3.2.10 RNA Co-immunoprecipitation 
3.2.10.1 Generation of CPEB2-FLAG construct 
The CPEB2 coding region was PCR amplified with Advantage HD polymerase (Clontech) 
using in-fusion primers which have NotI and EcoRI restriction overhangs (underlined), 5’- 
GAC AAG CTT GCG GCC GCC ATG AAT TTA CCT CAA CAG CAG CCG CC -3’ 
(forward) and 5’- ATC TAT CGA TGA ATT CGC TTA GTT CCA GCG GAA GTG GAT 
CTG ACG T -3’ (reverse). The PCR product was treated with cloning enhancer and further 
cloned into p3xFLAG-CMV-7.1 vector (Sigma-Aldrich) which was pre-digested with the 
same set of enzymes. TOP10 E. coli (Invitrogen) were transformed with the resulting plasmid 
and the positive clones were selected by ampicillin resistance as well as by sequencing the 
minipreps (Qiagen).  
 
3.2.10.2 Generation of EphA4 3’UTR-PGL construct 
The 3’UTR region of EphA4 which contains two CPEs was PCR amplified using Advantage 
HF 2 Polymerase and primers which have XbaI and SalI restriction overhangs (underlined), 
5’- TCT AGA GAA CAT CTC TTG GTT CAT ACA TGT TCC -3’ (forward) and 5’- GTC 
GAC CAG GTT TGT ATA CGG CAA CTA C -3’ (reverse). The obtained PCR product was 
run on a 1.2% agarose gel, the band excised and cloned into PCR-XL-TOPO vector. It was 
digested with XbaI and SalI and ligated into pGL4.75 luciferase vector (Promega) which was 
pre-digested with the same set of enzymes. TOP10 E. coli were transformed with the resulting 
plasmid and the positive clones were selected by ampicillin resistance as well as by 
sequencing the minipreps.  
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3.2.10.3 Transfection of HeLa cells 
HeLa cells were cultured regularly in Dulbecco’s Modified Eagle’s Medium (DMEM) 
(Invitrogen) with 10% heat inactivated foetal calf serum (FCS) (Gibco/Invitrogen) and 
penicillin-streptomycin (100 U/ml). The cells were trypsinized and 1.5 x 10
6
 cells were plated 
in each 10 cm dish and grown to 90% confluence for transfection. The cells were transfected 
with Lipofectamine as per the manufacturer’s recommendations (Invitrogen). The cells were 
transfected with either CPEB2-FLAG or FLAG-GFP (a control vector) and the CPEB2 that 
was bound to the endogenous β-catenin mRNA was co-immunoprecipitated using mouse 
monoclonal M2 FLAG antibodies (Sigma-Aldrich). In another experiment, cells were 
transfected with either full length (CPEB2-EGFP) or truncated CPEB2 constructs 
(CPEB2∆Zn-EGFP) and the CPEB2 that was bound to endogenous β-catenin mRNA was co-
immunoprecipitated using CPEB2 serum (custom made, designated as # 94). Similarly, the 
cells were transfected with either CPEB2-FLAG or FLAG-GFP and EphA4 3’UTR-PGL 
constructs, and the CPEB2 that was bound to EphA4 mRNA was co-immunoprecipitated 
using mouse monoclonal M2 FLAG antibodies.  
 
For CPEB1/2-CamKIIα co-immunoprecipitation, HeLa cells were transfected either with 
FLAG tagged CPEB1/CPEB2 or FLAG-GFP (a control vector) and CamKIIα 3’UTR-PGL 
constructs and CPEB1/2 that was bound to the CamKIIα mRNA was co-immunoprecipitated 
using mouse monoclonal FLAG antibodies (Sigma-Aldrich). Similarly the cells were 
transfected either with FLAG tagged CPEB1/CPEB1Δ5/CPEB1Δ17 and CamKIIα 3’UTR-
PGL constructs and CPEB1/CPEB1Δ5/CPEB1Δ17 isoforms that were bound to the CamKIIα 
mRNA was co-immunoprecipitated using mouse monoclonal M2 FLAG antibodies (Sigma-
Aldrich).  
 
3.2.10.4 Co-immunoprecipitation  
The co-immunoprecipitation of β-catenin or EphA4/CamKIIα mRNAs was done using either 
CPEB2 serum or M2 FLAG antibodies respectively. The cells were washed briefly with 8 ml 
of prechilled 1x PBS and lysed in 1 ml of lysis buffer (10 mM HEPES, 200 mM NaCl, 30 
mM EDTA, 0.5% triton X-100) with additives (200 U/ml RNasin, one protease inhibitor mini 
cocktail tablet/10 ml buffer, 1 µg tRNA/1 ml buffer). The cells were scraped using an ice cold 
cell scrapper for 1 min into a prechilled eppendorf tube. The cell lysates were passed through 
a 27 G prechilled needle to completely lyse the cells. The cells were centrifuged at 16,000 g 
Doctoral thesis – Sada Turimella                                                       Materials and Methods  
 55 
for 20 min and 1 ml of the supernatant was added to equilibrated Protein-A Sepharose (PAS) 
beads. The remaining material was used for Western blotting to confirm the expression of 
transfected construct. The equilibration of PAS beads was done as below: approximately 60 
µl of slurry was taken; 1 ml of lysis buffer with out additives was added and centrifuged at 
6000 g for a few minutes. The buffer was removed and fresh buffer was added. This was 
incubated at 4
o
C for 1 h on a POS-300 rotator (Grant-Bio, Cambridgeshire, GB) with 10-12 
rpm speed. After this incubation, the beads were pelleted down by centrifuging at 8000 g for 2 
min. The preadsorbed lysates were transferred to equilibrated protein G Dynabeads (PGDB) 
(30 µl each). The equilibration of PGDB beads was done as below: 30 µl of beads were 
aliquoted in each tube, 1 ml of lysis buffer without additives was added and later removed 
using Dynamagnet (Invitrogen). The equilibrated PGDB beads were blocked each with 500 µl 
of lysis buffer (containing 1 µg tRNA per 30 µl of beads /500 µl lysis buffer with 3% BSA) 
for 1 h. To these beads, the preadsorbed lysates were added, and either 50 µl of CPEB2 serum 
or 10 µl of M2 FLAG (mouse monoclonal, Sigma-Aldrich) was added and incubated for 2-3 h 
at 4
o
C on a rotator with 10-12 rpm speed. After this incubation, 30 µl of sample was taken out 
as input, 350 µl of RLT buffer (RNeasy kit, Qiagen) was added and freezed the tubes. The 
beads were washed 5-10 times, each time for 5 min with 1 ml of wash buffer (10 mM HEPES 
(pH 7.4), 500 mM NaCl, 30 mM EDTA, 0.5% triton X-100) with additives (100 U RNasin 
and one complete mini protease inhibitor cocktail table/50 ml of buffer). After washes, 350 µl 
of RLT buffer from RNeasy kit (Qiagen) was added to each tube and freezed the tubes.  
 
3.2.10.5 Isolation of RNA from co-immunoprecipitated samples 
RNA was isolated from both inputs and co-immunoprecipitated (pull downs) samples using 
RNeasy mini kit (Qiagen); the experiment was done in an RNase-free environment. To each 
tube, 245 µl of 100% ethanol (0.7 volume of the sample) was added and mixed by inverting 
the tubes several times. This mixture was applied onto the columns (provided in the kit) and 
centrifuged at 10,000 g for 1 min. After this step, isolation of RNA was performed as in 
methods part 3.2.9.1. The RNA samples were stored at -20
o
C until further use.  
 
3.2.10.6 Quantitative real time PCR 
The eluted RNA samples were subjected to reverse transcription as in methods part 3.2.9.2. 
The concentrations of RNA samples from inputs were checked and equal amounts RNA 
samples were taken for reverse transcription reaction. For pulldowns, 10 µl of each RNA 
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sample was used. The conditions used were: 50
o
C for 2 h followed by 70
o
C for 15 min) 
(Invitrogen). To analyze β-catenin or EphA4 transcript levels, quantitative real time PCR was 
done from the cDNA samples using luciferase primers. Porphobilinogen Deaminase (PBGD) 
was used as a housekeeping gene to which the results were normalized. The reaction mix 
contained gene expression master mix, luciferase primers/probe mix and diluted cDNA 
samples. The PCR conditions and the master mixes were as above in methods part 3.2.9.4 
with following modifications: 60 repeats were done instead of 40. The primers/probe 
sequences used for firefly luciferase were 5’- GGC TCC CGC TGA ATT GG -3’ (forward), 
5’- GCG ACA CCT GCG TCG AA -3’ (reverse) and 5’- ATC CAT CTT GCT CCA ACA 
CCC CAA CA -3’ (5’FAM-probe-TAMRA-3’); and for human PBGD were 5’-GCT ATG 
AAG GAT GGG CAA CT-3’ (forward), 5’-GTG ATG CCT ACC AAC TGT GG-3’ (reverse) 
and 5’-TGC CCA GCA TGA AGA TGG CC-3’ (5’FAM-probe-non fluroscent-3’).  
 
3.2.11 Dual luciferase reporter assay 
The 3’UTR region of Connexin36 (Cx36) which contains two CPEs was PCR amplified using 
Advantage HF PCR kit (Clontech) and primers which contain XbaI and SalI restriction 
overhangs (underlined), 5’- CTC TAG AGG GCA GGT TTG GGG -3’ (forward) and 5’- 
GTC GAC CCA GTT TAC AAA AAA AGG C -3’ (reverse). The PCR program was 94oC/15 
sec, 30 cycles of 94
o
C/15 sec, 52
o
C/1.5 min, 68
o
C/1.5 min with a final extension of 68
o
C/3 
min. The obtained PCR product was cloned into pGL4.75 vector (Promega) which was pre-
digested with the same set of enzymes. TOP10 E. coli (Invitrogen) were transformed the 
ligated product and the positive clones were selected by ampicillin resistance as well as by 
sequencing the minipreps.  
 
Approximately 150,000 HeLa cells/well were plated in 24-well plate and were grown to 90% 
confluence. Next day, the cells were transfected with CPEB2-EGFP (200 ng per well) and 
Cx36 3’UTR-PGL (200 ng per well) constructs using Lipofectamine 2000 (Invitrogen) 
following manufacturer’s instructions. For knockdown, 40 pmol of siRNA against CPEB2 or 
a negative control siRNA was used per well. The siRNAs used were, AUA UCU GAU UCA 
UAG UCC CCC (CPEB2), UAA GCA CGA AGC UCA GAG UCC CCC (negative control), 
purchased from Riboxx GmbH (Radebeul, Germany). 24 h post transfection, the cells were 
washed 3 times with 1x PBS, lysed in passive lysis buffer (1 ml/well) with 1000U of RNasin 
(Promega) and then incubated at room temperature for 10 min with rotation. Twenty 
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microlitres of each lysate was used for assay using Dual luciferase system (Promega) in a 96-
well polypropylene plate. Each assay was done in triplicates and the luminescence of both 
firefly and renilla luciferases were measured. FLAG-GFP was used as a non specific control 
to which the results were normalized. The ratio of firefly to renilla luciferase was calculated 
and the values were plotted in a graph.  
 
3.2.12 Rapid Amplification of cDNA Ends (3’ RACE) of CPEB2 
To analyze the 3’UTR of CPEB2, 3’RACE of mouse brain cDNA was performed using the 
Marathon cDNA Amplification kit (Clontech) and Advantage 2 polymerase. The master mix 
used for the PCR is shown below in table 19.  
Marathon-Ready cDNA 5 μl  
Gene specific primer (3R 1.1) (10 pmol/μl) 1 μl 
Adapter primer (AP1) 1 μl 
10x Advantage 2 buffer 5 μl 
10 mM dNTP 1 μl 
50x Advantage polymerase mix 1 μl 
dH2O 36 μl 
Total volume 50 μl 
Table 19: PCR master mix for 3’RACE of CPEB2. 
 
The PCR was performed using a gene specific primer that binds with in the CPEB2 coding 
region (primer 3R 1.1: 5’- GAC CAG ATG TGT GAC GAG TGC CAG GGT G -3’) and an 
adapter primer (AP1) that was provided in the kit. A touchdown PCR program was used as in 
table 20.  
94oC 30 sec 
94oC 5 sec 
72oC 4 sec 
94oC 5 sec 
70oC 4 sec 
94oC 5 sec 
68oC 4 sec 
Table 20: Touchdown PCR program used for 3’RACE of CPEB2. 
 
The PCR product was run on a 1.2% agarose gel. In parallel, a nested PCR was set up 
according to manufacturer’s recommendations using a nested adapter primer (AP2) and 
5x 
 
 
 5x 
 
 
 25x 
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primer 3R1.2 (5’- GCC AAC TGG CCT CGG TCT AGG AAG GAA GGA AA -3’). The 
above PCR product was diluted 1:10 with TE buffer and 5 μl was used as template for the 
nested PCR. The PCR program used is shown in table 21.  
94oC 30 sec 
94oC 5 sec 
72oC 4 sec 
94oC 5 sec 
70oC 4 sec 
94oC 5 sec 
68oC 4 sec 
Table 21: Nested PCR program used for 3’ RACE of CPEB2. 
 
This nested PCR product was run on a 1.2% agarose gel, the band was excised and the DNA 
was purified using Peqlab gel extraction kit (Peqlab,) according to manufacturer’s 
instructions. It was further cloned into the PCR-XL-TOPO vector (Invitrogen). TOP10 
competent E. coli were transformed with this plasmid and plated onto Luria Bertani (LB) 
plates with 50 μg/ml kanamycin (Carl Roth) as per the manufacturer’s recommendations. 
DNA was isolated from the clones (minipreps) and digested with EcoRI (New England 
Biolabs) since there are EcoRI restriction sites in the TOPO vector flanking the cloned 
product. The concentration of the minipreps was checked and the harvested plasmid DNA 
was sent for sequencing (Qiagen) with primers M13f-20 and M13r-24 which bind within the 
TOPO vector (Invitrogen). The sequencing reads were aligned using the Multalin program 
(Corpet, 1988) with the CPEB2 3’UTR reference sequence obtained from the Ensembl 
database (www.ensembl.org).  
 
 
 
 
 
 
 
5x 
 
 
 5x 
 
 
 10x 
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4 Results 
 
4.1 CPEBs in rat and human brain hippocampus 
Among CPEB family members, CPEB1 is well described in different species, whereas other 
CPEBs (CPEB2, 3 and 4) were studied only in mouse (Wilczynska et al., 2005; Theis et al., 
2003; Turimella et al., in revision). Hence the present study was aimed to investigate the 
expression and distribution of splice isoforms across species; particularly in rat and human. 
RT-PCR of rat and human hippocampus cDNA was performed with the corresponding 
species-specific primers used in Theis et al (2003) and Turimella et al., (in revision) for 
mouse CPEBs. The present study identified that CPEB2, 3 and 4 are expressed in rat and 
human hippocampus (Figures 12 A, B; Turimella et al., unpublished). Multiple splice 
isoforms were observed for each CPEB (Figure 12C). The isoforms were named according to 
the nomenclature used for mouse CPEBs. Among rat and human, the ‘a’ isoform was found to 
be the major isoform, similar to mouse CPEBs (except for rat CPEB3, which expressed the 
‘c’ isoform instead). All of them were found to contain the B-region which harbors a putative 
phosphorylation site for different kinases; in addition, ‘d’ isoform was also observed which 
lacks the B-region. This is in contrast to mouse CPEBs, where only B-region containing 
isoforms were observed in brain.  
 
 
Figure 12: Expression of CPEB2, 3 and 4 in rat (A) and human (B) brain hippocampus respectively. C) Multiple 
splice isoforms observed for each CPEB in the order of their distribution. M: marker, r: rat, h: human, and bp: 
base pairs.   
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4.2 CPEBs in PHCs 
The expression of CPEBs (1-4) in PHCs was studied with immunofluorescence. The cultures 
were stained with both CPEB antibodies and MAP2 antibodies. The expression pattern 
appeared to be heterogeneous among CPEBs. The immunoreactivity (IR) for CPEB2 and 
CPEB3 was high (Figures 13 B, C), whereas the IR was weak for CPEB1 and CPEB4 
(Figures 13 A, D). For CPEB2 and CPEB3, a typical punctate distribution was observed 
which was often dendritically localized, it is similar to the pattern of expression already 
described for CPEB3 (Huang et al., 2006). The nuclear exclusion was confirming its 
cytoplasmic localization as the name indicates.  
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Figures 13: Expression of CPEBs (1-4) in PHCs. The cultures were stained with CPEB antibodies (CPEB 
1/2/3/4) as well as with MAP2 antibodies.  A) CPEB1, B) CPEB2, C) CPEB3 and D) CPEB4. DAPI was used as 
counter stain. The IR was higher for CPEB2 and 3 when compared to CPEB1 and 4.  Scale bar: 25 µm.  
 
4.3 Single-cell RT-PCR: Expression of CPEBs in neurons and glia 
The expression of all four CPEBs (1-4) in different cells was studied in order to determine 
expression at the transcript level. Single-cell RT-PCR was done from the cytoplasm of 
harvested cells (neurons, astrocytes, NG2 glia and microglia) after whole cell patch clamp 
recording. The cell type specificity was confirmed using the following cell type specific 
markers in the PCR master mix: Synaptophysin for neurons, S100β for astrocytes, NG2 for 
NG2 glia and Iba-I for microglia. The expression pattern of CPEBs (1-4) was more frequent 
in neurons compared to glial cells. CPEB4 was the most abundant (> 50% incidence) among 
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all CPEBs (Figure 14A) whereas CPEB3 had the lowest abundance consistent with published 
results (Theis et al., 2003). The expression of CPEBs in astrocytes was rather infrequent 
(Figure 14B). Within glial populations, the expression of CPEBs was more frequent in NG2 
glia (Figure 14C) compared to astrocytes. The heterogeneous expression of the CPEBs might 
be related to the various roles played by each CPEB in different cell types. The data for 
CPEB1 expression in NG2 glia (Figure 14C) and microglia (Figure 14D) was not included as 
the number of cells analyzed was insufficient.  
 
 
Figure 14: Single-cell RT-PCR. A summary of cell type specific expression of different CPEBs (1-4) in neurons 
(A), astrocytes (B), NG2 glia (C) and microglia (D). The data of CPEB1 expression in NG2 glia and microglia 
was excluded due to insufficient numbers of analyzed cells.  
 
 
As an example, the expression of CPEB2 is shown across different cell types analyzed 
(Figure 15 A-D). Gel pictures showing the expression of other CPEBs (CPEB1, 3 and 4) can 
be found in appendix (A 9.2.1 - 9.2.3).  
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Figure 15: Representative gel pictures showing expression of CPEB2 in neurons (A), astrocytes (B), NG2 glia 
(C) and microglia (D). Numbers (1, 2, 3 etc.,) indicate the individual cells, ‘+’ is a positive control (total RNA 
from mouse brain) and ‘-’ is a negative control (dH2O). The double bands represent multiple splice isoforms of 
each CPEB (see table 22), M: marker.  
 
Individual PCR products were separated on 1.5% agarose gels, bands excised and the DNA 
was purified. These products were later cloned into PCR-XL-TOPO vector, and the minipreps 
were sequenced with both M13f-20 and M13r-24 primers. The resulting sequencing reads 
were aligned with the respective CPEB reference sequence using multalin program (Corpet, 
1988). Different isoforms were observed for each CPEB. A summary of the different isoforms 
observed for each CPEB in different cell types can be found in table 22.  
 
CPEB Incidence of expression Isoforms observed 
Neurons 
 
CPEB1 
 
6 of 22 
5x – sm 
1x - lg 
 
 
 
CPEB2 
 
 
 
10 0f 22 
4x – a 
1x – c > a 
1x – c* > c 
1x – a* 
1x - c > a > c* 
1x – c 
1x - f 
 
CPEB3 
 
3 of 18 
1x - a 
           1x – a > b 
1x – c 
 
 
 
CPEB4 
 
 
 
13 of 18 
7x – d 
2x – a 
1x – d > a > c 
1x – b > a 
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1x – a, b 
1x – a > c 
 
Astrocytes 
CPEB1 1 of 17 1x - n 
 
CPEB2 
 
4 of 21 
2x - a 
1x – d > c 
1x – a = c 
 
CPEB3 
 
3 of 19 
1x – a 
1x – d > c 
1x – a = c = d 
 
CPEB4 
 
2 of 20 
1x – a 
1x – d 
 
NG2 glia 
 
CPEB2 
 
5 of 13 
2x – a 
1x – c 
1x – c* > c 
1x - d 
 
CPEB3 
 
5 of 14 
4x – a 
1x – d 
 
CPEB4 
 
3 of 10 
2x – d 
1x – d > b 
 
Microglia 
 
CPEB2 
 
3 of 10 
2x – c 
1x - d 
CPEB3 1 of 15 1x – a 
CPEB4 2 of 10 2x - d 
Table 22: Summary of different isoforms observed for each CPEB in different cells analyzed (neurons, 
astrocytes, NG2 glia and microglia). The data of CPEB1 in both NG2 glia and microglia was excluded as the ‘n’ 
was insufficient. Multiple splice isoforms were observed for CPEB2, 3 and 4. This heterogeneity was more 
frequent for CPEB2 and CPEB4 in neurons.  
 
In neurons, the ‘sm’ isoform was the most abundant isoform for CPEB1. For CPEB2, the ‘a’ 
isoform was the most abundant isoform, similar to CPEB3 and CPEB4 in mouse brain (Theis 
et al., 2003). Although the majority of isoforms observed contain the B-region encoding a 
putative phosphorylation site for different kinases, CPEB4 is an exception with the ‘d’ 
isoform lacking the B-region as the major isoform in neurons. For CPEB 2-4, multiple 
isoforms were found within single neurons which might be due to different activity states of 
the corresponding neurons at the time of isolation. This heterogeneity could also be found in 
other cell types. The expression of CPEBs was rather infrequent in astrocytes compared to 
NG2 glia. Various isoforms were observed for CPEBs in glial cells. Until now, only the B-
region containing isoforms were reported for CPEB2 in the principal cell layers of the 
hippocampus (Theis et al., 2003) whereas the B-region lacking isoforms were described in 
germ cells (Kurihara et al., 2003). But, in the present study, the ‘d’ isoform was observed in 
all the glial types analyzed (Table 22).  
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4.4 In-fusion cloning of CPEB2/CPEB2∆Zn into pMM403-400 
Transgenic mice which overexpress either CPEB2 or CPEB2∆Zn particularly in CA1 
pyramidal neurons of hippocampus were generated. The Tet-OFF system (Gossen and Bujard, 
1992) was used to generate this set of mice. Either CPEB2-EGFP or CPEB2∆Zn-EGFP was 
cloned individually into the pMM403-400 vector which has tetO and a SV40 poly(A).  
 
4.4.1 Cloning  
The pMM403-400 vector was linearized with EcoRV (Figure 16A). The digested product was 
run on a 1% agarose gel, the corresponding band excised and the DNA was purified. Both 
CPEB2-EGFP and CPEB2∆Zn-EGFP were PCR amplified, run on a 1% agarose gel and the 
DNA was purified from gel (Figure 16B). Ligation of either CPEB2-EGFP or CPEB2∆Zn-
EGFP into pMM403-400 vector was done using in-fusion technology (Clontech) and Fusion 
Blue competent cells (Clontech) were transformed with the resulting plasmids. The positive 
colonies were selected by ampicillin resistance.  
 
 
Figure 16: In-fusion cloning of CPEB2/CPEB2∆Zn into pMM403-400. A) Digestion of pMM403-400 vector 
with EcoRV. The digested product was run on a 1% agarose gel along with a DNA ladder. B) PCR products of 
CPEB2-EGFP and CPEB2∆Zn-EGFP. Kb: kilobases.  
 
4.4.2 Verification of clones 
Single colonies were selected from the ampicillin plates and DNA was isolated using a 
miniprep kit (Qiagen). The clones were named as CPEB2-pMM and CPEB2∆Zn-pMM. The 
clones were verified both by restriction digestion (Figures 17 A, B) as well as by sequencing. 
Restriction digestion of minipreps was performed using NotI, which gave the following 
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bands. They were also sequenced and aligned with the template sequence using multalin 
program (Corpet, 1988).  
 
CPEB2-pMM:  
4.3 kb band - 2.4 kb CPEB2-EGFP + 1.9 kb tetO + SV40 poly (A)  
3.4 kb band -  pMM403-400 (Figure 17A) 
CPEB2∆Zn-pMM:  
4.1 kb band  -  2.2 kb CPEB2∆Zn-EGFP + 1.9 kb tetO + SV40 poly (A) 
3.4 kb band  -  pMM403-400 (Figure 17B) 
 
 
Figure 17: Restriction digestion of CPEB2-pMM and CPEB2∆Zn-pMM minipreps with NotI. A) CPEB2-pMM 
minis (lanes 1, 2, 4, 6 and 7) gave the expected bands of 4.3 kb and 3.4 kb in size. B) CPEB2∆Zn-pMM minis 
(lanes 1 and 2) gave the expected bands of 4.1 kb and 3.4 kb in size.  
 
4.5 Generation of CPEB2/CPEB2∆Zn transgenic mice 
One clone each for CPEB2 and CPEB2∆Zn cloning was selected and maxipreps (Qiagen) 
were done to obtain endotoxin free pure DNA. The DNA was digested and purified from the 
gel as described in methods part 3.2.5. The purified constructs (either CPEB2 or CPEB2∆Zn) 
were injected into the male pronucleus of zygotes for generating transgenic mice. The 
schematics of different constructs used for generating transgenic mice can be found in figure 
18. 
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Figure 18: Constructs of CPEB2/CPEB2∆Zn-pMM for generating transgenic mice. A) The schematic used for 
generating CPEB2 transgenic mice. B) The schematic used for generating CPEB2∆Zn transgenic mice. The tTA 
binds to tetO sequences thereby driving the transgene expression specifically in pyramidal neurons of mouse 
hippocampus. The CamKIIα promoter was used to drive neuronal specific expression.  
 
Genotyping of the newborn pups was done with two sets of tetO primers for tetO-
CPEB2/CPEB2∆Zn transgene. The founder mice which were positive for tetO-CPEB2 / tetO-
CPEB2∆Zn expression were bred with CamKII-tTA mice to achieve transgene expression 
specifically in pyramidal neurons of mouse hippocampus. The tTA binds to tetO thereby 
driving the transgene (either CPEB2 or CPEB2∆Zn) expression specifically in neurons.  
 
4.6 Screening of newborn mice for the presence of the transgene  
The newborn mice were tested for the presence of transgene: either CPEB2/CPEB2∆Zn. 
Genotyping was done with two different PCRs – tetO and tTA. The PCR products were run 
on a 1% agarose gel, and the positive samples were identified. The DT animals which were 
positive for both tetO-CPEB2/CPEB2∆Zn and CamKII-tTA were chosen for further analysis 
(Figure 19).  
 
 
Figure 19: Genotyping of new born mice: tTA and tetO PCRs. PC – positive control, NC – negative control. 
Numbers 1, 2, 3 and 4 indicate individual mice tested, arrows represent the DT animals which are positive for 
both tetO and tTA PCRs, bp: base pairs.  
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4.7 Screening of lines for transgene expression 
4.7.1 Screening different lines for CPEB2 transgene expression 
The DT animals from different lines were screened for the neuronal expression of CPEB2 
transgene by GFP staining. Among the five different lines screened, three lines (lines 27, 94 
and 11) were positive for CPEB2 transgene expression (Table 23). Mice from lines 94 and 11 
showed expression. Mice from line 27 showed moderate expression in hippocampus and 
cortex; some neurons expressed high amounts of CPEB2-EGFP whereas most neurons were 
weakly expressing (Figure 20), and hence were classified as moderate expressers.  
 
Line 
 
Name of  
mice 
Sex Genotype Age of mice Total no. of 
mice tested 
Comments 
63 149 F tTA+tetO+ 5 weeks 1 No expression 
104 140 F tTA+tetO+ 5 weeks 2 No expression 
141 M tTA+tetO+ 5 weeks 
58 127 F tTA+tetO+ 5 weeks 1 No expression 
27 187 F tTA+tetO+ 5 weeks 2 Moderate 
expression 191 M tTA+tetO+ 5 weeks 
94 206 M tTA+tetO+ 5 weeks 3  
Expression 210 F tTA+tetO+ 9 weeks 
215 M tTA+tetO+ 9 weeks 
11 294 F tTA+tetO+ 5 weeks 3  
Expression 295 F tTA+tetO+ 5 weeks 
311 F tTA+tetO+ 7 weeks 
Table 23: Analysis of tetO-CPEB2-EGFP mice lines. 
 
4.7.2 Screening different lines for CPEB2∆Zn transgene expression 
Two different lines (6 mice in total; lines 35 and 6) were screened for CPEB2∆Zn-GFP 
expression, out of which line 6 showed expression (Table 24).  
Line 
 
Name of 
mice 
Sex Genotype Age of mice Total no. of 
mice tested 
Comments 
35 105 M tTA+tetO+ 5 weeks 3 No expression 
111 M tTA+tetO+ 4 weeks 
128 F tTA+tetO+ 6 weeks 
6 246 F tTA+tetO+ 8 weeks 3 No expression 
251 M tTA+tetO+ 8 weeks Moderate 
expression 256 M tTA+tetO+ 8 weeks 
Table 24: Analysis of tetO- CPEB2∆Zn-EGFP mice lines. 
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4.8 Analysis of transgenic mice 
4.8.1 Immunofluorescence of CPEB2-EGFP    
The expression of CPEB2 transgene was confirmed with GFP fluorescence. To select the best 
age group for functional studies, CPEB2 expression was analyzed at three different ages of 
mouse development: 7, 13 and 20 weeks. After birth, CPEB2 expression can be seen in all the 
groups (Figure 20 A-L) analyzed, but mice aged 13 weeks were chosen for further 
experiments. The CaMKII promoter driven expression of CPEB2 transgene was found in the 
DG (Figures 20 A-F) and in cortex (Figures 20 G-L). The sections were also counterstained 
with Hoechst for nuclei.  
  
 
Figure 20: Expression pattern of CPEB2-EGFP in mouse hippocampus. Immunofluorescence of CPEB2-EGFP 
at three different age groups analyzed (7, 13 and 20 weeks) across brain regions: DG (Fig A-F) and cortex (G-L). 
Scale bar: 25 µm.   
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The expression of CPEB2 can be seen in the CA1 region where CPEB2 is often dendritically 
localized (Figure 21 A-C). Similar dendritic localization has been described for other CPEB 
family members such as CPEB3 in neurons (Huang et al., 2006).  
 
 
Figure 21: Expression pattern of CPEB2-EGFP in mouse hippocampus. Immunofluorescence of CPEB2-EGFP 
at three different age groups analyzed (7, 13 and 20 weeks) in CA1 region. Scale bar: 25 µm.   
 
As all CPEB family members are expressed endogenously in brain (Wu et al., 1998; Theis et 
al., 2003), double immunostainings were performed with both CPEB2 antibodies (to detect 
endogenous CPEB2) and GFP antibodies (to detect overexpressed CPEB2). Both the 
endogenous and overexpressed CPEB2 are found to be colocalized (Figures 22 A, B).  
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Figure 22: Analysis of CPEB2 transgene expression. A) Expression of endogenous CPEB2 in CA1 pyramidal 
neurons of mouse hippocampus of control animals. B) Double labelling with GFP and CPEB2 shows 
colocalization of the endogenous and overexpressed CPEB2 in CA1 pyramidal neurons of DT animals. Scale 
bar: 25 µm.    
 
To analyze the extent of neuronal overexpression, double stainings with the neuronal marker, 
NeuN and GFP were performed. Using Image J software (http://rsbweb.nih.gov/ij/), the 
number of GFP positive cells that are co-localizing with NeuN were quantified. It was found 
that 38% of neurons showed overexpression of the transgene and were GFP positive (Figure 
23). A total of 85% GFP positive cells were found to colocalize with the neuronal marker, 
NeuN.  
 
 
Figure 23: Histogram showing the extent of CPEB2 transgene expression. Approximately 38% of neurons 
overexpress CPEB2 transgene and 85% GFP positive neurons colocalize with NeuN. Error bars represent 
standard error of mean, n = 4 animals.    
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As CPEB2 was often dendritically localized (Figure 21), double stainings were performed 
with MAP2, a marker for dendrites. Double labelling with MAP2 and GFP revealed dendritic 
localization of CPEB2 where it might regulate the translation of different target mRNAs 
(Figures 24 A, B).  
 
 
Figure 24: Double labelling with GFP and MAP2, which labels dendritic processes. A) Control, B) DT animals. 
Scale bar: 25 µm.    
 
4.8.2 Immunofluorescence of CPEB2∆Zn-EGFP 
The CPEB2∆Zn transgene expression was confirmed with GFP immunofluorescence (Figure 
25). The expression of CPEB2∆Zn was observed in DG (Figures 25A, D), CA1 region of 
hippocampus (Figures 25B, E) as well as in cortex (Figures 25C, F). It also showed dendritic 
localization in CA1 pyramidal neurons similar to CPEB2 full length overexpression (Figure 
21).  
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Figure 25: Immunofluorescence of CPEB2∆Zn-EGFP in mouse hippocampus. Expression of CPEB2∆Zn-EGFP 
can be seen in DG (A, D), CA1 region (B, E) and cortex (C, F). Control sections were also stained in parallel (G, 
H and I). Scale bar: 25 µm. A-C were stained with GFP, D-L were stained with GFP and Hoechst.   
 
4.9 Analysis of protein levels of putative targets in CPEB2/CPEB2∆Zn mice  
A number of mRNAs were proposed as putative CPEB targets (Du and Richter, 2005). Some 
of the CPEB targets with potential CPEB binding sites and polyadenylation sequences in their 
3’UTRs can be found below in table 25. The protein levels of all the targets mentioned in the 
following table were analyzed in tetO-CPEB2-EGFP mice in comparison with their control 
littermates. 
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Target mRNA No. of CPEs in its 
3’UTR 
CPEs Poly(A) 
β-catenin 
(Kundel et al., 2009) 
3 UUUUUAAU 
UUUUAU 
UUUUAAUU 
AUUAAA 
EphA4 
(Winter et al., 2008) 
2 UUUUAU 
UUUUAU 
UUUUAU 
AAUAAA 
GluR1  
(Bioinformatics analysis) 
3 UUUUAAU 
UUUUAU 
UUUUAU 
AUUAAA 
GluR2 
(Bioinformatics analysis) 
 
14 UUUUAU 
UUUUAAAU 
UUUUAU 
UUUUAU 
UUUUAAU 
UUUUUAU 
UUUUUUUUUUAAU 
UUUUAU 
UUUUUAAAU 
UUUUUAU 
UUUUUUAAUUU 
UUUUUAU 
UUUUAAU 
UUUUAAAU 
AUUAAA 
ABP/GRIP2 
(Du and Richter, 2005) 
1 UUUUUUUUAAAU AAUAAA 
GRIP1 
(Bioinformatics analysis) 
2 UUUUAU 
UUUUAAAU 
AAUAAA 
Table 25: CPEB2 targets analyzed in the present study with potential CPEB binding sites and polyadenylation 
sequences in their 3’UTRs.  
 
4.9.1 CPEB2 represses the basal translation of β-catenin in neurons 
4.9.1.1 β-catenin downregulation in situ  
A putative target of CPEB2 is β-catenin, which has binding sites for CPEBs in its 3’UTR 
(Figure 5) and is regulated by CPEB1 (Kundel et al., 2009) in neurons. Since all four CPEBs 
(1-4) share strong similarity in their RNA binding domains (Theis et al., 2003), CPEB2 might 
be also regulating β-catenin translation. To check this possibility, the expression of β-catenin 
in CPEB2 mice was analyzed. In those neurons which overexpress CPEB2-EGFP, no signal 
(or very weak signal) for β-catenin was observed and vice versa (Figure 26). This negative 
correlation of β-catenin with CPEB2 was observed at the single cell level in situ. From these 
immunohistochemistry results, it could be speculated that CPEB2 might negatively regulate 
β-catenin translation.  
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Figure 26: β-catenin downregulation in situ in CPEB2 overexpressing mice. Coronal sections of CPEB2 mice 
were stained with β-catenin and EGFP antibodies. Neurons with CPEB2-EGFP overexpression (labelled in 
green) showed no signal (or very weak signal) for β-catenin (labelled in red) and vice versa. As an example, 
some of the neurons are marked with arrows in both channels to show the downregulation. Scale bar: 25 µm.   
 
4.9.1.2 Decreased β-catenin protein levels in CPEB2 overexpressing mice 
Since a negative correlation was observed between β-catenin and CPEB2 immunoreactivity in 
situ (Figure 26), immunoblotting of protein lysates was done to study the impact of CPEB2 on 
β-catenin translation. The immunohistochemistry data confirmed the genotypes of different 
mice (whether it was a control or a DT mouse). Immunoblotting of hippocampal protein 
lysates from both DT animals and their control littermates was performed and the intensity of 
the bands from both the genotypes was quantified using gene tools software (Syngene). The 
protein values of control animals were set to 100%. With immunoblotting, it was found that 
β-catenin protein levels were significantly decreased by 50% in CPEB2 overexpressing mice 
(Figures 27 A, B) compared to their control littermates (**p < 0.01, student’s t-test). Hence, 
from the immunohistochemistry and immunoblotting data, it can be concluded that 
overexpression of CPEB2 in pyramidal neurons repressed the basal translation of β-catenin in 
neurons.  
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Figure 27: Western blot analysis of β-catenin protein levels in CPEB2 mice. A) Histogram showing decreased 
protein levels in DT animals compared to their control littermates (**p < 0.01, student’s t-test). B) 
Representative Western blot image. n=3 animals/genotype. Error bars represent standard deviation. kDa: kilo 
Dalton.  
 
4.9.1.3 CPEB2- β-catenin co-immunoprecipitation 
As both immunohistochemistry (Figure 26) and immunoblotting (Figure 27) results confirmed 
that CPEB2 represses the basal translation of β-catenin, the physical interaction of CPEB2 
with β-catenin was investigated in vitro. HeLa cells were transiently transfected with CPEB2-
FLAG or FLAG-GFP (a non-CPE containing control) and the CPEB2 protein that was 
interacting with endogenous β-catenin mRNA was co-immunoprecipitated using FLAG 
antibodies. It was found that CPEB2 specifically interacts with β-catenin mRNA (Figures 28 
A, B) and this interaction was specific as shown by comparing the retention of β-catenin 
mRNA over PBGD mRNA which is a non specific control (Figure 28B). In another 
experiment, the cells were transfected with either CPEB2-EGFP or CPEB2∆Zn-EGFP and the 
bound β-catenin mRNA was co-immunoprecipitated using CPEB2 serum (custom made, 
designated as #94). The binding was significantly reduced when the cells were transfected 
with CPEB2∆Zn-EGFP which could not bind to β-catenin as it lacks the zinc finger essential 
for binding (Figures 28A). Real time PCR of transcripts from both the transfections was done 
and the results were normalized to the levels of PBGD, a housekeeping gene, which was used 
to test the specificity of binding.  
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Figure 28: CPEB2- β-catenin co-immunoprecipitation. A) Co-immunoprecipitation of endogenous β-catenin 
mRNA in HeLa cells transfected with different CPEB2 constructs. The binding was significantly reduced when 
transfected with CPEB2∆Zn construct (*p < 0.05, student’s t-test). B) The binding is mRNA specific as shown 
by comparing with the binding of CPEB2 to β-catenin and PBGD mRNAs. FLAG-GFP was used as an 
unspecific control. Experiments were done in triplicates. Error bars represent standard deviation. 
 
4.9.2 CPEB2 represses the basal translation of GluR2 in neurons 
GluR2 is an important subunit of the AMPA receptor complex, whose presence makes the 
AMPA receptors Ca
2+
 impermeable (Liu and Zukin, 2007). The translation of GluR2 is 
regulated by two members of the CPEB family, CPEB3 and CPEB4 (Huang et al., 2006). To 
find out if CPEB2 behaves similar to other CPEBs in translational regulation, GluR2 protein 
levels were analyzed in CPEB2 overexpressing mice. Western blotting of hippocampal 
protein lysates from both DT animals and their control littermates was performed and the 
intensity of the bands from both genotypes was quantified using gene tools software 
(Syngene). The protein values of control animals were set to 100%. GluR2 protein levels were 
significantly decreased by 66% (*p < 0.05, student’s t-test) in DT mice compared to their 
control littermates (n=3 animals/genotype) (Figures 29 A, B).  
 
Doctoral thesis – Sada Turimella                                                                                  Results  
 78 
 
Figure 29: Western blot analysis of GluR2 protein levels in CPEB2 mice. A) Histogram showing decreased 
GluR2 protein levels in DT animals compared to their control littermates (*p < 0.05, student’s t-test). B) 
Representative Western blot image. n=3 animals/genotype. Error bars represent standard deviation. 
 
4.9.3 GluR1 protein levels were unaltered in CPEB2 overexpressing mice 
CPEB2 was found to repress the basal translation of GluR2 in neurons. To find out if CPEB2 
also regulates other CPE containing AMPA receptor subunits, protein levels of other AMPA 
receptor subunits were analyzed. Since GluR1 is the predominant subunit expressed in the 
CNS along with GluR2 (Sans et al., 2003) and also contains CPEs in its 3’UTR (Figure 30A), 
the protein levels of GluR1 were analyzed in DT animals compared to their control 
littermates. No difference in GluR1 protein levels was observed between the genotypes (p = 
0.94, student’s t-test; Figures 30 B, C).  
 
Figure 30: Western blot analysis of GluR1 protein levels in CPEB2 overexpressing mice. A) The 3’ UTR of 
GluR1 with CPEs and poly(A) marked. The numbers indicate the distance in bases between the two elements.  
B) Histogram showing no significant difference in GluR1 protein levels between the genotypes. C) 
Representative Western blot image. n=3 animals/genotype. Error bars represent standard deviation. 
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4.9.4 The protein levels of GluR2 interacting proteins were not altered in CPEB2 
overexpressing mice 
The C-terminus of GluR2 interacts with several PDZ domain-containing proteins (Braithwaite 
et al., 2000) and this interaction facilitates the accumulation of functional AMPA receptors at 
synapses (Srivastava et al., 1998). Among these proteins, ABP/GRIP2 and GRIP1 were 
analyzed in the present study since both of them contain CPEs in their 3’UTRs (Figure 6). In 
addition, ABP has been confirmed as a CPEB3 target in neurons (Theis et al., 2011, in 
revision). Since GluR2 protein levels were decreased in CPEB2 overexpressing mice (Figure 
29), it was hypothesized that CPEB2 might interact with the GluR2 interacting partners as 
well, thereby interfering with AMPA receptor clustering. To find out, immunoblotting was 
performed and the protein levels were measured.  
 
The protein levels of ABP/GRIP2 were not altered in CPEB2 overexpressing mice (p = 0.94, 
student’s t-test; Figures 31 A, B). This could be due to the fact that CPEB mediated 
translational regulation may vary based on the stoichiometry of CPEs (Pique et al., 2008), and 
according to this study, at least a cluster of two or more CPEs is required for translational 
repression to occur. Since ABP contains a single CPE in its 3’UTR, it might have not been 
repressed by CPEB2. 
 
 
Figure 31: Western blot analysis of ABP/GRIP2 levels in CPEB2 mice. A) Histogram showing no significant 
difference in ABP/GRIP2 protein levels between the genotypes. B) Representative western blot image. n=3 
animals/genotype. Error bars represent standard deviation. 
 
GRIP1 is a PDZ domain-containing protein which interacts with the C-terminus of GluR2 
(Dong et al., 1997) and is a splice isoform of ABP/GRIP2 (Wyszynski et al., 1999). WB was 
performed from both DT animals and their control littermates and the blots were quantified as 
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above. The protein levels of GRIP1 were not altered in CPEB2 overexpressing mice 
compared to their control littermates (p = 0.90, student’s t-test; Figures 32 A, B). This might 
be due to the fact that even though there are three CPEs in the 3’UTR of GRIP1, the distance 
between two CPEs might be too far from each other (160 nucleotides) for repression to occur. 
It is known that cyclin B variants which have more distance between the two CPEs were 
weakly repressed compared to the other variants (Pique et al., 2008). Hence, it could be 
speculated that no repression observed in case of GRIP1 might be because of the larger 
distance present between two CPEs.   
 
 
Figure 32: Western blot analysis of GRIP1 protein levels in CPEB2 mice. A) Histogram showing no significant 
difference in GRIP1 protein levels between the genotypes. B) Representative western blot image. n=3 
animals/genotype. Error bars represent standard deviation. 
 
4.9.5 CPEB2 represses basal translation of EphA4 (a new CPEB target) in neurons 
4.9.5.1 Decreased EphA4 protein levels in CPEB2 overexpressing mice 
The current findings indicate that CPEB2 regulates the translation of two known CPEB 
targets expressed in neurons (β-catenin and GluR2). In addition to these, several mRNAs 
were proposed as putative CPEB targets, as they contain CPEs in their 3’UTRs (Du and 
Richter, 2005). In search of new targets for CPEB2 mediated translational regulation, EphA4 
receptor was selected since it contains two CPEs in its 3’UTR (Figure 8; Winter et al., 2008) 
and was reported to control glial glutamate transport via ephrin-A3 ligand (Filosa et al., 
2009). To find out if CPEB2 regulates EphA4 translation, hippocampal protein levels of 
EphA4 were measured in DT animals in comparison with their control littermates. With 
immunoblotting, it was found that EphA4 protein levels were decreased by 30% in DT mice 
compared to their control littermates (Figures 33 A, B) (*p < 0.05, student’s t-test). Hence, 
EphA4 can be proposed as a new CPEB2 target from the current findings.  
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Figure 33: Western blot analysis of EphA4 protein levels in CPEB2 overexpressing mice. A) Histogram 
showing decreased protein levels in DT animals compared to their control littermates (*p < 0.05, student’s t-
test). B) Representative Western blot image. n=3 animals/genotype. Error bars represent standard deviation. 
 
As neuronal EphA4 has been shown to participate in neuron-to-glia communication by 
modulating glial glutamate transport (Filosa et al., 2009), it could be speculated that by 
regulating the translation of EphA4, CPEB2 might also participate in neuron-glia 
communication. In addition, EphA4 knockout mice have elevated glutamate transporter levels 
(Filosa et al., 2009). To find out if CPEB2 regulates glial glutamate transport via EphA4, the 
protein levels of glial glutamate transporter (GLT-1) were further analyzed in CPEB2 
overexpressing mice. No significant changes in GLT-1 protein levels between DT animals 
and their control littermates were observed (not shown). This could be due to the fact that 
EphA4 protein levels were reduced only by 30% in CPEB2 mice. As the complete knockout 
of EphA4 caused 100% elevated glutamate transporter protein levels (Filosa et al., 2009), 
only 30% of EphA4 deficit might have an insufficient impact on GLT-1 translation. As glial 
glutamate is transported by two glial transporters (GLT-1 and GLAST), it could be that 
EphA4, by interacting with GLAST, regulates the glutamate transport in glial cells. To verify 
this, the translation of GLAST should be analyzed in CPEB2 overexpressing mice.  
 
4.9.5.2 CPEB2 interacts with EphA4 in vitro 
As immunoblotting results (Figure 33) confirmed that CPEB2 represses the basal translation 
of EphA4, the physical interaction of CPEB2 with EphA4 was investigated in vitro. HeLa 
cells were transiently transfected with CPEB2-FLAG and EphA4 3’UTR-PGL and the 
CPEB2 protein that was bound to EphA4 mRNA was co-immunoprecipitated using FLAG 
antibodies. As a control, FLAG-GFP was used. It was found that CPEB2 specifically interacts 
with EphA4 mRNA (Figure 34) as no interaction was found with FLAG-GFP. Real time PCR 
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of transcripts using luciferase primers was done and the results were normalized to PBGD (a 
housekeeping gene) levels.  
 
 
Figure 34: CPEB2-EphA4 co-immunoprecipitation. Co-immunoprecipitation of EphA4 mRNA in HeLa cells 
transfected with CPEB2-FLAG construct (***p <  1.5 x 10-9, student’s t-test). FLAG-GFP was used as an 
unspecific control. The results were normalized to PBGD. Experiments were done in triplicates. Error bars 
represent standard deviation. 
 
4.9.6 Synaptophysin protein levels were unaltered in CPEB2 overexpressing mice  
Synaptophysin contains no CPEs in its 3’UTR. To validate the results of CPEB2 mediated 
translational regulation in neurons; synaptophysin was used as a non CPE containing control 
(negative control). With immunoblotting, protein levels of synaptophysin were measured in 
CPEB2 overexpressing mice. No changes in the protein levels of synaptophysin (p = 0.66, 
student’s t-test) were observed in DT animals compared to their control littermates (Figures 
35 A, B). This confirms that CPEB2 binds specifically to CPEs in the 3’UTR of mRNAs. 
 
Figure 35: Western blot analysis of synaptophysin protein levels in CPEB2 mice. A) Histogram showing no 
significant difference in the protein levels between genotypes. B) Representative Western blot image. n=3 
animals/genotype. Error bars represent standard deviation. 
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4.9.7 No change in basal protein levels of β-catenin/GluR2/EphA4 in CPEB2∆Zn 
overexpressing mice 
CPEB2 requires the zinc finger to bind to its target mRNA (Hake et al., 1998; Turimella et al., 
in revision). To find out if RNA binding has any impact on translational regulation, transgenic 
mice which overexpress truncated CPEB2 protein that lacks zinc finger (CPEB2∆Zn) in 
pyramidal neurons were generated. In this set of mice, the protein levels of β-catenin, GluR2 
and EphA4 (whose protein levels were decreased in CPEB2 overexpressing mice) were 
analyzed. It was found that overexpression of CPEB2 protein without the zinc finger 
(CPEB2∆Zn), did not lead to changes in the protein levels of the above mentioned targets, β-
catenin (p = 0.96, student’s t-test, Figure 36A), GluR2 (p = 0.59, student’s t-test, Figure 36B) 
and EphA4 (p = 0.68, student’s t-test, Figure 36C). This confirms that the zinc finger is 
essential for CPEB2 in order to bind to target mRNA for regulating its translation.  
 
 
Figure 36: Western blot analysis of β-catenin (A), GluR2 (B) and EphA4 (C) protein levels in CPEB2∆Zn 
overexpressing mice. n=4 animals/genotype. Student’s t-test was done to evaluate the statistical significance. 
Error bars represent standard deviation. 
 
4.10 Estimating the efficiencies for Real Time PCR primers 
From the current findings, it is known that CPEB2 regulates the translation of several targets. 
To confirm that only the protein levels are changed (exclusive translational regulation), but 
not the transcript levels, real time PCR was done. The efficiencies of taqman primers used in 
the present study were estimated using the standard CT slope method (Liu and Saint, 2002). 
The CT values were plotted versus the concentration of cDNA samples. The slopes (R
2
 values) 
for a 10-fold dilution series of the cDNA sample were calculated.  The efficiencies of the 
amplification were calculated from the slope of the graph obtained for each primer set. The 
following equation was used for estimating the efficiency:  
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E = 10
(-1/slope)
 - 1 
 
The efficiencies for EphA4, GluR2 and GAPDH taqman primers were found to be 1.99, 1.86 
and 1.86 respectively (Table 26). The efficiencies of both β-catenin and PBGD primers were 
estimated as 2 (done in the institute before). The standard curves can be found in figures 37 
A-C.  
 
Taqman primers Efficiency (E) Slope (R
2
) 
EphA4 1.99 0.99 
GluR2 1.86 0.99 
GAPDH 1.86 0.99 
Table 26: The efficiencies (E) and slope values (R2) of the taqman primers analyzed.  
 
 
Figure 37: Standard curves for estimating the efficiencies for the following taqman primers: GluR2 (A), EphA4 
(B) and GAPDH primers (C).   
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4.11 Analyzing the transcript levels of putative targets by real time PCR 
To confirm the fact that CPEB2 regulates translation but not transcription, the transcript levels 
of β-catenin, GluR2 and EphA4 were analyzed in CPEB2 overexpressing mice compared to 
their control littermates. Real time PCR of the above targets revealed no change in either β-
catenin or GluR2 or EphA4 transcript levels in DT animals compared to their control 
littermates (Figure 38 A-D). This suggests the exclusive translational regulation by CPEB2 in 
neurons. The results were confirmed using two reference genes, β-actin and GAPDH to which 
the results were normalized. There was a slight decrease observed for transcript levels in DT 
animals though it was not significant. This could be due to the fact that CPEB2 might be 
interfering with RNA stability as CPEB3 does (Hosoda et al., 2011). 
Figure 38: Transcript levels of the putative targets in CPEB2 overexpressing mice. Real Time PCR of β-catenin 
and GluR2 using GAPDH (A) and β-actin (B) as reference genes. Real Time PCR of EphA4 using β-actin (C) 
and GAPDH as reference genes (D). The results were normalized to the reference genes used. Experiments were 
done in triplicates. Student’s t-test was done to evaluate the statistical significance. Error bars represent standard 
deviation. 
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4.12 Interaction of CPEBs with other target mRNAs 
4.12.1 CPEB2 interacts with the CamKIIα 3’UTR 
The 3’UTR of CamKIIα contains CPEs and thus could be a potential CPEB target. In deed, 
CPEB1 regulates the translation of CamKIIα (Wu et al., 1998). To find out whether CPEB2 
regulates CamKIIα translation, RNA co-immunoprecipitation was performed from HeLa cell 
lysates transfected with FLAG tagged CPEB1 or 2 constructs together with the CamKIIα 
3’UTR-PGL construct. Both CPEBs (CPEB1 and 2) interacted with CamKIIα 3’UTR, but 
CPEB1 had significantly higher affinity compared to CPEB2 (Figure 39A; Turimella et al., in 
revision). The interaction of different CPEB1 isoforms (CPEB1, Δ5, Δ17) with CamKIIα 
3’UTR was also analyzed in the present study. It was found that CPEB1 Δ5 had significantly 
higher affinity for CamKIIα 3’UTR compared to CPEB1 full length and CPEB1 Δ17 isoforms 
(Figure 39B; Turimella et al., in revision).  
 
 
Figure 39: A) Co-immunoprecipitation of CPEB1 and CPEB2 interacting with rat CamKIIα 3’UTR. A) CPEB1 
binds to CamKII 3’UTR with significantly higher affinity compared to CPEB2 (**p < 0.05, student’s t-test). B) 
Among CPEB1 isoforms, CPEB1 Δ5 binds significantly with higher affinity compared to the CPEB1 full length 
isoform, CPEB1 (***p < 0.001) and CPEB1 Δ17 (***p < 10-9). CPEB1 Δ17 has negligible binding when 
compared to CPEB1 (***p < 10-9). Error bars represent standard error of the mean.  
 
4.12.2 CPEB2 interacts with Cx36 3’UTR 
The 3’UTR of Cx36 contains CPEs (Figure 40A) and thus could be a CPEB target. By dual 
luciferase reporter assay, it was found that CPEB2 enhances the translation of Cx36. The 
translation of Cx36 was impaired when HeLa cells were treated with siRNA against CPEB2, 
indicating that siRNA knockdown of endogenous CPEB2 impaired the translation process. In 
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addition, when HeLa cells were transfected with CPEB2-EGFP, the translational efficiency of 
Cx36 was enhanced by 1.5 fold (Figure 40B), which could be brought back below the control 
levels upon siRNA knockdown. Altogether, the present study indicates that CPEB2 enhances 
the translation of Cx36.  
 
 
Figure 40: Cx36 luciferase reporter assay. CPEB2 interacts with the Cx36 3’UTR. A) The 3’UTR of Cx36 with 
CPEs and poly(A) marked. The numbers indicate the distance in bases between the two elements. B) CPEB2 
enhances the translation of Cx36, which can be decreased by siRNA against CPEB2. FLAG-EGFP was used as 
an unspecific control. The translation was also decreased when the endogenous CPEB2 in HeLa cells was 
knocked down. ***p < 1.6 x 10-10, ANOVA single factor. Error bars represent standard deviation; the 
experiments were done in triplicates.  
 
4.13 Rapid Amplification of cDNA ends (3’ RACE) of CPEB2 
It is known that CPEB2 has a major 3’UTR of 3.8 kb in length (Theis et al., 2003), but the 
sequence information was not available. In the present study, the 3’UTR of CPEB2 was 
analyzed for potential CPEB binding sites. Mouse brain cDNA was amplified with a gene 
specific primer that binds within the CPEB2 coding region and an adaptor primer (provided in 
the kit). Since a smear appeared along with the PCR product (result not shown), a nested PCR 
was performed as in methods part 3.2.12 using the above PCR product as a template. A PCR 
product of 3.8 kb was observed which is consistent with the previous findings (Figure 41A; 
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Theis et al., 2003). This nested PCR product was cloned into the PCR-XL-TOPO vector and 
the minipreps were digested with EcoRI. The digestion of minis revealed several RACE 
products: 1217 bp, 1647 bp, 2690 bp and 3778 bp (Figure 41B). The sequence analysis of all 
these different RACE products revealed a number of potential binding sites for CPEBs (as 
many as 26 CPEs) and several polyadenylation sequences (a total of 6). The presence of these 
multiple RACE products with different lengths might be due to alternative splicing of the 
3’UTR. As a number of poly(A) sequences were found along the 3’UTR of CPEB2, it could 
be that the different lengths of UTRs might have generated by utilizing different poly(A) 
sequences. Sequencing of a number of minipreps revealed that the 3.8 kb RACE product is 
more frequently observed compared to the other.   
 
 
Figure 41: A) 3’ RACE of CPEB2. A major PCR product of 3.8 kb was observed along with some minor bands 
at varying lengths. B) Nested PCR followed by cloning and digestion of minipreps with EcoRI revealed several 
RACE products. PCR-XL-TOPO has an EcoRI site, hence after digestion, a 3.5 kb band corresponding to the 
vector (top most band) and bands corresponding to PCR products were observed. Mini #1 gave 2.8 kb + 1 kb 
restriction product (together, a 3.8 kb RACE product), mini #2 gave 1 kb + 647 bp restriction products (together, 
a 1647 bp RACE product), mini #3 gave 1.6 kb and 1 kb restriction product (together a 2690 bp RACE product). 
All together, these results indicate multiple RACE products with variable lengths:  (#1  – 3778 bp, #2 – 1647 bp, 
#3 – 2690 bp).  kb – kilobases.  
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5 Discussion 
 
5.1 Cell type specific expression of CPEBs: Single-cell RT-PCR 
The expression pattern of all CPEBs (1-4) in neurons and glia was analyzed in the present 
study. Single-cell RT-PCR following electrophysiological characterization of different neural 
cell types (neurons, astrocytes, NG2 glia and microglia) was performed. CPEBs were more 
frequently expressed in neurons (Figure 14A) compared to glial cell types. In neurons, the 
‘sm’ isoform (with a small deletion of 5 amino acids in RRM1) was most frequently observed 
for CPEB1 (Table 22). For CPEB2, the ‘a’ isoform was the most abundant. All CPEB2 
isoforms observed in the present study contained the B-region which harbors a putative 
phosphorylation site for a number of kinases including PKA, CaMKIIα and p70S6 kinase. 
Earlier studies (Theis et al., 2003) pointed out that only those isoforms with the B-region are 
expressed in the principle cell layers of the hippocampus. But in the present study, isoforms 
lacking the B-region were also observed. For example, in case of CPEB3, although majority 
of the isoforms contained the B-region, one of the neurons contained ‘b’ isoform that lacks 
the B-region. In addition, for CPEB4, ‘d’ isoform that lacks the B-region was the major 
isoform observed, in addition to B-region containing isoforms. Multiple splice isoforms were 
observed within the same cell. This was more frequent in case of CPEB2 and CPEB4 (Figure 
14 and Table 22), but can also be seen for CPEB3. This heterogeneity could be related to 
different activity states of the corresponding neurons at the time of isolation.  
 
The expression pattern of CPEBs in glial subtypes was different from that of neurons. Among 
glia, CPEBs expression in astrocytes (Figure 14B) was found to be rather infrequent 
compared to NG2 glia (Figures 14C). For CPEB1, the full length isoform was observed. For 
CPEB2, isoforms lacking the B-region were observed in all the glial subtypes analyzed 
(astrocytes, NG2 glia and microglia). For the CPEB 2-4 subfamily, only isoforms containing 
the B-region are reported in the principal cell layers of the hippocampus (Theis et al., 2003) 
whereas the B-region lacking isoforms were described in non neuronal tissues, i.e. in testis 
(Kurihara et al., 2003). This is the first report showing the presence of B-region lacking 
isoforms (especially for CPEB2) in mouse brain. The presence of CPEBs in astrocytes 
suggests translational regulation of astrocyte-specific mRNAs which have CPEs in their 
3’UTRs. For example, several astrocytic mRNAs including the major gap junction proteins, 
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Connexin43 (Cx43) and Cx30 (Vangoor et al., in revision); glutamate transporters GLT-1 and 
GLAST and glutamine synthetase (GS) (an enzyme that converts astrocytic glutamate to 
glutamine) were found to contain CPEs in their 3’UTRs (Vangoor et al., unpublished). Hence, 
CPEBs in astrocytes might regulate the translation of one or more of these target mRNAs. 
Indeed, the translation of Cx43, Cx30, (Vangoor et al., in revision) GLT-1 and GS (Vangoor 
et al., unpublished) was repressed following overexpression of CPEB3 in astrocytes.  
 
CPEBs were highly expressed in NG2 glia compared to astrocytes (Figure 14 B, C), where 
they could modulate the translation of NG2 glia-specific mRNAs which contain CPEs in their 
3’UTRs. NG2 glia differs from astrocytes not only in pharmacological properties (Matthias et 
al., 2003), but also in receiving synaptic input from both glutamatergic (Bergles et al., 2000) 
and GABAergic neurons (Jabs et al., 2005). Even though several astrocytic mRNAs including 
Cx43 and GLT-1 are expressed in NG2 glia (Matthias et al., 2003; Gerald Seifert, 
unpublished data), the functional properties of these proteins such as gap junctional coupling 
and glutamate transporter functions respectively were not observed (Matthias et al., 2003; 
Wallraff et al., 2004). In addition, the GluR2 subunit of AMPA receptors, which is 
responsible for restricting the Ca
2+
 entry (Liu and Zukin, 2007) is also expressed in NG2 glia 
in addition to neurons. Hence, CPEBs in NG2 glia might control the translation of GluR2, 
Cx43 and GLT-1.  
 
CPEBs were also expressed in microglia (Figure 14D), where they could regulate microglia-
specific mRNAs which contain CPEs in their 3’UTRs. For example, tissue plasminogen 
activator (tPA) is expressed in microglia (Tsirka et al., 1995) and contains CPEs in its 3’UTR 
(Shin et al., 2004).  
 
5.2 CPEB2/CPEB2∆Zn overexpressing mice 
To analyze the role of CPEB2 in neurons, transgenic mice with neuronal overexpression of 
CPEB2 were generated in the present work. Among the transgenic systems, the conditional 
tetracycline system (tet-OFF system) has been widely used due to its advantage of high 
temporal control of the transgene (Gossen and Bujard, 1992). The transgene can either be 
activated, or silenced by the administration of tetracycline or its derivatives such as 
doxycycline (Figure 9; Lewandoski, 2001). In the present study, tet-OFF system (Gossen and 
Bujard, 1992) and neuron-specific CaMKIIα promoter (Mayford et al., 1997) were used to 
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drive CPEB2 expression specifically in pyramidal neurons of mouse hippocampus. The 
CaMKIIα promoter drives the transgene expression specifically in neurons of forebrain and 
has been successfully used in generating transgenic mouse models for studying various 
diseases including Alzheimer’s disease (Jankowsky et al., 2005), Huntington’s disease 
(Yamamoto et al., 2000), Parkinson’s disease (Nuber et al., 2008) and schizophrenia 
(Pletnikov et al., 2008). The CaMKIIα promoter lines were also used to study synaptic 
plasticity, learning and memory (Mayford et al., 1997). 
 
Since CPEB2 is tagged with EGFP protein at its C-terminus, the transgene expression was 
confirmed with GFP fluorescence (Figures 20 and 21). The overexpressed CPEB2 protein 
was colocalized with the endogenous CPEB2 (Figure 22), in addition, it was often found to 
localize in the dendrites (Figures 21, 24), where it could modulate the translation of several 
target mRNAs. This dendritic localization has been described for the other CPEB family 
members, CPEB3 and CPEB4 in neurons (Huang et al., 2006). CPEB2 has an RNA binding 
domain, which is conserved among CPEBs (CPEB1, 3 and 4) (Theis et al., 2003). Zinc finger 
is essential for binding of CPEB1 to the target mRNAs (Hake et al., 1998). To analyze the 
impact of RNA binding on translational regulation, CPEB2 mutant mice lacking the zinc 
finger (tetO-CPEB2∆Zn-EGFP) were generated using a similar strategy (Figure 18). Using 
this set of overexpressing mice (CPEB2 and CPEB2∆Zn), the impact of CPEB2 on the 
translation of different target mRNAs in neurons was investigated, mainly focused on the 
translation of key players involved in synaptic plasticity such as β-catenin, GluR2 and EphA4. 
 
5.3 CPEB2 regulates β-catenin translation in neurons 
β-catenin is an adherens junction (AJ) protein which has multiple roles in cell-cell adhesion, 
Wnt signalling pathway (Clevers, 2006) and in various stages of neuronal development. It has 
also been reported as a putative CPEB1 target both in astrocytes (Jones et al., 2008) and in 
neurons (Kundel et al., 2009). To find out if CPEB2 as well regulates β-catenin translation in 
neurons, both in vitro and in vivo approaches were used. The present work indicates that 
CPEB2 interacts with β-catenin in vitro and this interaction was zinc finger mediated, as a 
CPEB2 mutant without zinc finger showed significantly decreased binding (Figure 28). These 
results further confirmed the necessity of the zinc finger for CPEB2 for RNA binding. In an in 
vivo approach, the protein levels of β-catenin were analyzed in CPEB2 overexpressing mice 
in comparison with their control littermates. Overexpression of CPEB2 in neurons has led to a 
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significant decrease in the basal protein levels of β-catenin by 50% (Figure 27). This negative 
correlation was also observed at the single cell level in situ (Figure 26). As CPEB2 represses 
the basal translation of β-catenin which is important for dendritic morphogenesis (Yu and 
Malenka, 2003), and abnormal dendritic spines were associated with β-catenin dysfunction 
which might contribute to several neurological disorders, CPEB2 might control the 
morphogenesis of the spines via β-catenin. If this is the fact, there might be abnormal 
dendritic spines in CPEB2 overexpressing mice which are yet to be investigated. Together, 
these results suggest that CPEB2 might participate in dendritic morphogenesis or might be 
involved in neurological disorders associated with abnormal dendritic spines, by modulating 
the translation of β-catenin.  
 
5.4 CPEB2 might participate in Ca
2+
 permeability by regulating GluR2 
translation in neurons  
As GluR2 plays a crucial role in synaptic plasticity (Liu and Zukin, 2007), the mechanisms 
that regulate AMPA receptors were of great interest. Recent observations claim a role of 
activity-dependent local protein synthesis in regulating AMPA receptor function (Grooms et 
al., 2006). CPEBs participate in activity-dependent local protein synthesis (Wu et al., 1998). 
In addition, two members of the CPEB family, CPEB3 and CPEB4 regulate the translation of 
GluR2 (Huang et al., 2006). To find out whether CPEB2 regulates translation similar to other 
CPEBs, GluR2 protein levels were analyzed in CPEB2 overexpressing mice. The protein 
levels of GluR2 were significantly decreased by 66% in CPEB2 overexpressing mice 
compared to their control littermates (Figure 29). Similarly, in mice overexpressing CPEB3 in 
neurons, the protein levels of GluR2 were decreased (Kaczmarczyk, PhD thesis). Hence, it 
can be concluded that CPEB2, similar to CPEB3, represses the basal translation of GluR2. 
This result is further supporting the notion that CPEBs are translational repressors under basal 
conditions (Richter, 2007).  
 
Since a major amount of GluR2 was repressed in CPEB2 overexpressing mice, it might lead 
to excess entry of calcium inside the cell which might cause the neurons to become 
hyperexcitable (Brusa et al., 1995; Liu and Zukin, 2007). CPEB2 might also participate in 
LTP by modulating the translation of GluR2. As GluR2 is also expressed in NG2 cells, a glial 
subpopulation which receives glutamatergic input from neurons (Bergles et al., 2000), CPEB2 
might also regulate GluR2 translation in NG2 cells which is yet to be tested. Altogether, it 
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could be speculated that CPEB2 together with other CPEBs might participate in AMPA 
receptor function by modulating the translation of GluR2. 
 
5.5 CPEB2 does not regulate the translation of GluR1, an AMPA receptor 
subunit 
The protein levels of GluR2 were decreased in CPEB2 overexpressing mice. As there are four 
AMPAR subunits which share 70% similarity at the amino acid level (Bettler and Mulle, 
1995), bioinformatical analysis was carried out to find out if CPEB2 has binding sites in the 
3’UTRs of other AMPA receptor subunits. Among the other AMPA receptor subunits, GluR1 
and GluR4 possess CPEs in their 3’UTRs. To find out if CPEB2 regulates the translation of 
GluR1 or GluR4, Western blotting analysis was performed. GluR1 was selected for analysis 
due to the following reasons: i) GluR1 (along with GluR2) is the predominant subunit 
expressed in forebrain (Sans et al., 2003), ii) together with GluR2, it forms the most common 
combination of AMPA receptor subunits in the CNS (Cull-Candy et al., 2006). The protein 
levels of GluR1 were not changed in CPEB2 overexpressing mice compared to their control 
littermates (Figure 30) which means that CPEB2 selectively impairs GluR2 translation. A 
combinatorial code has been proposed for CPEB1 in Xenopus oocytes, according to which at 
least two CPEs are required for repression to occur (Pique et al., 2008). The authors also 
found that when two CPEs were far from each other, the repression was weak. In the present 
study, GluR1 protein levels were unchanged in CPEB2 overexpressing mice; it might be that 
even though there are three CPEs in GluR1 3’UTR, the distance between two CPEs might be 
too large for translational repression to occur according to the combinatorial code proposed. 
 
5.6 The GluR2 interacting partners are unaffected by CPEB2 in neurons 
GluR2 interacts with many PDZ domain-containing proteins similar to NMDA receptors 
which bind to PSD-95 family proteins (Kornau et al., 1995). Among those proteins, 
ABP/GRIP2, GRIP1 and PICK1 were found to be important in AMPA receptor clustering 
(Srivastava et al., 1998). From this list, ABP (GRIP2) and GRIP1 were chosen in the present 
study for further analysis because they contain CPEs in their 3’UTRs (Figure 6) and because 
ABP was shown to be a CPEB target (Theis et al., 2011, in revision). The protein levels of 
both ABP (GRIP2) and GRIP1 were analyzed in CPEB2 overexpressing mice compared to 
their control littermates. With immunoblotting, no change in either of the protein levels was 
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observed (Figures 31, 32). It is widely known that not all the mRNAs containing CPEs in 
their 3’UTRs are repressed (Barkoff et al., 2000) and the translation of a particular mRNA 
might depend on the stoichiometry of the regulatory elements present in the 3’UTR. For 
example, ABP contains a single CPE in its 3’UTR (Figure 6) which might be not enough for 
repression to occur (Pique et al., 2008). In addition, the CPE is overlapping with the 
polyadenylation signal which might render the CPE non-functional according to the 
combinatorial code proposed. GRIP1 protein levels were also found to be unaltered in CPEB2 
overexpressing mice. This could be due to the fact that even though there are more than two 
CPEs present in its 3’UTR (Figure 6), the distance between two CPEs might be too high for 
repression to occur.  
 
5.7 CPEB2 might participate in neuron to glia communication by 
regulating EphA4 protein levels 
EphA4 has two CPEs in its 3’UTR (Figure 8; Winter et al., 2008). To find out if CPEB2 
regulates EphA4 translation in neurons, both in vitro and in vivo approaches were used. In an 
in vitro approach, cells were transfected with CPEB2-FLAG and EphA4 3’UTR construct and 
the CPEB2 protein interacting with EphA4 3’UTR was co-immunoprecipitated using FLAG 
antibodies. It was found that CPEB2 interacts specifically with the EphA4 3’UTR (Figure 
34). In an in vivo approach, the protein levels of EphA4 were analyzed in CPEB2 
overexpressing mice. With the overexpression of CPEB2, EphA4 protein levels were 
significantly decreased (Figure 33). Thus, from the current findings, EphA4 is identified as a 
new CPEB2 target in neurons.  
 
Since EphA4 has been shown to interact with astrocytic ephrin-A3 ligand and modulates the 
glial glutamate transport (Filosa et al., 2009), the impact of neuronal CPEB2 on glutamate 
transporter, GLT-1 was investigated. The protein levels of GLT-1 were measured in CPEB2 
overexpressing mice in comparison with their control littermates, but the protein levels were 
unaltered (result not shown). This might be due to the fact that the EphA4 protein levels were 
decreased by only 30% in CPEB2 overexpressing mice. As the complete knockout of EphA4 
resulted in 100% elevated GLT-1 protein levels (Filosa et al., 2009), only 30% reduction of 
EphA4 might have an insufficient impact on GLT-1.  
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It is also known that either Eph receptors or ephrin ligands can function independent of each 
other (Pasquale, 2005), hence, in CPEB2 overexpressing mice, EphA4 might be functioning 
independent of the astrocytic ephrin-A3 ligand. Unlike the other ephrin receptors, EphA4 can 
interact with both classes of ligands: ephrin-A3 (Carmona et al., 2009; Filosa et al., 2009) and 
with ephrin-B2 and ephrin-B3 (Yamaguchi and Pasquale, 2004), it is possible that in CPEB2 
overexpressing mice, EphA4 might be interacting with other ephrin ligands (other than the 
classical ephrin-A3 ligand) thereby not interfering with glutamate transport.  
 
EphA4 knockout mice showed distorted spine architecture (Carmona et al., 2009). As EphA4 
protein levels were reduced in CPEB2 overexpressing mice, the spine morphology might have 
been altered in CPEB2 overexpressing mice which needs to be further evaluated. In addition, 
theta burst (TBS) induced LTP is impaired in EphA4 null mutants (Filosa et al., 2009). So, it 
can be speculated that CPEB2 overexpressing mice might have deficiencies in TBS-induced 
LTP. The dysfunction of Eph receptors might lead to neurological disorders such as 
schizophrenia (Glantz and Lewis, 2000), autism and mental retardation (Kaufmann and 
Moser, 2000). So, by interfering with the translation of EphA4, CPEB2 might lead to one of 
the disorders which are yet to be investigated.  
 
5.8 CPEB2 regulates each target mRNA differentially 
Although the extent of translational regulation is determined by the phosphorylation status of 
CPEBs (either repression or activation), it is not known how precisely CPEBs regulate 
translation. It is also not clear, which factors in combination with CPEBs contribute to either 
repression or activation of bound mRNA. To better understand the CPEB mediated 
translational regulation, a combinatorial code has been proposed for cyclin B regulation by 
CPEB1 in Xenopus oocytes (Pique et al., 2008). This code explained that the extent of 
translational regulation by CPEB1 can be varied depending on the number and position of 
CPEs along the 3’UTR, the distance between a CPE and the polyadenylation sequence as well 
as on other elements surrounding the CPE.  
 
In the present study, the impact of CPEB2 on the translation of several mRNAs was 
investigated. CPEB2 repressed the basal translation of β-catenin (Figure 27), GluR2 (Figure 
29) and EphA4 (Figure 33); but it has no impact on the translation of GluR1 (Figure 30), 
GRIP1 (Figure 32) and ABP/GRIP2 (Figure 31). These results suggest that even though all 
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target mRNAs that were analyzed in the present study contain CPEs in their 3’UTRs, their 
translation was not affected in the same way. Among those mRNAs whose translation was 
repressed, the number and position of CPEs in their 3’UTRs is different. The 3’UTR of β-
catenin contains three CPEs (Figure 5; Kundel et al., 2009), GluR2 contains several CPEs 
(bioinformatics analysis) and EphA4 contains two CPEs (Figure 8; Winter et al., 2008). The 
smallest distance between two CPEs is 70 nucleotides in EphA4, 71 nucleotides in GluR2 and 
73 nucleotides in β-catenin. The translation of all these mRNAs was differentially repressed 
in CPEB2 overexpressing mice compared to their control littermates.  
 
It was found that those mRNAs which have a single CPE in their 3’UTRs such as ABP, no 
basal repression of their protein levels was observed (Figure 31). ABP has a single CPE 
which is overlapping with poly(A) (Figure 6) and this might be making the CPE non-
functional for repression according to the combinatorial code proposed. Even though GRIP1 
and GluR1 contain two and three CPEs in their 3’UTRs respectively (Figures 6 and 30), their 
translation was not affected by CPEB2; it could be that the distance between two CPEs (160 
nucleotides for GRIP1 and 434 nucleotides for GluR1) might be too big for repression to 
occur. With the increasing distance between two CPEs, the extent of repression is also getting 
weakened (Table 27). As CPEBs regulate specifically the translation process, the RNA levels 
should remain unaltered. To confirm the fact that CPEBs interfere only with translation, 
quantitative real time PCR was performed to analyze the transcript levels of the 
aforementioned target mRNAs whose protein levels were decreased in CPEB2 overexpressing 
mice. None of the transcript levels were changed between CPEB2 overexpressing mice and 
their control littermates (Figure 38).  
 
In addition, the translation of β-catenin, GluR2 and EphA4 (whose translation was repressed 
in CPEB2 overexpressing mice) was not affected in CPEB2∆Zn overexpressing mice (Figure 
36). This is because of the lack of the zinc finger essential for RNA binding in CPEB2∆Zn 
overexpressing mice. From these results, it can be concluded that CPEB2 differentially 
regulates each target mRNA and its regulation is dependent on the zinc finger. A summary of 
translational regulation of various targets obtained using CPEB2/CPEB2∆Zn overexpressing 
mice can be found below in table 27.  
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Target No. of 
CPEs 
Shortest distance between 
two CPEs (nucleotides) 
Protein levels of respective targets with 
respect to their control littermates 
In CPEB2 mice In CPEB2∆Zn mice 
EphA4 2 70 Decreased by 28% No change 
GluR2 14 71 Decreased by 66% No change 
β-catenin 3 73 Decreased by 49% No change 
ABP/GRIP2 1 Overlapping with poly (A) No change ---- 
GRIP1 2 160 No change ---- 
GluR1 3 434 No change ---- 
Table 27: A summary of translational regulation of various targets using the set of CPEB2/CPEB2∆Zn 
overexpressing mice. Only in those mRNAs with two or more than two CPEs (GluR2, β-catenin, EphA4) with 
an optimal distance of ~70 nucleotides, the protein levels were repressed by CPEB2. Even if there are two or 
more than two CPEs (GRIP1 and GluR1), no repression was observed. The protein levels of GluR2, β-catenin, 
EphA4 were not changed in CPEB2∆Zn overexpressing mice indicating the importance of the zinc finger for 
RNA binding.  
 
5.9 The presence of the zinc finger is essential for CPEB2 mediated 
translational regulation 
The zinc finger, which is part of the RNA binding domain, is important for CPEBs in order to 
bind to target mRNAs, (Hake et al., 1998; Hagele et al., 2009). To investigate if the zinc 
finger is essential for CPEB2 binding, co-immunoprecipitation experiments were done in 
HeLa cells. HeLa cells were transfected either with full length or mutant CPEB2 fused to 
EGFP (CPEB2 or CPEB2∆Zn-EGFP) and the bound β-catenin mRNA was co-
immunoprecipitated using CPEB2 serum. The binding of full length CPEB2 to β-catenin was 
significantly higher than mutant CPEB2 lacking the zinc finger where only residual binding 
was observed (Figure 28). This residual binding observed might be due to the interaction of 
CPEB2 with deadenylating enzymes such as pumilio, an RNA binding protein. Pumilio has 
been reported to interact with CPEB1 in Xenopus oocytes (Nakahata et al., 2001).  
 
To confirm the above findings and to study the impact of RNA binding on translational 
regulation, experiments were done using CPEB2∆Zn overexpressing mice. Since the basal 
protein levels of all CPEB targets analyzed (β-catenin, GluR2 and EphA4) were decreased in 
CPEB2 overexpressing mice, the same proteins were analyzed in CPEB2∆Zn overexpressing 
mice. None of those were changed in these mice (Figure 36). Notably, CPEB2 and 
CPEB2∆Zn showed comparable expression of the transgenic proteins (Figures 21, 25). Since 
the zinc finger, which is essential for RNA binding, is not present in these mice, CPEB2 could 
not bind to any mRNA, hence no translational repression of the mRNAs was observed. Hence 
it can be concluded that the presence of the zinc finger is essential for CPEB2 for RNA 
binding.  
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5.10 CPEB2 might be a putative target for other CPEBs 
The 3’UTR of CPEB2 was amplified from mouse brain cDNA and sequenced. In addition to 
the 3.8 kb long 3’UTR described for CPEB2 (Theis et al., 2003), the present work identified 
several PCR products with variable lengths (1217 bp, 1647 bp, 2690 bp and 3778 bp) (Figure 
41). The sequencing of these PCR products revealed several CPEs as well as polyadenylation 
sequences. It is known that more than one 3’UTR is present for some of the mRNAs. For 
example, the AMPA receptor subunit GluR2 contains two transcripts (4 kb and 6 kb in size) 
which differ in their 3’UTRs (Kohler et al., 1994). Hence, it is possible that CPEB2, similar to 
GluR2, may have two different UTRs of variable lengths. They might have been generated by 
utilizing different polyadenylation sequences. But, it is not known which of the CPEs are 
functional and which polyadenylation element is being used. By cloning different lengths of 
UTRs and analyzing their functionality in vitro, one could find out which CPEs and poly (A)s 
are functional.  
 
Transgenic mice with neuronal overexpression of dominant negative (DN) CPEB1 were 
generated (Theis et al., in revision). DN CPEB1 lacks the phosphorylation site in the 
regulatory domain and can’t get activated by phosphorylation. DN-CPEB competes with the 
classical CPEBs (1-4) and occupies all the CPEs in the 3’UTR of target mRNAs. Hence, 
neither the translation of bound targets nor the activation of CPEBs by phosphorylation is 
allowed in these mice. CPEB3 contains CPEs in its 3’UTR and can be a putative target for 
other CPEBs. In DN-CPEB mice, the translation of both ABP (a CPEB target) and CPEB3 
has been impaired (Theis et al., in revision) which indicates that CPEB3 is a target for other 
CPEBs. In the current study, CPEB2 was found to contain several CPEs, hence, it can be 
speculated that CPEB2 can be a putative target for other CPEBs. On the other hand, CPEB2 
can also bind to other CPE containing CPEBs (CPEB1, 3 and 4) and regulates their 
translation. 
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6 Future directions 
The present work revealed that CPEB2 represses the basal translation of β-catenin, GluR2 and 
EphA4 in neurons. In addition to these, many other mRNAs which contain CPEs in their 
3’UTRs were proposed as putative CPEB targets (Du and Richter, 2005). Hence, the impact 
of CPEB2 on the translation of other target mRNAs in neurons should be analyzed; this will 
give insight into the role played by CPEB2 in neurons.  
 
As CPEBs participate in the polyadenylation induced translation, neurons from hippocampal 
slices of CPEB2 overexpressing mice can be stimulated with glutamate which might induce 
phosphorylation of CPEB2. This in turn might result in the activation of translation of the 
bound mRNAs which can be analyzed by measuring their protein levels in comparison with 
control littermates. In an independent experiment, kainic acid (a glutamate receptor agonist) 
should be injected intracortically into mice which might also phosphorylate CPEB2 and 
enhance the translation of target mRNAs. CPEB1, 3 and 4 were shown to be present in the 
post synaptic density (PSD) (Huang et al., 2006). But, the subcellular localization of CPEB2 
has not yet been investigated. Hence, synaptosomal fractions can be prepared to address this 
issue. These fractions should be stimulated with glutamate and the activity-induced protein 
synthesis of target mRNAs by CPEB2 should be studied similar to studies on CPEB1 (Shin et 
al., 2004).  
 
Since decreased protein levels of GluR2 were observed in CPEB2 overexpressing mice, 
AMPA receptors might become calcium permeable which might eventually lead to glutamate 
excitotoxicity. To test this, electrophysiological experiments should be performed to analyze 
calcium permeability in these mice. Mice deficient in GluR2 were reported to have enhanced 
LTP (Jia et al., 1996). To find out if CPEB2 has a role in LTP via regulating GluR2 
translation, LTP should be induced by stimulating CA1 pyramidal neurons in acute 
hippocampal slices from CPEB2 overexpressing mice (theta burst stimulations). For this 
experiment, CPEB2 mutant mice (CPEB2∆Zn) can be used as internal controls since they 
can’t regulate translation due to their inability to bind to target mRNAs. In addition, CPEB2 
overexpressing mice should be brought into the epilepsy model by performing intracortical 
kainate injections (Bedner et al., unpublished) and various parameters such as status 
epilepticus (SE), spontaneous seizures as well as morphological changes should be analyzed. 
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This will give a clue if the GluR2 deficiency (observed in CPEB2 overexpressing mice) might 
cause excess entry of calcium into the cell and thereby making neurons hyperexcitable. 
  
EphA4 in neurons regulate glial glutamate transport via interaction with astrocytic ephrin-A3 
ligand and participates in neuron to glia communication (Carmona et al., 2009; Filosa et al., 
2009). Since EphA4 protein levels were decreased in CPEB2 overexpressing mice, without 
altering GLT-1 protein levels, the translation of other glial transporters (such as GLAST) 
should be analyzed in these mice. 
 
Since the translation of β-catenin, GluR2 and EphA4 was repressed in CPEB2 overexpressing 
mice which might be linked to neurological disorders, the role of CPEB2 in these disorders 
should be analyzed thoroughly.  
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7 Summary 
Among four members of the CPEB family, much less information is available for CPEB2. 
Although the expression of CPEB2 has been reported in mouse brain (Theis et al., 2003; 
Hagele et al., 2009; Turimella et al., in revision), the functional role of CPEB2 was not 
reported before. Hence, the present study was aimed to elucidate the functional role of CPEB2 
in neurons of mouse hippocampus.  
 
In the first part of my work, I have analyzed the expression pattern of all CPEBs (1-4) in 
different cells (neurons, astrocytes, NG2 glia and microglia) of the mouse brain by single-cell 
RT-PCR. The incidence of CPEBs expression was higher in neurons compared to the glial 
subtypes analyzed. Even though CPEBs were described before in mouse brain, no information 
is available about which isoforms are present in each cell type and across species. The present 
study gives detailed information of the isoform distribution across cell types and in different 
species.  
 
In the second part of my work, I have studied the functional role of CPEB2 in mouse 
hippocampus. For that purpose, I have generated a set of CPEB2/CPEB2∆Zn transgenic mice 
using tet-OFF system (Lewandoski, 2001). These mice overexpressed either full length or 
mutant CPEB2 (which lacks the zinc finger essential for RNA binding) in pyramidal neurons 
of mouse hippocampus. Using immunofluorescence, I have confirmed the transgene 
expression in pyramidal neurons as well as in dendritic processes where CPEB2 could 
modulate local protein synthesis. By using this set of overexpressing mice, I have investigated 
the impact of CPEB2 on the translation of several mRNAs in neurons. CPEB2 was found to 
repress the basal translation of neuronal mRNAs such as β-catenin, GluR2 and EphA4. By 
regulating the translation of β-catenin, CPEB2 might regulate dendritic morphogenesis (Yu 
and Malenka, 2003) and participate in the Wnt signalling cascade (Clevers, 2006). As GluR2 
dysfunction is associated with neurodegeneration and epilepsy, CPEB2, by regulating the 
translation of GluR2, might lead to pathological conditions. CPEB2 also repressed the 
translation of EphA4, a key player which modulates the glial glutamate transport via 
interacting with the astrocytic ephrin-A3 ligand (Carmona et al., 2009) and participates in 
neuron to glia communication. The knockout of EphA4 leads to enhanced glutamate transport 
(increased GLT-1 and GLAST protein levels) (Filosa et al., 2009), but GLT-1 protein levels 
were not altered in CPEB2 overexpressing mice. EphA4 protein levels were decreased only 
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by 30% in CPEB2 overexpressing mice. Since a complete knockout of EphA4 lead to 
enhanced glutamate transport, it could be that only 30% decrease in EphA4 protein levels 
might have an insufficient impact on GLT-1. But, it was found that with the astrocytic 
overexpression of another CPEB family member, CPEB3, the protein levels of GLT-1 were 
decreased (Vangoor et al., unpublished). Since the transcript levels of all the target mRNAs 
analyzed in the present study were not changed, it can be concluded that CPEB2 regulation 
happens at the level of translation.  
 
I have also investigated the impact of RNA binding on the translation of CPEB target mRNAs 
in vitro as well as using CPEB2ΔZn overexpressing mice. By RNA co-immunoprecipitation, I 
have found that CPEB2 requires the zinc finger for RNA binding since only residual binding 
was observed with a mutant CPEB2 which lacks the zinc finger. In addition, I have analyzed 
the protein levels of β-catenin, GluR2 and EphA4 in CPEB2ΔZn overexpressing mice 
compared to their control littermates. Immunoblot analysis indicated that none of the protein 
levels were changed, indicating the importance of RNA binding for translational regulation. 
Since the zinc finger essential for RNA binding is not present in CPEB2ΔZn overexpressing 
mice, no translational regulation was observed.  
 
In the last part of my work, I have studied the interaction of CPEB2 with other target mRNAs. 
More than one CPEB can regulate same target mRNA, which means CPEBs have an overlap 
in the binding specificity of target mRNAs. In the present study, I have investigated the 
interaction of CPEB2 with CamKIIα (a CPEB1 target) and Cx36 using RNA co-
immunoprecipitation or luciferase reporter assays. I found that CPEB2 specifically interacted 
with CamKIIα, but with less affinity compared to CPEB1. CPEB2 also interacted with Cx36, 
which could be prevented by knocking down the endogenous as well as overexpressed 
CPEB2 in HeLa cells.   
 
Taken together, by regulating the translation of several key players in neurons, CPEB2 might 
participate in synaptic plasticity, learning and memory as well as in neuron to glia 
communication. From the results obtained in the present study, the following scheme can be 
proposed for the possible role of CPEB2 in neurons (Figure 42). 
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Figure 42: Scheme representing the possible role of CPEB2. By repressing the translation of several target 
mRNAs (β-catenin, GluR2 and EphA4), CPEB2 might impair various processes such as dendritic spine 
morphogenesis, neuron to glia communication as well as synaptic plasticity. By repressing the translation of 
GluR2, it might cause disturbances in synaptic plasticity and make neurons hyperexcitable, thereby leading to 
epilepsy and neurodegeneration.   
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9 Appendix  
 
A 9.1 Preparation of TOP10 chemically competent E. coli 
Glycerol stocks were made from commercial TOP10 competent E. coli (Invitrogen). Equal 
volume of E. coli and sterile glycerol (for example, 50 μl TOP10 E. coli + 50 μl of sterile 
glycerol) were mixed and stored at -80
o
C. From this stock, a loop full of E. coli was 
inoculated in 2.5 ml of LB broth with additives (20 mM MgSO4 and 10 mM KCl). For 
preparing 100 ml of LB broth with additives, 10 ml of 20 mM MgSO4 and 10 ml of 10 mM 
KCl were added to 80 ml of LB broth. The bacteria were grown at 37
o
C overnight with 250 
rpm shaking. From this overnight culture, 200 μl was taken and added to 5 ml of LB with 
additives and incubated at 37
o
C for 1 h 30 min. During this time, 100 ml of LB with additives 
was prewarmed in a sterile flask at 37
o
C for further use. After the incubation time, the OD 
was checked at 600 nm. The bacteria were grown until the OD was in the range of 0.7 – 0.8. 
When it reached the above range, the culture (5 ml) was poured into the 100 ml of prewarmed 
medium and grown for another 2 h and the OD checked. When the OD600nm was ≥ 0.5, the 
growth was stopped by placing the flask on ice for 5 min. After 5 min, the culture was 
aliquoted into two 50 ml falcon tubes and centrifuged at 3,500 rpm for 5 min. The supernatant 
was discarded and each pellet was resuspended in 10 ml of TFBI buffer (30 mM K
+
 acetate, 
50 mM MnCl2, 100 mM RbCl, 10 mM CaCl2, 15% glycerol in dH2O. The solution was sterile 
filtered and stored at 4
o
C), incubated on ice for 10 min and then centrifuged at 3,500 rpm for 
5 min. The supernatant was discarded and the pellets were resuspended each in 2 ml of TFBII 
buffer (10 mM morpholino propanesulfonic acid (MOPS) Na
+
 salt, 75 mM CaCl2, 10 mM 
RbCl, 15% glycerol in dH2O. The solution was sterile filtered and stored at 4
o
C). These 
competent E. coli were aliquoted (50 μl each) in sterile 1.5 ml eppendorf tubes and were 
immediately placed in liquid nitrogen for few minutes and then stored at -80
o
C.  
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A 9.2 Single-cell RT-PCR 
 
A 9.2.1 Expression of CPEB1 in neurons 
 
 
 
  
 
A 9.2.2 Expression of CPEB3 in neurons (A), astrocytes (B), NG2 glia (C) and microglia 
(D). 
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A 9.2.3 Expression of CPEB4 in neurons (A), astrocytes (B), NG2 glia (C) and microglia 
(D). 
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